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ABSTRACT 
Bone defects are a prevalent problem in orthopedics and dentistry. Calcium 
phosphate-based coatings and nanocomposites offer unique solutions towards producing 
scaffolds with suitable physical, mechanical and biological properties for bone 
regeneration. 
We developed a novel method to synthesize hydroxyapatite (HA) particles with 
high aspect ratio using sol-gel chemistry and hydrothermal treatment. We obtained 
tunable pure-phase carbonated-HA in the form of micro/nanorods and nanowires 
(diameters 25-800 nm). To mimic the structure of bone, HA nanowires were 
homogenously mixed within poly(ε-caprolactone) (PCL) to produce nanocomposites 
with improved mechanical properties as determined by uniaxial tensile testing. 
Surface chemistry and topography of biomaterials play prominent roles in 
regulating cell adhesion and differentiation. Bone-like apatite coatings, produced by 
incubating materials in a simulated body fluid (SBF), improve the osteoconductivity of 
scaffold materials. However, few studies have controlled the surface topography of 
biomimetic HA. We assessed the effect of SBF ion concentration and soaking time on 
the surface properties of apatite coatings. Calcium phosphates such as carbonated-HA 
with similar chemical composition and stiffness were deposited onto PCL films. 
Characterization of these coatings revealed an increase in topographical complexity and 
surface roughness with increasing ion concentration of SBF and soaking time.  
To investigate their potential application in bone regeneration, we studied the 
influence of topography of biomimetic HA coatings on the behavior of osteoblasts and 
osteoclasts in vitro. Osteoblast attachment and differentiation were significantly greater 
  iv 
when cultured on rougher HA surfaces (Ra ~2 µm) than on smoother topographies (Ra 
~1 µm). In contrast, activity of tartrate-resistant acid phosphatase (an osteoclast marker) 
was greater on smoother than on rougher HA surfaces. Furthermore, osteoclastic 
resorption lacunae were found exclusively on smoother HA coatings. Inhibition of 
resorption on rougher HA surfaces was associated with disruption of filamentous actin 
sealing zones. In conclusion, HA coatings can be prepared with different topographies, 
which regulate responses of osteoblasts and osteoclasts.  
Thus, it may be possible to design HA-polymer composites and HA-coated 
polymers with physical, mechanical and biological properties suitable for tissue 
engineering. By modulating topography, rates of bone formation and biodegradation 
could be tailored for specific applications in orthopedics and dentistry. 
 
KEYWORDS: bone regeneration; tissue engineering; hydroxyapatite; polycaprolactone; 
calcium phosphate; coatings; nanowires; nanorods; composite; biomaterial; osteoblast; 
osteoclast; surface topography; roughness; 
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1Sections 1.1, 1.2.1, 1.2.2, 1.3.1, 1.3.2, 1.3.3.1 have been reproduced with permission 
from: Allo, B. A., Costa, D. O., Dixon, S. J., Mequanint, K., and Rizkalla, A. S. (2012). 
Bioactive and Biodegradable Nanocomposites and Hybrid Biomaterials for Bone 
Regeneration. Journal of Functional Biomaterials, 3(2), 432-463. 
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1.1 Bone Tissue Regeneration 
Bone defects, ranging from small voids to large segmental defects are a prevalent 
and persistent problem in clinical orthopedics and dentistry. Bone defects and voids arise 
from a variety of causes including fracture nonunion [1, 2], dental and orthopedic 
implant fixation [2], trauma or tumour resection [1, 3, 4], periodontitis [5, 6], and 
musculoskeletal disorders such as rheumatoid arthritis [7]. In these and other clinical 
circumstances, bone repair and regeneration can be accelerated using natural and 
synthetic bone grafts, which are desired to ensure rapid restoration of skeletal function. 
Furthermore, intervention is necessary to repair nonunions or critical size defects, which 
are intraosseous wounds of a size that do not heal by regeneration, or in which some 
pathologic process exists that prevents regeneration. In these cases, bone-graft materials 
are often required to provide an osteogenic response promoting the formation of new 
bone [1]. 
 
1.2 Regenerative Medicine 
1.2.1 Autografts and Allografts 
Current standard procedures for bone defect repair include autografts and 
allografts [8, 9]. These are tissues harvested from one individual and implanted into the 
same or a different individual, respectively. Autografts such as those derived from 
aspirated bone marrow, cancellous or cortical bone, or vascularized grafts are osteogenic, 
osteoconductive and osteoinductive and are considered the gold standard [10, 11]. 
However, autografts are associated with high operating costs for harvesting the graft, 
limited availability, donor site morbidity and complications including infection, pain, and 
3 
 
 
hematoma [8, 9, 12-14]. On the other hand, allografts are subject to cleaning and 
preparation processes designed to remove cells to minimize immune response. These 
processing techniques potentially reduce the osteoinductivity, osteoconductivity and 
mechanical strength of the graft [8, 10]. To overcome these limitations, significant effort 
has been devoted to the development of biomaterials as bone-graft substitutes that can 
augment or regenerate bone [8]. 
 
1.2.2 Scaffold-based Tissue Engineering 
Treatments based on the interdisciplinary field of tissue engineering may be 
useful for inducing the regeneration of bone.  Regeneration as compared to repair is a 
relatively slow process, one which mimics many of the steps which normally occur 
during embryonic tissue development [15]. Tissue engineered regeneration is designed to 
inhibit the initial host rapid repair response, which typically results in scar tissue 
formation and can be a site for future failure [15].  
Tissue-engineered regeneration of bone requires: (1) an osteogenic signal; (2) 
host cells that will respond to the signal; (3) a three-dimensional (3D) scaffold, designed 
to support the growth of responsive host cells and permit the formation of extracellular 
matrix (ECM); and (4) a vascularized host bed [8]. The scaffold serves as a space filling 
construct providing cell anchorage sites, structural cues, bioactive agents, and/or growth 
factors or stem cells, as well as inhibiting the formation of fibrous or bridging tissue (a 
consequence of the rapid repair sequence), while providing space for newly synthesized 
tissue and integration with surrounding host tissue [15, 16]. Ideally, the scaffold material 
provides mechanical stability to the individual cells, but also to the surrounding tissue 
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prior to the synthesis of functioning new tissue [16]. Therefore, it is advantageous to 
match the mechanical properties of the scaffold material to those of the target tissue in 
order to withstand in vivo stress and loading [12, 17]. 
Bone tissue engineering can be defined as the use of a scaffold to induce bone 
formation from the surrounding tissue in vivo, or to act as a delivery template for 
implanted bone cells and/or tissue, which have been grown and expanded in vitro [8]. A 
number of different strategies exist for the tissue engineering of bone. Hutmacher [12] 
describes one common strategy, which is subdivided in to six phases: (1) fabrication of a 
bioresorbable scaffold; (2) seeding of osteoblasts into the scaffold in static culture; (3) 
growth of immature tissue in a dynamic environment (spinner flask); (4) growth of 
mature tissue in a physiologic environment (bioreactor); (5) surgical transplantation; and 
(6) tissue-engineered transplant assimilation/remodeling. However, a range of different 
tissue engineering concepts, varying from acellular scaffolds to cellular scaffold 
constructs, which are implanted with little or no in vitro culturing, have been studied in 
various situations including large animal models and clinical applications. In these 
studies, the animal or human body served as the bioreactor [8, 18, 19]. 
In order to promote bone healing, a scaffold construct must provide osteogenic, 
osteoconductive and/or osteoinductive activity to the specific defect site [10]. In the case 
of noncritical size defects, which heal naturally, tissue engineering principles can be used 
to accelerate bone regeneration by providing a construct to support attachment of 
osteoblasts and synthesis extracellular matrix (ECM) to bridge the defect. For nonunions 
and defects of critical size, often the osteogenic response is insufficient to promote 
complete healing. As such, the scaffold must provide an enhanced response by including 
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a sufficient number of osteoblast precursors and/or ideal concentrations of osteoinductive 
growth factors [9]. 
 
1.3 Bone Physiology 
1.3.1 Structure and Composition 
The skeletal system is highly dynamic and serves several important functions 
including: 1) protection of vital organs, 2) support of posture, musculature and teeth, 3) 
facilitation of movement, and 4) reservoir for bone marrow, and calcium, phosphate and 
magnesium ions. Functional demands present throughout life dictate the regulation of 
bone structure and mass via a remodeling process, in which old or damaged bone is 
replaced by new bone. The remodeling process, including bone repair and regeneration, 
is facilitated by an intricate balance between the function of different bone cell types: 
osteoblasts (bone-forming cells), osteocytes (terminally differentiated osteoblasts found 
within the bone matrix), and osteoclasts (bone-resorbing cells). 
At the macroscopic level, bone can be subdivided into two distinct types: cortical 
(dense, compact) and trabecular (spongy, cancellous), which are easily distinguishable by 
the difference in macro-porosity [20]. Mature cortical bone (Fig. 1.1) consists of multiple 
dense and compact layers of mineralized ECM and bone cells, known as lamellae [21, 
22]. The lamellae are organized in concentric layers surrounding a Haversian canal 
(blood vessel), and form a structure known as an osteon. Cortical bone is comprised of 
several densely packed osteons in parallel arrays. Trabecular bone is characterized by a 
honeycomb-like network with a large degree of macro-porosity and low bone density, 
wherein lamellae form individual trabeculae [20, 21]. Trabecular bone is interspersed in 
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the bone marrow compartment, whereas cortical bone surrounds the marrow of long 
bones and comprises the exterior of bones [21].  
At the cellular level, bone is comprised of a highly organized and mineralized, 
inorganic-organic composite matrix. The organic component consists primarily of the 
major ECM protein collagen type I, and other non-collagenous proteins including 
osteocalcin (OCN) bone sialoprotein, osteopontin, osteonectin, as well as proteoglycans, 
and accounts for 20-40% of the wet weight of bone [21, 23]. The collagen I matrix is 
characterized by a unique fibril structure, which initially presents as non-oriented in 
woven bone, found during the development and healing of the skeleton [21]. As bone is 
remodeled, the collagen fiber network becomes highly organized and oriented as parallel 
layers, and woven bone is eventually replaced by lamellar bone. The mineralized 
collagen fibril structure, in combination with the highly organized manner in which bone 
is arranged, gives rise to bone’s unique toughness and tensile strength [20, 23].  
The inorganic component of bone consists predominately of a calcium-deficient  
and carbonated-HA (with respect to stoichiometric HA) mineral, which comprises 
approximately 60% of compact bone’s wet weight [21]. The carbonated-HA nucleates 
and grows along the collagen fibers and forms as nano plate-like crystals, producing an 
inorganic-organic nanocomposite [20]. The HA mineralization of osteoid, the organic 
phase of bone matrix, contributes to bone mechanics and its high mechanical strengths in 
shear, compression and tension. 
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Figure 1.1 The hierarchical levels of cortical bone. (A) A longitudinal section of long 
bone; (B) Enlargement of a cross-sectional slice of cortical bone. Most of the volume 
of mature cortical bone consists of cylindrical osteons. Photomicrograph shows a thin-
section of cortical bone with numerous osteons; (C) Enlargement of one osteon, 
consisting of a central vascular cavity with concentric lamellae. The black elliptical 
spots are osteocyte lacunae. Photomicrograph shows a single osteon; (D) One 
collagen fiber, created by the bundling of hundreds of fibrils, forms the structural 
framework of bone. Evenly spaced, dark bands represent periodic gaps (i.e., “holes” 
seen in F) that occur between the ends of collagen fibrils laid down in overlapping 
arrays; (E) The smallest unit of the organic component in bone is the triple-helix 
collagen molecule. Five collagen molecules are bundled side by side in a staggered 
array, forming a microfibril; (F) Microfibrils, in turn, are bundled into fibrils. Note 
that apatite crystallites (not to scale) form in voids. Each microfibril is ~300 nm long 
and ~4 nm thick; (G) An individual platelet of apatite. Reprinted from Reference 
[113] with permission (Appendix A). 
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1.3.2 Bone Remodeling   
Bone is a highly dynamic tissue, constantly remodeling in response to mechanical 
stimuli, structural fatigue and damage. During bone remodeling, old bone is replaced by 
new bone, by sequential actions of the different bone cell types. The coordination of 
bone cells, particularly osteoblasts and osteoclasts, form a transient structure called a 
basic multicellular unit (BMU) [24]. Bone cells of the osteoblast lineage differentiate 
from mesenchymal stem cells and are characterized by their ability to synthesize organic 
matrix proteins, producing osteoid [21, 25]. Osteoblasts subsequently mineralize the 
osteoid by formation of HA. During matrix synthesis and mineralization, some mature 
osteoblasts become surrounded and entrapped in osteoid and terminally differentiate into 
osteocytes [21]. Osteocytes are thought to be responsible for mechanotransduction and 
cell communication [25]. Osteoclasts are large, multinucleated cells, which are derived 
from the fusion of monocytes and macrophages, and when active, are capable of 
resorbing bone by secreting protons and hydrolytic enzymes [21]. Active osteoclasts 
form a tight seal with the bone surface and release protons producing an acidic 
microenvironment, which dissolves HA, and proteases, which degrade the organic 
components of the bone ECM. 
Bone remodeling is highly orchestrated and dictated by the sequential activity of 
the BMU. Remodeling is characterized by four distinct phases: activation, resorption, 
reversal and formation [21]. The activation phase marks the onset of remodeling, 
wherein osteoclast precursors are recruited to the bone site of interest. Osteoclastogenesis 
is induced by the interaction and binding of receptor activator of nuclear factor-κB ligand 
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(RANKL), a membrane-bound or soluble protein produced by bone marrow stromal cells 
and osteoblast, to its receptor RANK found on osteoclast precursors [21, 25, 26].  
During the resorption phase, active osteoclasts form a ruffled border, surrounded 
by a sealing zone on the bone surface. The resorption compartment within the sealing 
zone is the site where bone degradation occurs, resulting in formation of a resorption 
lacuna (or pit). Coupled with the acid conditions, enzymes are secreted that degrade the 
organic matrix. The resorption phase lasts for approximately 2-4 weeks and ends with the 
apoptosis of osteoclasts [21].  
The reversal phase is the transition from resorption to formation of new bone, 
and includes the release of signaling molecules to recruit pre-osteoblasts to the remolding 
site [21]. Furthermore, a layer of glycoproteins and proteoglycans known as the cement 
line matrix is deposited and delineates the old bone from the subsequently formed bone 
[27].  
Recruited cells of the osteoblast lineage begin to proliferate and differentiate at 
the onset of the formation phase. Differentiated osteoblasts secrete organic matrix 
proteins forming the osteoid, which is eventually mineralized by HA [25]. The formation 
phase lasts approximately 4 months, during which osteoblasts either die through 
apoptosis, remain on the surface of bone as lining cells, or terminally differentiate into 
osteocytes [21]. In vitro, mineralization of osteoblast cultures represents the final stage of 
differentiation and correlates with osteoblast maturation [21, 28]. 
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1.4 Synthetic Biomaterials 
1.4.1 Biocompatible and Biodegradable Polymers 
Scaffolds for tissue regeneration are required to be at the very least, capable of 
supporting cell attachment and provide sufficient mechanical strength to resist tractional 
forces produced by cells and contractile forces exerted by the natural healing process in 
vivo [16, 17]. For bone tissue engineering, the defect must be shielded from intrusion of 
competing cell types and formation of non-osseous tissue such as scar tissue [10, 29].  
The scaffold material should be biodegradable and bioresorbable, allowing for 
excretion of the initial foreign material and its degradation by-products. Ideally, the 
scaffold degradation rate is expected to be similar to or lower than the remodeling rate of 
the tissue under physiological loading [12, 16]. Bone regeneration scaffolds are thought 
to maintain their physical and mechanical properties for 3–6 months with mass loss only 
to occur after 12–18 months [17]. The majority of degradable polymer systems undergo 
bulk degradation, which involves a two-stage degradation process [12]. Initially, 
biodegradation begins with slow reduction in viscosity and molecular weight of the 
polymer. The second stage results in mass loss characterized by the diffusion of 
molecular chains out of the bulk polymer, resulting in an accelerated degradation and 
resorption kinetics. The release of acidic by-products, often associated with mass loss 
degradation of polymer systems, could be a cause of inflammatory reactions [12]. 
A fundamental requirement for the design of a tissue engineering scaffold is the 
selection of a biocompatible material, which does not induce an immune response or a 
clinically detectible primary or secondary foreign body reaction [12].  A wide selection 
of naturally derived polymers (e.g., collagen, poly hyaluronic acid, chitosan, or alginate) 
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and synthetic polymers (polyglycolide (PGA), polylactides (PLA), or polycaprolactone 
(PCL)) may provide suitable matrix materials for scaffold fabrication [12, 30-33]. Due to 
concerns regarding the feasibility and availability of naturally derived polymers in large 
quantities for clinical applications, researchers are focusing on the use of synthetic 
polymers [34].  
A commonly used class of synthetic polymers, polyesters, have found use as 
suture materials and have garnered attention for use as bone tissue regeneration scaffolds 
[34]. Polyesters are readily degraded by hydrolysis of the ester linkages and include 
PGA, PLA, PCL and their copolymers. The physical and degradation properties of 
synthetic polymers can be tailored to meet the requirements of specific orthopedic 
applications and have sufficient mechanical strength for use as screws and fixation 
devices [35].  
 
1.4.1.1 Biodegradable Polyester: Polycaprolactone (PCL) 
PCL is a biocompatible and bioresorbable polyester approved by the United 
States Federal Food and Drug Administration (FDA) for use in numerous medical and 
drug delivery applications [36]. In vitro cultures using PCL have showed good 
attachment and proliferation of human osteoblasts [36, 37]. Moreover, in vivo 
implantation revealed no inflammatory response with only a thin layer of connective 
tissue surrounding PCL capsules implanted for 480 days [38]. 
The degradation kinetics of PCL are suitable for bone tissue engineering 
applications, as studies have revealed molecular weight loss and loss of mechanical 
properties at 9 – 12 months, with mass loss occurring only after 24 – 36 months [12, 39]. 
The primary degradation mechanism of PCL is random hydrolytic chain scission of the 
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ester linkages with two distinct stages [36-38, 40]. Initially, water diffusion into the 
amorphous regions of the polymer results in cleavage of the ester bonds and a reduction 
in the molecular weight with little weight loss or deformation. The second stage, which 
typically occurs at a reduction of the molecular weight to 5000, involves degradation of 
the amorphous regions and hydrolysis of the crystalline phase leading to mass loss. 
Surface erosion by enzymatic hydrolysis and thermal degradation have also been 
suggested as contributing factors to the biodegradation of PCL in vivo [38, 41, 42]. The 
slow degradation kinetics of PCL make it suitable for bone tissue engineering 
applications as the scaffold is required to maintain its mechanical strength for the initial 
12 months. The preservation of the mechanical properties has made PCL a candidate as a 
temporary joint spacer in total joint prostheses [39], and as scaffolds for applications 
where a resilient material is desired [43]. 
At the cellular level, the PCL macromolecules are ingested and degraded by 
phagocytes and giant cells [44]. In vivo studies involving rats indicated that PCL 
excretion occurred very rapidly, with radioactively traced PCL appearing in the blood 
stream, urine and feces virtually simultaneously [38]. The authors concluded that the 
excretion of PCL mainly occurs through the biliary or gastrointestinal route and occurred 
almost immediately after being metabolized in the body. Distribution studies revealed 
low levels of radioactivity, close to or below background values in various organs, 
indicating that the PCL does not bio-accumulate. 
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1.4.2 Calcium Phosphate 
Calcium phosphates (CaP) are biocompatible and osteoconductive, and possess 
remarkable ability to bond directly to bone (bioactivity) [45, 46]. In particular, 
hydroxyapatite (HA) has attracted a great deal of attention for dental and orthopedic 
applications due to its similarity to the mineral phase of bone and teeth [47, 48]. 
Stoichiometric HA has the chemical formula, Ca10(PO4)6(OH)2 with a hexagonal crystal 
structure (Fig. 1.2) [49, 50]. The mineral constituent of bone, enamel and dentin consists 
of one phase known as B-type HA, which consists of carbonate ion substitution for 
phosphate groups in the HA crystal lattice [5]. HA crystals grow along the c-axis when 
nucleated on collagen fibers in mineralized tissue (Fig. 1.2) [49, 50]. 
Synthetic HA powder can be produced by a variety of wet chemical methods and 
solid state reactions [5, 51]. Wet precipitation represents a common commercial route for 
HA production where the drop-wise addition of phosphoric acid to a suspension of 
calcium hydroxide, or reactions between calcium nitrate and ammonium phosphate (both 
under alkaline conditions) results in a calcium-deficient apatite precipitate [52, 53]. 
Hydrolysis methods are also used to prepare HA, using acid calcium phosphates such as 
dicalcium phosphate dihydrate (DCPD), octacalcium phosphate (OCP) or dicalcium 
phosphate anhydrous [5]. Commercially available CaP, such as beta-tricalcium 
phosphate (β-TCP), are also easily hydrolyzed to produce HA [54].  
Sol-gel chemistry is a well-known and widely studied synthesis route. It involves 
the hydrolysis of phosphorous containing alkoxides and calcium salt and subsequent 
polycondensation. Advantages of sol-gel techniques include molecular level mixing 
providing a high degree of control over the composition and chemical homogeneity of 
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the final product. However, production of crystalline HA powders using sol-gel synthesis 
typically requires calcinations at elevated temperature, which are associated with the 
formation of secondary phases such as β-TCP and granular particle shapes [55, 56]. 
Alternatively, hydrothermal processes synthesize crystalline HA at relatively low 
temperatures (< 250 °C) by subjecting calcium and phosphorus precursors to high 
pressure steam in an acid digestion bomb [57, 58]. 
The synthesis of compact and dense HA and TCP scaffolds for bone regeneration 
often requires high temperature sintering. These are poorly degradable in their highly 
crystalline form, while their amorphous counterparts are mechanically too fragile to be 
used for fabrication of highly porous scaffolds. The dissolution rate for calcium 
phosphates is in the following order: 
amorphous HA > α-TCP > β-TCP > crystalline HA. 
The crystalline HA, which is sintered at high temperature, has high chemical stability in 
contact with tissue fluids, which limits its bioactivity and osteoconductivity [59]. 
Alternatively, its amorphous counterpart is characterized by a high dissolution rate in 
vivo, which accelerates material desorption and can elicit immunologic responses. 
Consequently, the dissolution rate and subsequent bioactivity have been improved by 
synthesizing biphasic calcium phosphates (BCP) consisting of mixtures of HA and the 
more soluble β-TCP. BCP in the form of granules, blocks or specifically designed shapes 
are commercially available and are used in numerous orthopedic and dental applications 
[60]. 
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Figure 1.2 Crystal structure of stoichiometric hydroxyapatite. A) In mineralized 
tissues, apatite develops primarily along the c-axis of the hexagonal structure, and is 
oriented along the extended collagen microfibril. B) Hexagonal crystal structure of 
hydroxyapatite projected onto the 001 plane (as visualized down the c-axis). 
Reprinted from References 40 and 41, with permission (Appendix A). 
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In vitro studies using human bone marrow cells showed improved cellular 
attachment, proliferation and differentiation when cultured on HA as compared to other 
commonly used biomaterials – titanium and high molecular weight polyethylene [61]. In 
vitro culturing of osteoblast-like cells on porous PCL scaffolds showed significant 
increase in osteoconductivity and bone formation when the PCL was embedded with HA 
particles or coated with biomimetic HA [62].  
Osteoconductivity is clearly evident from in vivo experiments. Improved bone 
ingrowth into porous implant materials was obtained when the implant was coated with 
CaP [63-70]. As well, CaP coatings as eliminated fibrous tissue encapsulation commonly 
seen at the tissue/material interface of implanted polymer scaffolds [71, 72]. Indeed, 
clinical applications of calcium phosphate coatings for total joint arthroplasty have 
shown improved osseointegration at the bone/implant interface resulting in superior 
implant stability [73]. Further, in vivo studies have shown potential osteoinductivity of 
biomimetic CaP coatings, where ectopic bone formation occurred when coated implants 
were inserted in nonosseous sites [74-76]. 
 
1.4.2.1 Micro- and Nano-Hydroxyapatite 
Hydrothermal synthesis methods, utilizing high pressure conditions obtained in 
an acid digestion bomb, have been used to produce HA powders with controlled particle 
size, morphology and crystallinity [77-82]. The hydrothermal process operates at 
relatively low temperatures (< 200 °C) and HA nanorods and nanowires are produced 
from a variety of precursor materials, including mixtures of calcium hydroxide and 
phosphoric acid [80] or dicalcium phosphate dihydrate [81], calcium nitrate and 
tripolyphosphate gel [78] or ammonium hydrogen phosphate [77, 79, 82], and calcium 
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carbonate or calcium silicates with phosphate solutions [83, 84]. Traditionally, 
hydrothermal synthesis occurs in aqueous environments; however, various co-solvents 
[78, 80] or different organic additives, such as urea [77], citrate [82] and acetamide [79], 
are used to help control particle morphology. Furthermore, carbonated-HA is produced 
by hydrothermal systems containing urea as an additive, and the solubility of the 
carbonate-substituted HA is higher than phase-pure, highly crystalline HA [77, 85]. 
Carbonated-HA is expected to have dissolution rates comparable to TCP [85], and is 
considered more bioactive then stoichiometric HA [86]. 
In an effort to obtain a higher degree of control over particle morphology of the 
resulting HA powders, solvothermal processes have been used [87-89]. The solvothermal 
process is a modification of the traditional hydrothermal synthesis route, which utilizes 
organic solvents and surfactants to yield reverse micelle emulsions. The reverse micelle 
solutions provide an effective method to synthesize HA nanorods, nanowires and 
nanofibers of varying diameters and aspect ratios (L/D = 100).  The organic surfactants 
in the solvothermal mixture provide organized micelle templates, which guide the 
synthesis of one-dimensional inorganic nanomaterials by controlling nucleation and 
growth through geometric and electrostatic interactions [90].  
The diameter and aspect ratio of the HA powders are an important characteristic 
for biomedical applications, as diameters in the nano-scale are desirable for optimal 
biological and mechanical performance [91-93]. Nano-scale HA in the form of rods and 
wires has shown superior osteoconductive and bioactive properties as compared to their 
micron-scale counterparts [93]. In vivo experiments, using rabbit radius bone defects, 
showed greater osteoconductivity and bone ingrowth in defects treated with nano-HA, as 
compared to micro-HA or untreated groups [94]. In addition, nano-HA has been used to 
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produce nanocomposites and their mechanical properties and in vivo performance, 
assessed using an osteochondral rabbit defect model, were compared to microcomposites 
fabricated using micro-scale HA. The use of nano-scale HA yielded nanocomposites 
with superior stiffness and strength, and induced greater trabecular bone formation at the 
tissue-implant interface [95]. 
 
1.4.2.2 Biomimetic Surface Coatings 
CaP coatings have the potential to improve the biocompatibility, bioactivity, and 
osteoconductive properties of scaffold surfaces [96, 97]. In vitro culturing of osteoblast-
like Saos-2 cells on PCL porous scaffolds showed a significant increase in 
osteoconductivity and bone formation when PCL was embedded with HA particles or 
coated with biomimetic HA [62].  
The commercial coating processes for deposition of CaP, such as HA, have 
traditionally used the plasma-spraying method [98]. However, plasma-spraying processes 
occur at elevated temperatures, and therefore, are not a suitable coating procedure for 
temperature sensitive materials such as most medical grade polymers [99].  
A biomimetic process using a simulated body fluid (SBF) and operating at mild 
conditions (of temperature and pH) offers an economical method to apply a bone-like 
apatite coating to various materials, including polymers and metal alloys, with complex 
shapes and porous structures [100, 101]. SBF is a buffer solution containing ion 
concentrations similar to those found in human blood plasma. Kokubo et al. first 
demonstrated the ability of SBF to deposit surface layers of a calcium-deficient, 
carbonated HA onto material surfaces [102]. Advantages of biomimetic procedures 
include mild operating conditions at physiological pH (7.4) and temperature (37°C), and 
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an aqueous solution-based self-assembly system, which allows for coating complex 
surfaces and 3D porous structures.   
Biomimetic processes using SBF solutions have successfully produced coatings 
of bone-like apatite on various material surfaces, including natural and synthetic 
polymers, metal alloys and titanium, in the presence of proper surface functional groups 
[103-108].  Negatively charged functional groups such as carboxylic acids (COOH) and 
hydroxyl (OH) groups act as nucleation sites, first by electrostatic attraction of Ca2+ ions, 
which culminate in the adsorption of PO43- ions from the SBF solution [109].  Once 
critical size nuclei are formed on the material surface, the nuclei spontaneously grow into 
a dense apatite layer by further consuming calcium and phosphate ions from the SBF 
[109].  However, due to the low ionic activity product of traditional SBF (1x, 1.5x), 
lengthy incubation periods on the order of weeks are often required to achieve adequate 
surface coverage.   
Recent efforts to accelerate the coating process have focused on increasing the 
supersaturation of the SBF solutions, specifically, the calcium and phosphate ion 
concentrations.  Several studies have investigated the ability of a supersaturated SBF 
(e.g. 5xSBF) to depositing various crystalline CaP coatings. The careful design of SBF 
composition allows one to induce the deposition of coatings consisting of carbonated-HA 
[110-114], octacalcium  phosphate (OCP) [111, 112, 115], and dicalcium phosphate 
dihydrate (DCPD) [110, 113], as well as an amorphous calcium phosphate (ACP) coating 
[110, 113-115] within 1 – 3 days incubation.  The different CaP coatings were produced 
by varying the ionic composition of the 5xSBF solution, specifically, the concentration 
of crystal growth inhibitors, Mg2+ and HCO3- [110, 113]. The amorphous calcium 
phosphate coating, which is considered a precursor to other crystalline phases, can be 
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subsequently hydrolyzed into OCP and HA after incubating in concentrated SBF 
solutions devoid of crystal growth inhibitors [114-116]. Further increasing the ion 
concentration of the SBF 10-fold (10xSBF) induces apatite coatings within hours [117-
120]. However, the increased supersaturation results in rapid solution precipitation and 
the 10xSBF must be replenished, and the incubation process repeated several times to 
promote formation of apatite over other crystalline phases [117, 119]. Moreover, 
subjecting material substrates to numerous incubation cycles results in an increase in 
coating thickness, which can mask designed surface features or block porous networks 
[119]. 
 
1.4.3 Nanocomposites 
Currently, biomaterials for bone tissue regeneration suffer from the inability to 
satisfy every design consideration, including biodegradability, bioactivity, 
osteoconductivity, and mechanical competency. Biomaterials deemed to have sufficient 
mechanical properties are often bio-inert and nondegradable [121], whereas 
biodegradable polymers or resorbable, bioactive and osteoconductive bioceramics are 
inherently weak [33]. As such, nanocomposites – combining biodegradable, bioactive 
and mechanically resilient materials – offer a unique solution towards producing scaffold 
materials with suitable biological, physical and mechanical properties [34]. 
The rationale for the development of nanocomposites for bone tissue engineering 
was inspired by the natural physiological structure of bone tissue (Fig. 1.1), which 
consists of inorganic HA mineral embedded in a collagen-rich ECM [22, 34]. From this 
perspective, the different components of nanocomposites aim to mimic the organization 
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of bone tissue. Nanocomposites consist of inorganic reinforcing filler (nano-HA), 
resembling the mineral apatite crystals, embedded in an organic polymer matrix, 
resembling the collagen-containing ECM.  
From a mechanical properties point of view, bioceramics such as HA, are 
inherently stiffer than polymers; however, their intrinsic brittleness and sensitivity to 
crack propagation and catastrophic failure limit their use as scaffold materials. On the 
other hand, synthetic polymers, including PCL, have suboptimal biocompatibility due to 
release of acidic degradation products, and limited strength and mechanical stability 
when fabricated with large degrees of macro-porosity, a fundamental design criterion for 
tissue regenerative scaffolds [34]. Furthermore, synthetic polymers are not 
osteoconductive or bioactive and, therefore, do not bond directly to bone and are 
typically encapsulated by fibrous tissue when implanted in vivo [38, 71]. 
Nanocomposites, prepared from biodegradable synthetic polymers in 
combination with bioresorbable HA, are ideal candidates for bone tissue engineering 
scaffolds. The bioresorbable HA component of nanocomposites imparts its bioactivity, 
osteoconductivity and mechanical strength to the more resilient biodegradable polymer 
matrix [34]. Furthermore, the basic resorption by-products of HA can potentially buffer 
the acidic polymer by-products, which are normally a cause of inflammatory reactions.  
Inorganic nanoparticles, nanowires or nanofibers are added to different organic 
biodegradable polymer matrices to produce nanocomposite biomaterials. The particle 
size and morphology of the inorganic filler have a direct influence on its ability to 
reinforce materials [91, 122, 123]. In particular, smaller diameters and larger aspect 
ratios have the greatest beneficial effect on mechanical properties. Due to the large 
surface area of nano-sized fillers, an intimate interface with the polymer matrix is 
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formed, and the intrinsic properties of the fillers contribute to an increase in the 
mechanical strength and stiffness of composites [34].  
 
1.4.3.1 Hydroxyapatite-based Nanocomposite 
Recent studies have shown that HA powders consisting of micron-sized particles, 
were successful in improving the mechanical performance of high-density polyethylene-
based materials [122, 123], silk-based porous scaffolds [124] and calcium phosphate 
cements [125]. The emergence of nanotechnology, coupled with the need for bioactive 
and biodegradable synthetic biomaterials, has led to the use of HA powders consisting of 
nano-sized particles, rods and wires for producing nanocomposites for bone regeneration 
[126-130]. 
Highly porous PLLA nanocomposite scaffolds have been prepared by a thermally 
induced phase separation technique [126]. Unfilled PLLA and HA/PLLA nanocomposite 
scaffolds with greater than 89% porosity and pores sizes ranging from 50–100 µm were 
produced. Compressive modulus of nanocomposites scaffolds were significantly higher 
(8.3 MPa) as compared to unfilled PLLA (4.3 MPa). Scaffolds with varying HA content 
were immersed in fetal bovine serum/phosphate buffer solution to evaluate protein 
adsorption, which is thought to be a determining factor for cell adhesion and survival. 
Composite scaffolds with high HA loading adsorbed 2–3 times more serum proteins than 
unfilled PLLA scaffolds. The authors proposed that greater HA loading was more 
effective in protein adsorption because the increased HA weight fraction allowed for 
more HA particles to be exposed on the surfaces of the pore walls. The authors further 
showed that, for high HA loading, composite scaffolds containing nano-HA improved 
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protein adsorption compared to scaffolds synthesized with micron-sized HA particles 
with similar loading rates.  
Using a salt leaching and phase inversion process, Biossard et al. [127] developed 
porous nanocomposite scaffolds composed of biocompatible poly(ester urethane) (PU) 
and PCL with HA nano-particles. Micro-computed tomography (micro-CT) scans of 
scaffolds showed that scaffold pore size and porosity decreased with an increase in HA 
content, while the wall strut thickness increased. Results from the tensile testing 
indicated that the Young’s modulus was moderately greater for the nanocomposites 
compared to polymer without HA. However, the authors did not address whether the 
improvement in mechanical properties of the composite was due to reinforcement of the 
polymer matrix by the HA filler, or by the decrease in porosity and increase in strut 
thickness as measured by the micro-CT analysis.  
PU/HA nanocomposites were further evaluated in vitro by a protein adsorption 
study and in vivo by a mouse dorsal skin fold chamber model to assess the 
biocompatibility and vascularization [131]. The nanocomposite and the unfilled PU 
scaffolds adsorbed protein on their surfaces; however, the nanocomposite scaffolds 
exhibited greater levels of protein adsorption. Moreover, the in vivo results demonstrated 
that the host tissue response to the scaffolds were comparable for the PU/HA 
nanocomposites and the unfilled PU. The scaffolds promoted only a weak angiogenic 
host response; however, they showed favorable biocompatibility with little acute 
leukocytic inflammatory activity throughout the entire study period. 
Prabhakaran et al. [132] fabricated nanofibrous PLLA and PLLA/collagen/HA 
nanocomposite scaffolds, containing HA nanoparticles, by electrospinning. In vitro 
experiments, using cultures of human fetal osteoblasts, showed that the inclusion of HA 
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nanoparticles in nanocomposite scaffolds enhanced cell proliferation, differentiation, and 
mineralization. 
 In summary, despite the multitude of nanocomposite technologies, most fail to 
combine the nano-scale and osteoconductive filler bioceramics, with scaffolds having the 
ideal surface chemistry and topography to promote bone forming stimulus and 
appropriate rates of biodegradation. 
 
1.5 Osteoblasts and their Interactions with Biomaterials 
1.5.1 Origin and Differentiation of Osteoblasts 
Cells of the osteoblast lineage are derived from an osteoprogenitor cell, which 
originate from mesenchymal stem cells. Mesenchymal stem cells are capable of 
differentiating into bone, cartilage, fat or fibrous connective tissue, and are directed 
towards the commitment to the osteoblast phenotype through the canonical Wnt/β-
catenin pathway [21, 133]. In bone, transcription factors such as Runx2 and osterix have 
been identified as master regulators of osteoblast differentiation [133]. Runx2 directs 
mesenchymal progenitor cells towards preosteoblasts. Downstream, Runx2, β-catenin, 
and osterix further induce preosteoblasts to become immature osteoblasts, capable of 
expressing bone matrix protein genes, such as osteopontin [134]. 
Osteoblast differentiation towards mature osteoblasts and the subsequent matrix 
synthesis and mineralization of matrix is described by three distinct biological phases: 1) 
cellular proliferation, 2) matrix maturation, and 3) matrix mineralization [28, 135]. 
During these stages a host of collagenous, non-collagenous, and bone-related proteins are 
synthesized including type I collagen, alkaline phosphatase (ALP), OCN, osteopontin, 
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osteonectin, and bone sialoprotein [135]. These proteins are thought to serve multiple 
functions including regulation of mineral deposition, bone turnover and cell activity [21]. 
Therefore, no single specific gene can fully describe osteoblast differentiation, matrix 
synthesis, and mineralization, and as such, the gene expression of several different bone-
related genes must be examined when investigating osteoblast differentiation. 
During the initial stage of cellular proliferation, maximal expression of genes 
associated with ECM biosynthesis, are observed such as type I collagen and osteonectin 
[28]. Bone matrix is composed mostly of type I collagen, with small amounts of types III 
and V, whereas osteonectin is the most prevalent non-collagenous protein and is thought 
to influence osteoblast growth and proliferation [21]. The next phase, matrix maturation, 
is a post-proliferative stage highlighted by maturation of the ECM and is associated with 
maximal expression of ALP [21, 28]. ALP is a major glycosylated protein in bone, and is 
thought to increase local concentrations of inorganic phosphate, hydrolyze and inactivate 
inorganic pyrophosphate (an inhibitor of mineral deposition) and modify 
phosphoproteins to control HA nucleation [21]. The final stage of matrix mineralization, 
is characterized by gene expression of OCN, osteopontin and bone sialoprotein. It is 
believed that these proteins bind calcium and phosphate, and help regulate mineral 
deposition by controlling amount and size of the HA crystals formed [21, 28]. In this 
regard, OCN expression is considered a marker of osteoprogenitor differentiation to a 
mature osteoblast phenotype [134]. 
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1.5.2 Adhesion and Morphology of Osteoblasts 
Cell adhesion is typically divided into two phases – an attachment and an 
adhesion phase [136]. Attachment involves the short term interaction of cells with 
substratum via physiochemical linkages, whereas adhesion is described as a long-term 
phenomenon involving ECM proteins, cell trans-membrane proteins, and cytoskeletal 
proteins. Cell adhesion to ECM and synthetic material surfaces directly influences 
proliferation, ECM biosynthesis, and differentiation [137].  
Adhesion is facilitated by various ECM  proteins, including collagen, fibronectin, 
osteopontin, osteonectin and bone sialoprotein; however, in vitro osteoblast adhesion is 
mediated primarily by fibronectin and vitronectin [137]. These matrix proteins contain 
adhesive Arginine-Glycine-Aspartic acid (RGD)-peptide sequences, which facilitate 
specific interactions with cell membrane receptors, most notably, the integrin 
superfamily. Furthermore, the RGD-peptide motif is of critical importance for 
osteoprogenitor cell adhesion to various substrata [137]. 
Integrins are transmembrane adhesion molecules consisting of a large 
extracellular domain, a transmembrane domain and a short cytosolic domain [137]. 
Integrins are responsible for cell-substratum adhesion through interaction of their 
extracellular domain with extracellular ligands, and many have a high specificity for 
RGD sequences of ECM proteins [136]. The membrane-spanning domain links the 
external domain to the internal, cytosolic domain, which in turn is linked to intracellular 
proteins such as talin, paxillin and vinculin [136, 137]. After integrin binding to a ligand 
(RGD sequence of ECM protein), integrins cluster together and form focal adhesions 
[136]. Several other intracellular proteins will co-localize with vinculin and talin in the 
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adhesion plaque, including proteases, protein kinases, phosphatases, and other signaling 
molecules [137]. As such, integrin interaction with extracellular proteins can regulate not 
only cell adhesion, but motility, spreading, growth, signal transduction, and 
differentiation [136, 137]. Furthermore, vinculin and talin mediate interactions between 
integrins and actin filaments and, therefore, cellular adhesion and ECM proteins have a 
direct effect on cell morphology.  
Osteoblast precursors initially present themselves as spindle-shaped 
osteoprogenitors and undergo changes in morphology and exist as large cuboidal cells 
when fully differentiated [21]. Mature osteoblasts have large nuclei, and Golgi structures 
and extensive endoplasmic reticulum [21]. The architecture and organization of 
filamentous actin (F-actin) dictates cell shape and morphology. When assembled in long 
bundles, F-actin promotes finger like projections of the plasma membrane known as 
filopodia. Furthermore, if bundles of F-actin are associated with focal adhesions, stress 
fibers are produced. Sheet-like protrusions, known as lamellipodia, result if F-actin is 
organized in a mesh-like structure [137]. 
 
1.5.3 Bone Formation 
Skeletogenesis consists of four main phases – 1) mesenchymal cell migration to 
the targeted site of bone formation, 2) interactions between existing tissue and cells, 3) 
aggregation or condensation of mesenchymal cells, and 4) differentiation of 
mesenchymal cells into osteoblasts and/or chondroblasts [138]. Mesenchymal cell 
condensation is a necessary prerequisite for bone formation, which occurs through two 
distinct developmental processes, endochondral and intramembranous ossification [133, 
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138]. Endochondral ossification represents the most common pathway for bone 
formation, particularly for long bones, and occurs during development and through 
adolescence. In contrast, intramembranous ossification facilitates the majority of skull 
and flat bone synthesis.  
During intramembranous ossification, osteoblasts differentiate from a condensed 
mesenchymal cell layer housed within a sheet of connective tissue. The differentiating 
osteoblasts synthesize and secrete a fibrillar, non-mineralized matrix (osteoid), which is 
later mineralized and reorganized into compact bone [133]. Similarly, endochondral 
ossification begins with an aggregated and condensed population of mesenchymal cells. 
However, the pluripotent mesenchymal cells first differentiate into chondrocytes, and 
then produce a cartilage template of the bone. Mesenchymal cells located on the 
periphery of the cartilage template, flatten and form the perichondrium, a condensed 
multilayered tissue. The cartilage matrix then mineralizes and is subsequently invaded by 
osteoclasts and blood vessels. Osteoblast precursors surrounding the blood vessels 
differentiate into osteoblast that then form bone on the remnants of calcified cartilage 
matrix. Ossification in the diaphysis and epiphyses of long bones gives rise to 
intermediate structure known as the growth plates. The growth plates are cartilaginous 
structures that serve as sites for the future longitudinal growth of long bones. In the 
region near the perichondrium, a host of signaling pathways induces the differentiation of 
osteoblasts and forms a region known as the periosteum. These differentiated osteoblasts 
begin to secret osteoid, which is eventually mineralized and organized into compact bone 
[133]. 
In the context of bone regeneration therapies using scaffolds, or fracture repair 
systems (using intramedullary screws or fixation plates) bone formation and healing can 
30 
 
 
occur via intramembranous or endochondral ossification [139, 140]. Porous ceramic 
scaffolds, seeded with donor osteoblasts, produced bone via intramembranous 
ossification when implanted in vivo. However, identical scaffold constructs, loaded with 
mesenchymal cells and implanted in vivo, stimulated host bone formation through the 
activation of an endochondral process [140]. In a murine fracture model, femurs 
stabilized with an intramedullary screw showed considerable cartilaginous tissue within 
the newly formed callus, which was attributed secondary healing response through 
simultaneous endochondral and intramembranous ossification [139]. In contrast, femur 
fixation using a plate and screw system, showed accelerated bone formation bridging the 
fracture gap. The enhanced healing response was predominately by intramembranous 
ossification and was attributed to a more stable and improved fracture fixation as 
compared to the intramedullary screw [139]. 
 
1.5.4 Interactions of Osteoblasts with Biomaterials 
Cellular interactions with biomaterial surfaces are crucial for the success of any 
tissue engineering scaffold [16]. The scaffold is required to provide not only mechanical 
stability to the tissue engineering construct, but also cell anchorage sites and structural 
cues. Morever, surface chemistry and topography play prominent roles in regulating 
cellular adhesion, proliferation and differentiation [8, 11]. The material surface also 
represents the interface between the scaffold and the tissue. Osseointegration, which is a 
phenomenon where bone forms within and at the endosseous implant surface, is a 
defining factor for the success of orthopedic and dental implants and tissue engineering 
scaffolds [141]. 
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Osteoblast-biomaterial interaction is influenced by the biomaterial surface 
characteristics including chemistry and topography, which encompasses chemical 
composition, surface charge and energy, hydrophobicity/hydrophilicity, and roughness. 
These surface attributes determine the adsorption, orientation and conformation of ECM 
proteins, which influence osteoblast adhesion, proliferation, and differentiation on the 
biomaterial [137]. 
 
1.5.4.1 Surface Chemistry 
Surface chemistry, through specific protein binding, controls focal adhesion 
assembly, composition and signaling [137]. Adsorbed proteins (such as 
immunoglobulins, vitronectin, fibrinogen, and fibronectin) can bind to integrins and 
distinctive biomaterial surface properties impart different integrin binding specificities 
through the presentation of various adsorbed proteins [142-145]. In particular, the 
presentation of the major integrin binding domain in fibronectin was found to be 
sensitive to material surface functional groups with specificity ranking as follows [143]: 
OH > NH2 = COOH > CH3. 
Mineralization and matrix formation by osteoblast-like cells was also found to be 
dependent on surface chemistry and correlated well with the integrin binding capacity of 
different surface functional groups [143].  Studies investigating osteoblast attachment on 
materials with different surface functional groups have reported preference towards 
oxidized surfaces, corresponding well with reported protein binding preference [142]. 
Integrin function is dependent on divalent cations and the presence of charged elements 
plays a crucial role in bone remodeling and development.  Ion implantation of Mg2+ on 
the surface of various biomaterials (such as titanium and Al2O3 bioceramics) has 
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improved osteoblast adhesion and differentiation and maintenance of the osteogenic 
phenotype [144-146].  
 
1.5.4.2 Surface Topography 
The surface topography of biomaterials is typically quantified in the form of 
numeric standard integral surface roughness parameters [147]. The most commonly used 
parameter is the average surface roughness (Ra), which is defined as the arithmetic mean 
of the absolute of the height (peak and valley) deviations from the mean value [147, 
148]: 
!! = 1! ! !!!!!!  
where z is the height deviation from the mean line at each individual point (xi) along the 
evaluation length having m number of ordered and equally spaced points. Several other 
parameters exist including Rq, which is the square root of the arithmetic mean of the 
squares of the deviations from the mean line, and Rz, the arithmetic mean of the 
maximum peak to valley deviation over five consecutive sampling lengths [147].  
Numerous techniques exist for the characterization of surface roughness 
parameters, including mechanical and non-contact laser profilometry, interference 
microscopy, scanning tunneling microscopy, and atomic force microscopy (AFM) [147]. 
However, each system has its own vertical and lateral resolution limits and reported 
roughness parameters are scale-dependent and will vary with measurement scale and 
sampling length. Therefore, it is difficult to describe complex isotropic surfaces and fine 
nano-scale surface features, which are often masked by the coarser surface roughness 
[147]. As such, it is important to obtain scale-dependent roughness measurements at 
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several dimensional ranges, using different measurement techniques. As an example, 
coarse topographical features in the size range of micrometers to millimeters may be 
obtained using profilometry; whereas, AFM has sensitivity within the nanometer range 
and is suitable for assessing high resolution roughness. 
Modification of biomaterial surface roughness, by imparting micro-, sub-micron 
and nanometer isotropic surface features, affects osteoblast adhesion, proliferation and 
differentiation. Formation of submicro- and nanometer surface features on titanium 
increased cellular adhesion when compared to flat surfaces [149]. In contrast, variation in 
micro- and nano-topography of gold coatings had negligible effect on cellular adhesion; 
however, increased proliferation and differentiation was observed on gold coatings with 
isotropic nano-topography [150]. 
Increase in surface porosity and roughness of sintered HA discs, improves 
cellular attachment, proliferation, differentiation and bone ingrowth [151, 152].  
Osteoblast-like cells are capable of discerning the apatite microenvironment, and appear 
to favor large plate-like HA crystals over finer apatite crystals as indicated by elevated 
expression of osteocalcin and bone sialoprotein [153]. Bone-bonding at biomaterial 
surfaces is expected to occur if the material possesses topographical features at both the 
micrometer level and nanometer range [27]. It is believed that materials can be rendered 
bioactive given proper levels of surface complexity, and bone formation occurs through 
contact osteogenesis.  Discrete nano crystals of CaP, deposited on titanium implants with 
micron-scale surface roughness, imparted a nano-scale surface complexity and improved 
the osseointegration of implants surfaces when implanted in vivo and at the posterior 
maxilla in a human clinical trial [154, 155]. 
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 The culmination of numerous in vitro and in vivo studies has identified an 
optimal Ra of biomaterials to be in the range of 1-7 µm for inducing maximal changes in 
cell behavior and bone formation [148, 156, 157]. On the other hand, bone nodule 
formation in vitro was limited to surfaces topographies having Ra <0.3 µm, and fibrous 
tissue encapsulation occurred for implants with Ra <0.4 µm, when placed in an osseous 
environment in vivo [148]. However it should be noted that conclusions on the effect of 
surface topography of biomaterials on the in vitro and in vivo success, should not be 
limited only to the measurement of the amplitude of the Ra. Osteoblastic activity is 
affected by subtle changes in surface architecture and other surface features, such as 
spatial distribution, aspect ratio, and curvature [148, 158]. Furthermore, bone formation 
is dependent on synergistic influences of surface roughness at different dimensional 
scales, i.e. micro-, sub-micrometer-, and nanometer range [158]. 
In summary, the osteoblast/biomaterial interface offers a distinctive opportunity 
to improve the performance of scaffolds and implants for applications in bone 
regeneration. Biomaterials with enhanced osteogenic stimulus may be achieved by 
combining appropriate surface chemistry, through the addition of bioactive and 
osteoconductive bioceramics, with ideal surface topographies having complex and 
isotropic nano-, sub-micrometer- and micro-scale features.  
 
1.6 Osteoclasts and their Interaction with Biomaterials 
1.6.1 Origin and Differentiation of Osteoclasts 
The osteoclast is a multinucleated-giant cell, which is derived from the 
differentiation and fusion of mononuclear monocyte/macrophage precursor cells at or 
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near the bone surface [159]. Typically, osteoclasts are large cells having diameters 
ranging from 50-100 µm, and are characterized by having 3 or more nuclei, numerous 
mitochondria, lysosomes, and free ribosomes, and extensive Golgi complexes [160]. 
Furthermore, osteoclast precursors and mature osteoclasts have a significant level of the 
phosphohydrolase enzyme, tartrate-resistant acid phosphatase (TRAP), which is a marker 
commonly used for identifying osteoclasts. 
The mononuclear osteoclast precursor develops from a myeloid hematopoietic 
progenitor that it shares with the granulocyte and monocyte lineages [160]. 
Osteoclastogenesis is dependent upon a permissive environment consisting of stromal, 
bone marrow and osteoblastic cells, and the presence of cell-associated or soluble 
hematopoietic factors – the cytokine RANKL and the polypeptide growth factor 
macrophage colony-stimulating factor (M-CSF) [159, 160]. RANKL exists as both a 
transmembrane and soluble protein (sRANKL), and along with M-CSF, is produced by 
stromal cells and osteoblasts in the bone marrow [159]. RANKL binds to and activates 
the transmembrane signaling receptor RANK found on osteoclast precursors. In 
combination with M-CSF, RANKL causes osteoclast differentiation and activation. 
TRAP-positive osteoclast precursors subsequently fuse together to form the 
multinucleated osteoclasts, which are considered terminally differentiated. In addition, 
M-CSF is crucial for the survival and proliferation of osteoclast precursors, as well as the 
survival of osteoclasts. In the case of mature osteoclasts, activation of RANK by its 
ligand triggers cytoplasmic signaling pathways, which control various functions 
including bone resorption and survival [159, 160]. 
Osteoclastogenesis, and subsequently bone resorption, are regulated by the decoy 
receptor osteoprotegerin (OPG) – a soluble tumor necrosis factor receptor-related protein 
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[159]. OPG inhibits osteoclastogenesis and prevents osteoclast formation in vitro, and 
bone resorption in vivo. The OPG decoy receptor binds to RANKL, effectively 
preventing RANKL interaction with RANK. Similar to the soluble form of RANKL, 
OPG is secreted by osteoblasts and, therefore, the expression of RANKL and OPG is 
coordinated to control the activation of RANK and subsequently, regulate bone 
resorption and density [159].  
 
1.6.2 Adhesion and Morphology of Osteoclasts 
Osteoclast-substratum interactions are mediated through the dynamic formation 
of specialized adhesion plaques known as podosomes. These are dot-like, discrete and 
conical structures, which function as short membrane protrusions and provide cell-
substratum adhesion through contacts with gaps less than 10 nm [161]. Podosome 
structures are typically organized in clusters [162]. Inside the cell, podosomes consist of 
a central core of bundled F-actin microfilaments with a diameter of 0.3 µm and height of 
0.6-1 µm, surrounded by a cloud of F-actin and actin monomers [163]. Encompassing the 
actin core is a ring comprised of integrins and their associated adaptor and signaling 
proteins, including vinculin, paxillin talin and different kinases [161, 163]. Through 
integrins osteoclast podosomes recognize the extracellular matrix via interaction with the 
RGD sequence of specific ECM adhesive macromolecules, such as fibronectin, 
vitronectin, osteopontin, collagen and bone sialoprotein. Furthermore, the interaction of 
integrins with RGD proteins has been shown to activate signal transduction mechanisms 
in osteoclasts [160]. In this regard, podosomes in osteoclasts are analogous to focal 
adhesions in osteoblasts, with main the difference attributed their organization and 
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dynamics, as podosome assembly and disassembly occurs within a few minutes [161]. In 
vitro, podosomes are constantly reorganizing during osteoclast differentiation, 
maturation and motility. Podosomes present initially as individual structures scattered 
throughout the osteoclast, which can then develop into rings, extend to the cell periphery, 
and eventually evolve into an F-actin belt or sealing zone [163]. 
During bone resorption, osteoclasts become functionally polarized with a 
basolateral membrane domain facing the vascular stream and an apical membrane facing 
the substratum. The basolateral cytoplasm contains the nuclei and organelles, whereas 
the apical cytoplasm towards the substratum contains lysosomes and a specialized 
structure at the periphery, known as the ruffled border (Fig. 1.3). The ruffled border is 
actively involved in bone resorption, and is formed by finger-like membrane 
interfoldings of the inner domain of the apical membrane. Protons are transported and 
enzymes are secreted extracellulary into the resorption compartment across the ruffled 
border. These protons and enzymes degrade the bone mineral and the organic ECM, 
respectively [161]. The resorbing compartment containing the ruffled border is enclosed 
by a unique and characteristic F-actin ring-like structure, called the sealing zone. The 
sealing zone is essential to segregate the resorption compartment from the extracellular 
fluid, in order to establish the conditions appropriate for bone resorption [161, 164]. 
When osteoclasts are not resorbing, they often exhibit a spread morphology and are 
highly motile [164].  
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1.6.3 Bone Resorption 
During each remodeling cycle, osteoclast-mediated bone resorption requires 
approximately 2-4 weeks. As mentioned above, resorption requires the formation of a 
sealing zone. The sealing zone is composed of several condensed podosomes, cross-
linked by interconnecting F-actin filaments [165]. The F-actin ring is surrounded on the 
inner and outer domains by rings of adhesive proteins, including vinculin and paxillin 
[164]. The interaction between F-actin and adhesive proteins in the interconnected 
sealing zone transmits the local properties of the substratum through the adhesion 
receptors (integrins), to the adhesion plaques (vinculin), and finally to the F-actin 
network, effectively sensing the condition of the substrate and thereby regulating the 
resorptive activity [163]. The uniformity and continuity of substrate adhesiveness is of 
critical importance for the formation of the sealing zone, and it has been shown that non-
adhesive barriers as small as 1 µm can effectively inhibit the organization of a sealing 
zone [165]. 
Within the resorbing compartment, the ruffled border secrets hydrogen ions via  a 
proton pump (H+-ATPase), which results in acidification of the resorption compartment, 
lowering the pH to ~4.5 (Fig. 1.3). The acidic conditions in the resorption compartment 
dissolve the HA mineral. The organic ECM is degraded by secretion of TRAP, cathepsin 
K, matrix metalloproteinase 9, and gelatinase and other enymes, resulting in the 
formation of saucer-shaped Howship’s lacunae on the surface of trabecular bone and 
dentin, and Haversian canals in cortical bone [21, 166]. 
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Figure 1.3 Schematic representation of a resorbing osteoclast. The osteoclast 
produces a sealing zone. The osteoclast acidifies the resorptive compartment by 
secreting H+ and Cl- ions for demineralization, and hydrolytic enzymes for degradation 
of type I collagen. Reprinted with permission from Reference [166] with permission 
(Appendix A). 
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1.6.4 Interaction with Biomaterials  
The ideal resorbable biomaterial would be integrated into the physiological bone 
environment through “smooth assimilation”, wherein osteoblast bone formation occurs in 
concert with osteoclastic resorption of the biomaterial [167]. Degradation of resorbable 
biomaterials is mediated by cellular resorption and physiochemical dissolution [167]. A 
host of international standards on medical biomaterial resorption assays, characterize 
degradation under two separate conditions – degradation in an extreme environment 
(solution pH = 3) and degradation in a solution that mimics the common in vivo 
environment (pH = 7.4) [168]. However, many of the synthetic bone graft substitutes 
identified as resorbable are still present several years after implantation in vivo [168]. In 
vivo degradation consists of other factors beyond simply body fluid dissolution, 
including enzymes, body movements, and cell-mediated resorption [167, 168]. On the 
other hand, excessive in vivo biomaterial degradation prior to adequate bone formation 
can lead to detrimental results. As such, the determination of biomaterial resorbability 
using cell-based assays is an integral step prior to in vivo application [168]. 
 
1.6.4.1 Surface Chemistry  
Osteoclast adhesion, differentiation and resorptive activity are influenced by the 
chemical composition of biomaterials. Chemical characteristics of bioceramics that affect 
osteoclast behavior in vitro include crystal phase [169-171], solubility [172] and 
carbonate content [173].  
Bioceramics consisting of various CaP, such as monetite, TCP, DCPD, OCP, 
sintered HA and carbonated-HA have been investigated for their susceptibility to 
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osteoclastic resorption in vitro, with varying outcomes. Contradictory results regarding 
the resorption of sintered, crystalline HA have been reported [160]. Some investigators 
have shown osteoclastic resorption of sintered HA [174], while others have reported 
degradation of HA by osteoclasts only when in combination with TCP [170]. 
Furthermore, HA/TCP ceramics showed typical scallop-like resorption lacunae, whereas 
more soluble pure TCP ceramics had only island-like excavations. The difference in pit 
morphology was attributed to an inhibitory reaction to the increased release of Ca2+ from 
the more soluble, pure TCP.   
Carbonate-substitution in biomimetic HA coating was shown to enhance 
resorption by osteoclasts in vitro in a particular study [171], whereas another study 
indicated that increased carbonate content in HA limited resorption [173]. The authors 
suggested that an increase in HA solubility (due to increase in carbonate substitution) 
does not necessarily correlate with increased osteoclastic resorption. Furthermore, a 
calcium-deficient HA also showed minimal degradation [169]. However, several other 
crystalline CaP  (DCPD, OCP, monetite) undergo osteoclastic resorption in vitro [169, 
171] and a decrease in CaP solubility inhibited osteoclastic resorption [172]. 
 
1.6.4.2 Surface Topography 
Osteoclasts isolated from rat bone marrow [174], and osteoclast-like cells 
differentiated  in vitro from human peripheral blood moncytes [175] showed increased 
adhesion and differentiation when cultured on surface-abraded sintered-HA discs with 
increased surface roughness. By contrast, osteoclast-like cells derived from human 
peripheral blood cells co-cultured with human bone marrow stromal cells, showed 
decreased TRAP activity when incubated on HA discs with increasing surface roughness 
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[175]. The area resorbed by osteoclasts was limited when rat bone marrow cells were 
cultured on rougher surfaces [174]. A similar effect was observed for osteoclast-like cells 
derived from human peripheral blood cells co-cultured with human bone marrow stromal 
cells, when plated on the rougher surfaces. Interestingly, the addition of M-CSF and 
RANKL negated any surface roughness influence of surface roughness. Furthermore, the 
opposite effect was reported for osteoclast-like cells cultured without supplementation 
with bone marrow cells [175]. However, the level of surface roughness of the sintered 
HA discs was well below the Ra value considered ideal for bone formation [148, 156]. 
Thus, the behavior of osteoclasts on optimal biomaterial surfaces remains poorly defined. 
 
1.7 Rationale, Objectives and Hypotheses of the Research 
The overall objective of this research was the synthesis of biomaterials for 
scaffolds for applications in tissue engineering and bone regeneration. In particular, our 
aim was to produce a composite biomaterial consisting of a PCL matrix reinforced with 
nano-scale HA to mimic the collagen and mineral organization of bone. The rationale 
was that composite biomaterials will have improved mechanical properties and will yield 
a mechanically competent material to maintain the porous structure of scaffolds in vivo. 
A further aim was to improve the biomaterial-cell interface by depositing a bone-like 
apatite coating on functionalized PCL substrates. Specifically, we sought to control the  
surface topography of biomimetic HA coatings to differentially regulate bone formation 
by osteoblasts and resorption by osteoclasts. 
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1.7.1 Synthesis of High-Aspect Ratio Hydroxyapatite Nanowires and 
Fabrication of Hydroxyapatite/Polycaprolactone Composites 
Rationale – HA in the form of powders consisting of micro- and nano-sized 
particles, can be used as a reinforcing filler in polymer composites [123, 126], and 
calcium-phosphate bone cements [91, 176], and may impart their bioactive and 
osteoconductive properties [92, 177].  
HA whiskers with high aspect ratios have been synthesized using a variety of 
hydrothermal precipitation methods [77-79]. However, the HA whiskers typically have 
diameter and length in the micrometer range. The current drive towards nanotechnology 
has shown that HA having at least one dimension in the nano-scale is required to obtain 
the high biological and mechanical functionality [92, 93, 95]. As such, nanowires and 
nanorods have been produced by hydrothermal processes utilizing surfactants and 
reverse micelle solutions, a method known as solvothermal synthesis [87-89]. However, 
concerns with use of solvothermal processes exists due to low aspect ratio [88, 89, 178], 
and the highly aggregated nature of the HA powders [87, 178]. As well, the use of 
surfactants and solvents may result in undesired organic impurities being incorporated 
into the final HA products [82, 89, 178]. 
Recently, HA nanowires and hollow microspheres were synthesized by 
hydrothermal processing of xonolite and calcium carbonate precursors of similar micro- 
and nano-scale dimensions and morphology [84]. It was suggested by these authors, that 
during hydrothermal processes, the scale and structure of the precursor starting material 
dictates the final morphologies of the HA product by dictating crystal nucleation and 
growth. Therefore, it would be beneficial to develop a method to produce phase pure HA 
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powders having nanowire morphology with high aspect ratio for use in nanocomposites. 
A novel method for the synthesis of nano-scale HA powders may be achieved by 
utilizing hydrothermal treatment in place of typical high temperature calcination of nano-
scale amorphous CaP precursors produced via sol-gel chemistry. 
 
Objectives 
1. To develop a novel method for the synthesis of nano-scale HA by utilizing 
sol-gel chemistry in combination with hydrothermal processing. 
2. To characterize morphology of sol-gel-hydrothermal synthesized powders, 
and quantitatively asses particle diameter distribution and aspect ratio. 
3. To determine the effect of reaction pH and time on the control of particle 
diameter and length of sol-gel-hydrothermal synthesized powders. 
4. To characterize HA crystals, presence of functional groups, and calcium to 
phosphorous ratio. 
5. To fabricate HA/PCL nanocomposite biomaterials and assess HA particle 
distribution within the composite, and the resulting composite’s mechanical 
properties. 
Hypotheses 
1. The nano-scale amorphous CaP precursors prepared by sol-gel chemistry 
provide a nano-precursor starting material for the synthesis of HA nano-wires. 
2. The morphology of the HA powders, including particle diameter and length, 
can be controlled by adjusting hydrothermal reaction conditions and kinetics. 
3. The nano-scale HA disperses homogenously within a PCL matrix, and 
effectively reinforces the HA/PCL composites. 
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1.7.2 Control of Surface Topography in Biomimetic Calcium Phosphate 
Coatings 
Rationale – The tailored design of surface topography offers an effective and 
facile strategy to improve the biological performance of implant and scaffold materials. 
In vitro cultures using osteoblasts have shown a remarkable osteogenic response to 
roughened biomaterial surfaces, with studies showing increased levels of differentiation 
and mineralization [157, 179]. Several in vitro and in vivo studies have identified an ideal 
surface roughness (Ra) in the range of 1 – 7 µm for inducing optimal changes in 
osteoblast behavior and stimulation of bone formation [148, 156, 157]. However, despite 
the multitude of research studies showing the potential of surface roughness to regulate 
osteogenic responses to biomaterials, few studies have attempted to directly design and 
control the surface topography of biomimetic coatings [180].  
 
Objectives 
1. To develop a method to control the surface topography and roughness of 
biomimetic HA coatings. 
2. To assess the effect of SBF ion concentration and soaking time on the 
deposition of biomimetic CaP coatings. 
3. To evaluate the CaP crystallography, presence of functional groups, and 
calcium to phosphorous ratio of deposited CaP coatings. 
4. To evaluate and target HA coatings with isotropic surface topography and 
roughness at low and high resolution by characterization using profilometer 
and atomic force microscopy. 
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Hypotheses 
1. The ionic concentrations of SBF and soaking time have controllable and 
reproducible effects on the surface topography of deposited CaP coatings. 
2. HA coatings consisting of isotropic and complex surface topography can be 
deposited having surface roughness parameters within the range considered 
ideal for osteoblast differentiation and bone formation (Ra = 1 – 7 µm). 
 
1.7.3 Surface Topography of Biomimetic Hydroxyapatite Coatings 
Differentially Regulates Osteoblast and Osteoclast Activity 
Rationale – Biomaterials for orthopedic and dental applications may be coated 
with biomimetic HA to improve their bioactivity and osteoconductivity [96], and thus 
facilitating the in vitro differentiation of osteoblastic cells [181] and bone growth in vivo 
[66, 71, 182]. Furthermore, biomimetic carbonated-HA coatings are resorbed by 
osteoclasts in vitro, with classical resorption lacunae [171].  
In vitro investigations using preosteoblasts cultured in osteogenic medium 
revealed differential cell viability, proliferation, and gene expression, towards 
biomimetic HA having varying crystal size [153]. The authors suggested that 
preosteoblasts respond to small changes in the apatite microstructure. However, the 
authors did not characterize the macroscopic surface topography and roughness. 
Therefore, it is not known whether changes in osteoblast behavior were due to 
differences in apatite crystal structure or the nano- and micro-topography of the HA 
coatings. Furthermore, the effect of surface topography on osteoclast activity remains 
poorly defined. Few studies have attempted to investigated the influence of biomaterial 
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surface roughness on osteoclast behavior. Those studies that have examined this question 
have reported widely varying results and utilized HA discs with roughness parameters 
well below those accepted as ideal for biomaterial design [174, 175]. 
 
Objectives 
1. Determine the in vitro effect of surface topography of biomimetic HA on 
primary osteoblast attachment and focal adhesion formation. 
2. Measure the gene expression of osteogenic marker genes (collagen I, alkaline 
phosphatases and osteocalcin) by osteoblasts cultured in vitro on biomimetic 
HA coatings with varying surface roughness considered ideal for biomaterial 
design. 
3. Determine the effect in vitro of surface topography of biomimetic HA on 
TRAP activity and attachment of authentic osteoclasts. 
4. Determine the effect of surface topography of biomimetic HA on osteoclast 
resorptive activity in vitro. 
5. Assess the F-actin organization in the resorption apparatus of osteoclasts 
cultured on biomimetic HA with differential surface topographies. 
Hypotheses 
1. Biomimetic HA coatings with isotropic, complex and rough surface 
topography improve the attachment and differentiation of osteoblasts in vitro. 
2. Surface roughness regulates the activity of authentic osteoclasts in vitro. 
 
In Chapter 2, a novel synthesis method for the production of HA powders 
consisting of high aspect-ratio nanowires will be presented. The carbonated-HA 
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nanowires will be used as bioactive, reinforcing filler in a synthetic polymer matrix to 
yield nanocomposite biomaterials for application in bone regeneration. Chapter 3 will 
focus on the deposition of biomimetic CaP coatings on synthetic polymers. In particular, 
the control of surface topography of HA coatings will be demonstrated. Chapter 4 reports 
on the effect of the surface topography of these biomimetic HA coatings on the behavior 
of osteoblasts and osteoclasts. Chapter 5 will present our overall summary and 
conclusions, with a general discussion, as well as suggestions for future studies. 
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CHAPTER TWO 
 
 
 
ONE- AND THREE-DIMENSIONAL GROWTH OF 
HYDROXYAPATITE NANOWIRES DURING SOL-GEL-
HYDROTHERMAL SYNTHESIS1 
 
 
 
 
 
 
 
 
 
  
                                                
 
1Chapter 2 has been reproduced (with some modifications ) with permission from:  
Costa, D. O., Dixon, S. J., and Rizkalla, A. S. (2012). One- and three-dimensional   
growth of hydroxyapatite nanowires during sol-gel-hydrothermal synthesis. Acs Applied 
Materials & Interfaces, 4(3), 1490-1499. Copyright © 2012, American Chemical 
Society. 
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2.1 Chapter Summary 
Nanoscale hydroxyapatite (HA) is an optimal candidate biomaterial for bone 
tissue engineering due to its bioactive and osteoconductive properties. In this study, 
micro- and nano-scale HA particles with rod and wire-like morphology were synthesized 
by a novel sol-gel-hydrothermal process. Sol-gel chemistry was used to produce a dry gel 
containing amorphous calcium phosphate (ACP), which was used as a precursor material 
in a hydrothermal process. The sol-gel-hydrothermal products were characterized by 
scanning electron microscopy (SEM), X-ray diffraction (XRD), and Fourier transform 
infrared spectroscopy (FTIR) to determine particle morphology, crystal structure, and the 
presence of chemical functional groups. A pure HA crystal was synthesized, which 
underwent both one- and three-dimensional growth, resulting in tunable microrod and 
nanorod, and wire morphologies. The effects of solution pH and reaction time on particle 
diameter and length were assessed. Particle diameter ranged from 25 nm to 800 nm and 
decreased with increase in solution pH, while both particle length and diameter increased 
as the hydrothermal process was prolonged. Nanowire HA powders (10-50 wt%) were 
mixed with poly(ε-caprolactone) (PCL) to produce PCL/HA composites. Fracture 
surfaces of PCL/HA composites showed a well-dispersed and homogeneous distribution 
of HA nanowires within the PCL matrix. Mechanical testing revealed a significant 
(p<0.05) increase in the Young’s and compressive moduli of PCL/HA composites 
compared to PCL alone, with 50 wt% HA producing a 3-fold increase in Young’s 
modulus from 193 to 665 MPa and 2-fold increase in compressive modulus from 230 to 
487 MPa. These HA nanowires can be used to reinforce polymer composites and are 
excellent biomaterials for tissue engineering of bone.  
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2.2 Introduction 
 Hydroxyapatite (HA), Ca10(PO4)6(OH)2, is a synthetic ceramic that has attracted 
much attention for biomedical applications owing to its chemical and structural similarity 
to the mineral constituent of human bone and teeth [1]. HA is biocompatible and 
osteoconductive [2], serving as an excellent biomaterial for use as bone graft substitutes 
[3], and implant coatings [4]. In particular, HA powders consisting of micro- and nano-
sized particles, can be used to reinforce polymer composites [5, 6], and calcium-
phosphate bone cements [7, 8]. 
Two common methods of HA synthesis are sol-gel and hydrothermal processes. 
Sol-gel synthesis methods involve atomic level molecular mixing, providing control of 
composition and chemical homogeneity [9, 10]. However, sol-gel powders require 
calcination at high temperature in the presence of air to produce crystalline products. 
Moreover, sol-gel HA synthesis is often accompanied by the formation of secondary 
phases such as calcium oxide and tricalcium phosphate (TCP) [9, 10], and gives rise to 
granular particle shapes [10, 11]. Alternatively, HA powders with controlled particle 
size, morphology and crystallinity have been successfully synthesized by a variety of 
hydrothermal methods [12, 13].  Hydrothermal homogenous precipitation is capable of 
producing HA whiskers with high aspect ratio [14]. However, the HA whiskers have 
diameter and length scales in the micron-range, and it is known that having at least one 
dimension in the nano-scale size range optimizes the biological and mechanical 
functionality of HA [15-17]. Recently, HA nanowires and hollow microspheres were 
synthesized by hydrothermal processing of xonolite nanowire and calcium carbonate 
microsphere precursors of similar micro- and nano-scale dimensions [18]. It was found 
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that the scale and structure of the precursor material dictated the final morphologies of 
the HA product. Furthermore, hydrothermal treatment of calcium silicate-based starting 
materials can produce various element-substituted HA nano-structures [19]. Thus, in 
hydrothermal processes, characteristics of the precursors determine crystal nucleation 
and growth, and therefore dictate the final morphology of the product. Surfactants and 
reverse micelle solutions in solvothermal processes can be used to produce nanowires 
and nanorods of varying aspect ratios [20-22]. Surfactants provide organized organic 
templates that guide the synthesis and growth of inorganic nanomaterials through 
geometric, electrostatic and stereochemical interactions. However, HA products from 
solvothermal synthesis are typically of low aspect ratio [21-23], and highly aggregated 
[20, 23], and the presence of surfactants and solvents during the solvothermal process 
may result in undesired organic components being incorporated into the final HA 
products [21, 23, 24]. Therefore, the goal of the present study was to develop a method 
for the synthesis of HA nanowires with high aspect ratio.  
In the present study, a novel method is presented for the synthesis of HA 
nanowires with high aspect ratio. Sol-gel chemistry was used to produce a nano-scale 
amorphous calcium phosphate (ACP). The subsequent nano-ACP was subjected to 
hydrothermal treatment in aqueous solvent to induce the formation of crystalline HA 
micro- and nanowires. To our knowledge, this is the first report of the synthesis of high 
purity HA nanowires by a tunable crystal growth mechanism using a combination sol-
gel-hydrothermal method. By varying the initial pH of the aqueous solvent/sol-gel 
precursor mixture and the hydrothermal synthesis time, HA powders with varying 
particle diameters and lengths were obtained. This aqueous based hydrothermal treatment 
of a sol-gel product is a simple, cost effective, and environmentally friendly synthesis 
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route, offering a high degree of control on the particle morphology of the HA product. 
The as produced nano-scale HA powders were used as a reinforcing filler in 
polycaprolactone (PCL) composites. These nano-scale HA-embedded PCL composites 
mimic the nano-apatite/collagen composite of bone. Therefore, such materials are 
excellent candidates for the production of scaffolds for bone tissue engineering 
applications. 
 
2.3 Materials and Methods 
2.3.1 Materials  
Triethyl phosphite (TEP, 98%), calcium nitrate tetrahydrate (CaNO34H2O, 99%), 
sodium hydroxide (NaOH, 98.5%), ammonium hydroxide (NH4OH, 30%), anhydrous 
ethanol (EtOH), and dichloromethane (DCM, 99.5%) were purchased from Sigma-
Aldrich (Milwaukee, WI). Poly(ε-caprolactone) (PCL) (CAPA 6800, MW 80 000 g/mol) 
was generously donated by Solvay Chemicals Inc. (Houston, TX). 
 
2.3.2 Preparation of dried Calcium Phosphate (CaP) Gel  
A dry CaP gel was prepared by a sol-gel method similar to that developed by Liu 
et al [10]. Briefly, TEP solution was diluted in EtOH such that the concentration was 1.8 
M. A small amount of water was added to the phosphite sol (6:1 molar ratio), and the 
mixture was sealed in a round-bottom flask and stirred vigorously for 30 min. The 
solution was allowed to age for 24 h to ensure complete hydrolysis of phosphite. A 
stoichiometric amount of CaNO3•4H2O dissolved in EtOH, was added drop-wise to the 
phosphite sol such that the Ca/P ratio was 1.67. The resulting mixture was stirred 
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vigorously for 30 min and aged at room temperature for 24 h. The sol was dried at 80 °C 
to produce a white gel which was ground to a fine powder using a mortar and pestle.  
 
2.3.3 Hydrothermal Treatment 
For hydrothermal treatment, 0.5 g of the dried CaP gel was suspended in 30 ml 
aqueous solution and vigorously stirred for 30 min. Aqueous solutions used as 
suspension medium were selected to achieve the desired pH. Aqueous solvents included 
deionized H2O, NH4OH (0.1 M) and NaOH (5 M). Suspensions were ultrasonically 
treated for 5 min and vigorously stirred for 30 min. The effect of pH on HA synthesis 
and particle morphology was determined by setting the initial pH of the CaP gel aqueous 
suspension to 5.20, 7.50 or 13.70. Suspensions were poured into a 125-ml Teflon-lined 
acid digestion bomb (Parr Instrumentation Company, Moline, IL) and heated to 170 °C 
using a band heater. Heating was regulated using a thermocouple, and a temperature and 
process controller (iSeries, Omega, Stamford, CT). For each initial pH condition, the 
hydrothermal treatment time was 6, 16 or 24 h. At the end of each time period, the bomb 
was cooled by means of a fan to room temperature and the product, which formed as 
white precipitates, had settled to the bottom of the Teflon liner. The aqueous solvent was 
carefully decanted and the particles were collected, washed with deionized H2O several 
times and sedimented. The recovered pellet was dried at 50 °C and ground into a fine 
powder using a mortar and pestle. 
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2.3.4 Scanning Electron Microscopy (SEM) and Energy Dispersive X-ray 
Spectroscopy (EDX)  
Particle morphology was examined using a FIB/SEM LEO 1540XB microscope 
(Carl Zeiss, Göttingen, Germany) equipped with an energy dispersive X-ray 
spectrometer for elemental analysis. Samples were first coated with 3 nm osmium metal 
using a Filgen OPC-80T instrument. Representative images were selected from three 
fields of view for each synthesis condition. Mean particle diameter calculations were 
determined by measuring a total of 300 particles from three fields of view (n=300) using 
ImageJ software (National Institutes of Health, USA). Elemental analysis of powders 
was performed by EDX on three fields of view for each synthesis condition (n=3). 
 
2.3.5 X-ray Diffraction Analysis (XRD)  
Crystal structures of the powders were determined by XRD using a Rotaflex RTP 
300 RC (Rigaku Co., Japan) operating on CoKα radiation at 45 kV and 160 mA. Spectra 
were collected in the 2θ range between 5° and 65°, with 0.05° step and 10°/min scan 
speed. 2θ for equivalent CuKα radiation was obtained using Bragg’s Law, λ = 2d·sin θ, 
where λ = 1.54056 and 1.79026 Å for Cu and Co, respectively [25]. 
 
2.3.6 Fourier Transform Infrared Spectroscopy (FTIR)  
Functional group identification of the CaP gel and hydrothermally synthesized 
powders were obtained by FTIR using a Bruker Vector 22 (Bruker Optics LTD, Milton, 
ON). Specimens were prepared by mixing 4 wt% of each sample with potassium 
bromide (KBr) and then pressing into a pellet. Specimens were analyzed at a resolution 
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of 4 cm-1 and transmittance spectrums from 4000 to 500 cm-1 wavenumbers were 
collected. 
 
2.3.7 Preparation of PCL and PCL/HA Composites 
PCL specimens were prepared by dissolving PCL pellets in DCM to produce a 12 
wt% PCL mixture. The solvent was allowed to evaporate in a fume hood to yield a PCL 
film. The PCL film was heat-pressed at 100 °C and 670 N for 2 min. PCL/HA 
composites were produced by adding HA powder, synthesized at a pH of 13.70 for 24 h, 
to DCM and stirring for 15 min, and sonicating for 5 min. PCL was then added to the 
HA/DCM suspension to produce a PCL/HA slurry containing 10-50 wt% HA. The 
PCL/HA slurry was cast in a glass dish and the solvent evaporated in a fume hood. The 
resulting PCL/HA films were heat pressed at 100 °C and 670 N for 2 min. Fracture 
surfaces of PCL/HA composites were prepared for SEM analysis and EDX elemental 
mapping by submerging 60:40 (w/w) PCL:HA samples in liquid nitrogen and subsequent 
fracturing. 
 
2.3.8 Mechanical Testing of PCL/HA Composites  
Mechanical properties were determined using an Instron 3345 universal testing 
machine (Instron, Canton, MA) equipped with a 500 N (tension) and 5 kN (compression) 
load cell. For tensile testing, 10 mm x 30 mm specimens were cut from the PCL and 
PCL/HA films using a sharp blade. For compressive tests, cylindrical specimens 
(diameter=6 mm, length=5-9 mm) were prepared by slicing the PCL and PCL/HA films 
and adding 0.3 g to a stainless steel mold. The mold was heated at 100 °C for 30 min and 
72 
 
 
heat pressed at 100 °C and 670 N for 2 min. Prepared specimens were soaked in 
deionized H2O at 37 °C for 24 h prior to testing. For each group, 5 independent 
specimens (n=5) were tested in tension and compression at a crosshead speed of 1 
mm/min. Stress-strain relationships were obtained from the load and displacement data. 
The Young’s and compressive moduli were determined by calculating the slope of the 
linear portion of the stress-strain curves. The tensile strength, defined as the maximum 
stress achieved, and the compressive stress at 10% strain were obtained from the stress-
strain curves of each specimen.  Nonlinear regression analysis was performed to 
determine the correlation between HA content and the stiffness and strength of the 
PCL/HA composites. 
 
2.4 Results 
2.4.1 FTIR, XRD, and SEM Analysis of CaP Gel  
Drying of the aged sol at 70 °C removed the EtOH solvent and produced a white 
gel. FTIR (Fig. 2.1 (a)) and XRD (Fig. 2.1 (b)) spectra of the CaP gel were obtained. 
From FTIR of the CaP gel (Fig. 2.1 (a)), typical peaks attributed to PO43- groups are seen 
by the sharp ν3 P-O asymmetric stretching band at 1040 cm-1 and a broad band in the 
range of 600-500 cm-1, characteristic of O–P–O bending of the ν4 PO43- groups in apatite 
[26]. This featureless broadband suggests a disordered phosphate structure in the CaP 
gel, indicating the presence of ACP in the CaP gel precursor [1]. Crystalline nitrate peaks 
are also evident at 730, 812, 1350, and 1420 cm-1. P-H and P=O at 2450 cm-1 and 1100 
cm-1, respectively, are characteristic of hydrolyzed phosphite. H2O in the precursor 
produced a significant broad band at 3400 cm-1 and sharp peak at 1630 cm-1. XRD 
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spectra of the CaP gel (Fig 2.1 (b)) confirms the presence of a crystalline nitrate in the 
form of Ca(NO3)2 anhydride. All visible peaks in the XRD spectra could be ascribed to 
Ca(NO3)2, with the major peaks at 2θ = 20.2, 26.2 and 41.1° (JCPDS # 7-204) [27]. SEM 
was performed on a large particle of the CaP gel after being ground by mortar and pestle 
(Fig. 2.1 (c)). The surfaces of CaP gel particles were featureless, typical of amorphous 
products [28]. 
In summary, FTIR and SEM analyses of the CaP gel indicated the successful 
synthesis of an ACP precursor. 
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Figure 2.1 Dried CaP Gel. (a) FTIR, (b) XRD and (c) SEM of the CaP gel produced 
after drying the 24 h aged sol-gel at 70 °C. Representative of two independent 
samples. At the bottom of the XRD spectrum is the Joint Committee on Powder 
Diffraction Standards (JCPDS # 7-204) pattern for Ca(NO3)2 [27]. Scale bar = 1 µm. 
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2.4.2 SEM Analysis of Powders Produced by Hydrothermal Treatment 
The combination of a sol-gel method with hydrothermal treatment produced 
powders consisting of particles having micro- and nanowire shapes. When the initial pH 
of the aqueous solvent/CaP gel suspension was slightly acidic at 5.20, powders 
consisting of particles with diameters ranging from 20 – 800 nm were produced (Fig 2.2 
(a-c)). The image and frequency distribution plot at 6 h (Fig. 2.2 (a)) revealed short 
nanorods with diameters of 30 nm as determined from the best fit value of the non-linear 
regression curve. Increasing the hydrothermal reaction time to 16 h (Fig. 2.2 (b)) resulted 
in growth of the long axis of the particle, with only a minor increase in the diameter. 
Further crystal growth was seen by extending the reaction time to 24 h, which increased 
particle length and radial growth (Fig. 2.2 (c)). The SEM images and corresponding 
frequency distribution plots highlight the dependence of particle morphology on 
hydrothermal time. Allowing the hydrothermal reaction to proceed to 24 h resulted in a 
large shift of the mean particle diameter to 300 nm and broadening of the particle 
diameter distribution plots (Fig. 2.2 (d)), indicating greater inhomogeneity in particle 
diameter. The particles varied from short nanorods with L/D (length/diameter) of ∼ 9 at 6 
h to nanowires and microwires with L/D in the range of 50 to 80 at both 16 and 24 h. 
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Figure 2.2 Hydrothermal synthesis at pH 5.20: (i) SEM images and (ii) particle 
diameter frequency distribution plots of CaP gel powders after hydrothermal treatment 
for (a) 6 h, (b) 16 h, and (c) 24 h. Hydrothermal time effect illustrated by (d) non-
linear regression curves of the particle diameter distributions obtained from measuring 
100 particle diameters for three fields of view (n = 300). Scale bar = 500 nm. 
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Increasing the initial pH using NH4OH or NaOH permitted tuning of nanowire 
diameter. The addition of aqueous NH4OH (0.1 M) to H2O slurries was used to achieve a 
pH of 7.50. SEM micrographs (Fig. 2.3 (a-c)) showed substantial reduction in particle 
diameter compared to powders produced under acidic conditions, with particle diameters 
ranging from 20 to 200 nm. Six-h hydrothermal reaction produced short nanorods having 
diameters of 35 nm and a narrow size distribution (Fig. 2.3 (a)). Extending the 
hydrothermal time to 16 h resulted in the formation of nanowires with growth in the long 
axis (Fig. 2.3(bi)), whereas little growth was seen in the radial direction as illustrated by 
the comparable distribution plots at 6 and 16 h (Fig. 2.3 (aii) versus Fig. 2.3 (bii)). In 
contrast, crystal growth in both the long axis and radial directions occurred at 24 h (Fig. 
2.3 (c)), giving rise to a broad distribution in particle diameter (Fig. 2.3 (cii)). When 
compared to the particle morphology observed at earlier time points, the 24 h reaction 
time resulted in a distribution that was no longer represented by a Gaussian distribution, 
but rather was skewed to the right due to the crystal growth along the radial axis (Fig. 2.3 
(d)). The particles varied from long nanorods with L/D of ~ 15 at 6 h to nanowires with 
L/D in the range of 60 to 90 at 16 and 24 h. 
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Figure 2.3 Hydrothermal synthesis at pH 7.50: (i) SEM images and (ii) particle 
diameter frequency distribution plots of CaP gel powders after hydrothermal treatment 
for (a) 6 h, (b) 16 h, and (c) 24 h. Hydrothermal time effect illustrated by (d) non-
linear regression curves of the particle diameter distributions obtained from measuring 
100 particle diameters for three fields of view (n = 300). Scale bar = 500 nm. 
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When aqueous 5 M NaOH was used to increase the initial pH to 13.70, there was 
a further reduction in particle diameter (Fig. 2.4 (a-c)), with the majority of particle 
diameters ranging from 15 to 100 nm. Nanorods produced after 6 h (Fig. 2.4 (a)), 
underwent crystal growth resulting in the formation of long nanowires by 16 h, the 
majority of which had diameters of ~25 nm (Fig. 2.4 (b)). Further hydrothermal 
treatment induced radial crystal growth resulting in a bimodal distribution of diameters, 
with nanowires having diameters in the ranges of 25 to 50 nm and 55 to 75 nm (Fig. 2.4 
(cii)). In contrast to the crystal growth observed at lower pH (5.20 and 7.50), the non-
linear regression curves for pH 13.70 did not display as large an increase in breadth at 24 
h (Fig 2.4 (d)), although there was a slight increase in mean diameter. Particles varied 
from long nanorods with L/D ~ 17 at 6 h to nanowires with L/D in the range of 60 to 100 
at 16 and 24 h. We also assessed whether processing (sedimentation and grinding) 
affected the morphology of the micro- and nanowires. Using SEM, we found no apparent 
difference in the morphology of samples that were processed (Figs. 2.2-2.4) versus those 
that were not (Fig. 2.5). 
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Figure 2.4 Hydrothermal synthesis at pH 13.70: (i) SEM images and (ii) particle 
diameter frequency distribution plots of CaP gel powders after hydrothermal treatment 
for (a) 6 h, (b) 16 h, and (c) 24 h. Hydrothermal time effect illustrated by (d) non-
linear regression curves of the particle diameter distributions obtained from measuring 
100 particle diameters for three fields of view (n = 300). Scale bar = 500 nm. 
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Figure 2.5 SEM analysis of HA micro- and nanowires synthesized for 24 h under 
hydrothermal conditions at initial pH of (a) 5.20, (b) 7.50, and (c) 13.70. SEM images 
reveal no observable difference in particle morphology as compared to powders that 
have been washed and recovered by centrifugation. Scale bar = 500 nm. 
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The average particle diameters (Table 2.1) showed no statistical differences 
(p>0.05) between powders produced at 6 and 16 h for any of the initial pH values, 
indicating that any observed growth occurs exclusively at the long axis of the particles. 
However, prolonging the hydrothermal treatment to 24 h resulted in significant increases 
(p<0.05) in the nanowire diameter as crystal growth occurred at the radial axes. The 
effect of initial pH on the particle diameter is not significant (p>0.05) at 6 and 16 h. 
However, at 24 h, there were significant decreases in diameter with increasing pH 
(p<0.05).  
These results demonstrate the ability to produce nanorods and nanowires with 
tunable aspect ratios by applying a hydrothermal treatment to a dried sol-gel product 
composed of ACP. 
 
Table 2.1 Particle Diameter of Sol-Gel-Hydrothermal Powders. 
 Particle Diameter (nm) 
pH 6 h 16 h 24 h 
5.20 32.6 ± 0.5a 36.3 ± 0.6a 343.2 ± 10.5b 
7.50 38.9 ± 1.3a 38.9 ± 0.6a 65.8 ± 2.3c 
13.70 29.8 ± 0.7a 38.3 ± 1.5a,d 44.2 ± 2.3d 
Particle diameter values are mean ± SD calculated from the average of 3 fields of view and 100 
measurements per field of view (n=300). Statistical significance determined by a two-way ANOVA and a 
Bonferroni post-test. Effect of hydrothermal time and pH on particle diameter was determined, where 
matching letters indicate groups with no statistical difference (p>0.05) in particle diameter values as 
measured using ImageJ software. 
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2.4.3 XRD Analysis of Nanoparticles Produced by Hydrothermal 
Treatment 
For all durations of hydrothermal treatment, the XRD spectra of powders 
produced with an initial pH of 5.20 or 7.50 revealed a crystalline and pure HA (Fig. 2.6 
(a, b)). All visible peaks in the XRD spectra could be ascribed to HA, with the major 
peaks at 2θ = 31.8, 32.2 and 32.9° corresponding to the (211), (112) and (300) diffraction 
planes of crystalline HA (JCPDS # 9-432) [1, 27]. 
XRD spectra of the powders produced at an initial pH of 13.70 (Fig. 2.6 (c)) 
indicated the presence of Ca(OH)2 in conjunction with HA at 6 h of hydrothermal 
treatment (revealed by peaks at 2θ = 18.1, 34.5 and 47.2°; JCPDS # 44-1481) [27]. 
However, when the hydrothermal synthesis time was extended to 16 and 24 h, only HA 
was detected.  
The HA powders produced after 24 h, independent of the initial pH, displayed a 
stronger preference for the (300) XRD reflection (2θ = 32.9°) compared to the JCPDS 
standard, consistent with crystal growth along the c-axis which leads to increased 
development of the a-plane [12]. The XRD spectra of the as produced powders indicated 
the successful synthesis of crystalline HA nano-rods and wires with varying aspect ratios.  
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Figure 2.6 XRD spectra of the CaP gel after hydrothermal treatment in aqueous 
solvent at initial pH of (a) 5.20, (b) 7.50 and (c) 13.70 for 6, 16 and 24 h. 
Representative of two independent samples. At the bottom of each spectrum is the 
Joint Committee on Powder Diffraction Standards (JCPDS # 9-432) pattern for HA 
[27]. 
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2.4.4 FTIR Characterization of Nanoparticles Produced by Hydrothermal 
Treatment 
FTIR analysis confirmed the synthesis of HA after hydrothermal treatment of the 
CaP gel precursor (Fig. 2.7 (a-c)). Similar bands were observed for powders produced at 
the different initial pH values and spectra are in good agreement with IR data reported 
for HA [26]. Characteristic peaks of PO43- groups are clearly visible at 1091 and 1028 
cm-1 for the ν3 asymmetric stretching mode of the P–O bond, and 960 cm-1 for the ν1 
symmetric stretching mode of the P–O bond. Additionally, the broad, featureless peak in 
the range 600-500 cm-1, which was initially seen in the spectra of the CaP gel (Fig. 
2.1(a)), resolved into well-defined bands at 600 and 561 cm-1 attributable to the ν4 
bending mode of the O–P–O bond of PO43- groups found in apatite.  
Hydroxyl (OH) groups were identified by peaks at 3570 and 631 cm-1, ascribed to 
the stretching and librational modes of hydroxyl anions, the latter indicating a well-
developed OH component in the apatite structure [26, 29]. CO32- substitution in the HA 
lattice is noticeably absent for HA produced at pH 5.20 and 7.50. CO32- substitution was 
only seen at the elevated pH of 13.70 (Fig. 2.7 (c)), signified by the presence of broad 
bands at 1450 and 1415 cm-1 (A and B-type HA), and sharp peak at 877 cm-1 (A-type 
HA), typical of partial CO32- substitution [1, 26]. For pH 13.70, the absence of the 
librational band of OH- (631 cm-1) at 6 and 16 h suggests possible CO32- substitution for 
OH groups characteristic of A-type HA [1]. The additional stretching peak at 3644 cm-1 
(Fig. 2.7 (c)) at 6 h is associated with the presence of Ca(OH)2 [30]. The decrease in 
CO32- bands at 1450, 1415 and 877 cm-1 from 6 to 24 h correlates with the appearance of 
the OH librational peak at 631 cm-1, consistent with a decrease in CO32- substitution. 
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CO32- substitution is likely due to the presence of atmospheric CO2, which dissolved in 
the H2O used for slurry preparation and hydrothermal processing. 
 
2.4.5 EDX Elemental Analysis of Nanoparticles Produced by Hydrothermal 
Treatment  
EDX elemental analysis was used to measure the calcium to phosphorous (Ca/P) 
atomic ratio of HA powders produced after hydrothermal treatment (Table 2.2), and 
indicate a predominately stoichiometric HA crystal (Ca/P ≈ 1.67). There was no 
significant difference (p>0.05) among the Ca/P ratios of the HA powders synthesized at 
different pH conditions or hydrothermal treatment times, with the exception of HA 
produced at pH 13.70 for 6 h (p<0.05). The powder synthesized at pH 13.70 for 6 h is a 
mixture containing HA and Ca(OH)2, as determined by XRD (Fig 2.6 (c)), which 
accounts for the elevated Ca/P atomic ratio. Even at 16 and 24 h, the Ca/P atomic ratio of 
HA synthesized at pH 13.70 was higher compared to the other pHs (although this was 
not significant), likely reflecting lower PO43- content. FTIR spectra of HA synthesized at 
pH 13.70 (Fig. 2.7 (c)) indicate the presence of CO32- bands for both A and B-type HA. 
Therefore, it is possible that the higher Ca/P atomic ratios are attributed to partial 
substitution of CO32- for PO43- in the HA crystal lattice characteristic of B-type HA [31].  
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Figure 2.7 FTIR transmittance spectra of the CaP gel after hydrothermal treatment in 
aqueous solvent at initial pH of (a) 5.20, (b) 7.50 and (c) 13.70 for 6, 16 and 24 h. 
Representative of two independent samples. 
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  In summary, the EDX analysis indicated the synthesis of stoichiometric HA at pH 
5.20 and 7.50, whereas an initial pH of 13.70 appeared to yield a Ca-rich, B-type CO32--
substituted HA. Thus, the EDX results, combined with SEM, XRD and FTIR, reveal a 
pH of 13.70 and hydrothermal treatment time of 16 – 24 h as ideal for the synthesis of A- 
and B-type CO32--substituted HA nanowires. In this regard, CO32--substituted HA is 
thought to be more bioactive than stoichiometric HA [31].  
 
Table 2.2 Ca/P Atomic Ratio of Sol-Gel-Hydrothermal Powders. 
 Ca/P 
pH 6 h 16 h 24 h 
5.20 1.68 ± 0.03a 1.60 ± 0.04a 1.68 ± 0.04a 
7.50 1.66 ± 0.06a 1.60 ± 0.06a 1.71 ± 0.10a 
13.70 3.71 ± 1.62b 1.89 ± 0.03a 2.19 ± 0.23a 
Ca/P values are mean ± SD calculated from the average of 3 fields of view (n=3). Statistical significance 
was determined by a two-way ANOVA and a Bonferroni post-test. Effect of hydrothermal time and pH on 
Ca/P was determined, where matching letters indicate groups with no statistical difference (p>0.05) in 
Ca/P values as measured using EDX. 
 
 
 
 
 
 
2.4.6 Characterization of PCL/HA Composites  
Composite biomaterials were prepared by combining HA nanowires as 
reinforcing filler with a PCL matrix. HA nanowires (produced by hydrothermal treatment 
at pH 13.70 for 24 h) were mixed with PCL in the following ratios (PCL:HA, w/w): 
90:10, 80:20, 70:30, 60:40 and 50:50. Fractured surfaces of PCL/HA composites 
comprising 40 w/w % HA were characterized by SEM and EDX elemental mapping 
(Fig. 2.8) to determine the distribution of HA nanowires in the PCL matrix.  SEM image 
(Fig. 2.8 (a)) of a fractured PCL/HA composite showed a uniform matrix, free of void 
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spaces. EDX elemental mapping of the same field demonstrates a relatively 
homogeneous distribution of carbon (Fig. 2.8 (b)), the major elemental component of 
PCL. Furthermore, EDX mapping of calcium (Fig. 2.8 (c)) and phosphorus (Fig. 2.8 (d)), 
found exclusively in HA, reveals a uniform distribution. Higher magnification SEM 
images (Fig. 2.8 (e, f)) clearly showed HA nanowires embedded isotropically within the 
PCL matrix and in intimate contact with the polymer (arrow).  From the SEM analysis 
and EDX elemental mapping of PCL/HA composite fracture surfaces, we conclude that 
HA nanowires were uniformly and homogeneously distributed throughout the composite 
biomaterial.  
The Young’s modulus and tensile strength of PCL and PCL/HA composites were 
determined by uniaxial tensile testing (Fig. 2.9). An exponential increase (p<0.05) in the 
Young’s modulus was observed with increase in the HA content (Fig. 2.9 (a)). On the 
other hand, an increase in HA content resulted in an exponential decrease (p<0.05) in the 
tensile strength of the composites compared to unfilled PCL (Fig. 2.9 (b)). 
Similarly, compressive modulus and stress at 10% strain increased exponentially 
(p<0.05) with HA content (Fig. 2.10 (a, b)). It was noted that during compressive testing 
of PCL and PCL/HA composites, bulging of the cylindrical specimens occurred resulting 
in an increase in the cross-sectional area of the specimens. This increase in cross-
sectional area, and the ductile nature of PCL and PCL/HA composites produced a 
continuous increase in the measured stress during deformation. Therefore, the 
compressive stress at 10% strain was chosen to assess the strength of PCL and PCL/HA 
composites.  
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Figure 2.8 SEM and EDX analysis of PCL/HA composites: (a) SEM image, and EDX 
elemental mapping of (b) carbon, (c) calcium, and (d) phosphorus of fractured surface 
of PCL/HA composite (40% HA synthesized by sol-gel-hydrothermal process at pH 
13.70 for 24 h) (scale bars = 400 µm). Higher magnification (e, f) SEM images of 
fractured surface show HA nanowires (e.g. arrow) embedded in the PCL matrix (scale 
bars = 500 nm). 
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Figure 2.9 Uniaxial tensile testing of PCL/HA composites: (a) Young’s modulus and 
(b) tensile strength of PCL/HA composites comprising 0-50 w/w % HA synthesized 
by sol-gel-hydrothermal process at pH 13.70 for 24 h. Young’s modulus and tensile 
strength values are the mean calculated from five independent samples (n=5) 
measured under uniaxial tension. Error bars are standard deviation. The solid line 
represents the nonlinear regression analysis fit of tensile test data (p<0.05). 
92 
 
 
 
  
Figure 2.10 Compressive testing of PCL/HA composites: (a) Compressive modulus 
and (b) compressive stress at 10% strain of PCL/HA composites comprising 0-50 w/w 
% HA synthesized by sol-gel-hydrothermal process at pH 13.70 for 24 h. Young’s 
modulus and tensile strength values are the mean calculated from five independent 
samples (n=5) measured under compression. Error bars are standard deviation. The 
solid line represents the nonlinear regression analysis fit of the compressive test data 
(p<0.05). 
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There was a significant increase in Young’s modulus (p<0.05) after the addition 
of 20-50% (w/w) HA, with more than a 3-fold increase from 193 MPa for unfilled PCL, 
to 665 MPa for specimens containing 40-50% (w/w) HA (Table 2.3). However, a 
significant decrease in tensile strength (p<0.05) is seen after the addition of 20% (w/w) 
HA.   
Comparable to its effect on Young’s modulus, the addition of 20-50% (w/w) HA 
to PCL significantly increased the compressive modulus (p<0.05) of the composites, 
with a maximum compressive modulus achieved with 50:50 (w/w) PCL/HA at 487 MPa 
(Table 2.3).  Furthermore, a significantly greater compressive stress at 10% strain 
(p<0.05) was observed after the addition of 30-50% (w/w) HA (Table 2.3). The largest 
stress value was observed for composites containing 50% (w/w) HA, with a value of 19.9 
MPa as compared to 12.7 MPa for unfilled PCL. 
 
Table 2.3 Mechanical Properties of PCL/HA Composites 
PCL:HA        
(w/w) 
Young’s 
Modulus (MPa) 
Tensile 
Strength (MPa) 
Compressive 
Modulus (MPa) 
Compressive 
Stress at 10% 
Strain (MPa) 100:0 193.1 ± 14.7a 13.0 ± 0.6a 229.0 ± 17.0a 12.7 ± 1.1  
90:10 241.8 ± 20.7a,b 10.6 ± 0.2a,b 232.3 ± 54.7a 12.7 ± 2.1a 
80:20 331.3 ± 12.8b,c 8.8 ± 1.5b,c 311.3 ± 17.0b 14.9 ± 0.7a,b 
70:30 401.8 ± 21.5c 8.2 ± 1.0b,c 312.0 ± 32.5b 15.5 ± 0.9b 
60:40 666.4 ± 54.3d 10.1 ± 0.7b 399.2 ± 13.6c 18.1 ± 0.2c 
50:50 671.8 ± 94.6d 6.6 ± 2.0c 486.5 ± 30.5d 19.9 ± 0.7c 
Mechanical properties are mean ± SD calculated from the average of five independent specimens (n=5) 
measured under uniaxial tension and compression. Statistical significance determined by a one-way 
ANOVA and Tukey’s multiple comparison test. Effect of HA filler content on mechanical properties of 
PCL/HA composites was determined, where matching letters indicate groups with no statistical difference 
(p>0.05). 
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2.5 Discussion 
 The synthesis of HA with nanowire morphology has been the subject of extensive 
research. The sol-gel-hydrothermal process described in the present study provides a 
novel method for the synthesis of HA with micro- and nanowire morphologies, without 
the use of organic solvents or surfactants. The synthesis of an amorphous precursor via a 
sol-gel approach in combination with hydrothermal crystallization results in a high-purity 
product and provides control over HA particle diameter and length. 
The formation of ACP in the sol-gel process occurs via the following stages: 1) 
hydrolysis of the phosphite sol, 2) interaction with the Ca2+ sol to produce colloidal CaP 
intermediates consisting of Ca–O–P bonds, which are thought to be stabilized by 
electrostatic repulsive forces and have oligomeric dimensions on the order of a few 
nanometers (polycondensation) [29], and 3) drying of the sol at 80 °C where ethanol and 
H2O are removed, resulting in thermal dehydration and further polycondensation of the 
colloidal CaP intermediates forming more Ca–O–P bonds and producing a dried CaP gel 
[10]. FTIR spectra of the CaP gel revealed that the CaP intermediates are amorphous. 
The spectra also suggested an incomplete reaction between the hydrolyzed phosphite and 
Ca2+ sol during the 24 h aging process. The visible P=O and P–H bands are likely due to 
the presence of hydrolyzed phosphite precursors in the CaP gel [29]. However the 
presence of the hydrolyzed phosphite precursor does not seem to disturb the formation of 
HA during the hydrothermal process.  
The 24 h aging step during sol-gel preparation is sufficient to produce a pure 
apatite-like ACP intermediate as shown in a previous study [32], and confirmed by FTIR 
of the CaP gel in the present study. The dried CaP gel is an agglomeration of small 
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particles with dimensions in the nano-scale range (~ 8 nm in diameter) [29]. These 
particles are assembled through weak van der Waals attractive forces, which allow for 
their facile dispersion and dissolution in aqueous solvents prior to hydrothermal 
processing [29]. It is this critical feature of the CaP gel precursor that allows for the 
successful synthesis of HA nanowires by hydrothermal processing [33]. 
Typical hydrothermal crystallization involves a transformation process via 
dissolution and precipitation where amorphous nano-particles act as a precursor for the 
formation of small crystalline nuclei (Fig. 2.11(a)) [23]. In the present study, the 
dissolution of the ACP intermediate in the hydrothermal solution provided a 
supersaturated medium containing apatite precursors. Subsequently, upon heating of the 
hydrothermal vessel, the energy input and high-pressure conditions produced crystalline 
nuclei that grew to form HA nano-rods and wires.  
The growth of the HA nanowires and the resulting particle morphology is 
governed by an Ostwald ripening process and diffusion-controlled crystal growth (Fig. 
2.11). The Ostwald ripening and Gibbs-Thompson theory state that larger crystals grow 
at the expense of dissolving smaller crystals, which are inherently less stable than the 
larger ones [34]. In diffusion-controlled crystal growth, the concentration of the ACP in 
the bulk solution is a critical factor [35].  
During crystal growth, the ACP diffuses from the bulk solution and approaches 
the solution-crystal interface. The autogenous pressure and high energy input of the 
hydrothermal process accelerates Brownian motion and provides efficient circulation of 
the ACP [36]. The concentration of ACP at the solution-crystal interface governs the 
solubility of the HA crystal faces by either rapid growth onto, or dissolution from the 
different faces depending on the concentration [35]. The atomic structure of the HA unit 
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cell makes the interfacial free energy of the (001) plane (perpendicular to the c-axis) 
greater than the other faces [37]. At a high critical concentration of ACP in the bulk 
solution, the chemical potential of the ACP is significantly greater than the chemical 
potential of the (001) face of HA [35]. At this stage, 1D growth occurs as the metastable 
ACP colloids migrate to the (001) face, causing the crystals to grow exclusively along 
the c-axis of HA. Such growth gives rise to the constant particle diameter and increasing 
particle length seen at early hydrothermal times from 6 to 16 h in Figures 2.2-2.4. When 
the hydrothermal process is extended to 24 h, the concentration of the ACP drops to a 
level where the overall chemical potential of the bulk solution decreases. This makes it 
difficult for the diffusion flux of ACP to preferentially go to the (001) face of HA. The 
result is 3D growth, in which ACP is shared by each face of the HA crystal and both 
particle diameter and length increase, giving rise to the broad distribution of particle 
diameters seen at pH 5.20, the skewed distribution at pH 7.50, and the bimodal 
distribution at pH 13.70. 
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Figure 2.11 Schematic diagram of sol-gel-hydrothermal formation mechanism 
showing (a) hydrothermal crystallization process involving (i) supersaturation of ACP 
nanoparticles resulting in the formation of crystalline nuclei, followed by (ii) crystal 
growth of large nanowires at the cost of smaller, less stable crystals, and (iii) Ostwald 
ripening process [24, 34]. The growth of HA nanowires is a (b) diffusion-controlled 
crystal growth process, which is governed by the ACP concentration in the bulk 
resulting in either 1D or 3D growth of HA [35]. Arrows near the crystal indicate the 
diffusion direction of the ACP molecules. 
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As evident from the XRD spectra, the evolution of the HA from 6 to 24 h at each 
pH value was associated with a relative increase in the (300) reflection. This in turn 
signifies expansion of the a-plane of HA, which corresponds to crystal growth along the 
c-axis. 
A marked effect of pH on particle diameter was observed. The solubility of HA 
decreases with increase in pH [1]. As a result of the lower solubility, smaller HA 
particles precipitate out of solution at higher pH levels as indicated by the significantly 
lower particle diameter values at 24 h.  
During in vivo and in vitro applications of biomaterials, maintaining the porosity 
and preventing collapse of the porous structure of scaffolds is a determining factor in 
their success [4]. In PCL/HA composites, the HA nanowires were uniformly distributed 
throughout the PCL matrix and mechanical testing demonstrated the reinforcing ability 
of HA nanowires. Nano-scale HA particles impart the stiffness and strength of 
bioceramics to the toughness and ductility of PCL. When HA nanoparticles are used as 
filler materials in polymer matrices, the nanoparticle diameter and aspect ratio govern the 
strengthening effect. The ideal filler material has the smallest possible particle diameter, 
while maximizing the particle length and thereby having a large aspect ratio [6, 38]. HA 
nanowires synthesized at pH 13.70 for 24 h were selected as the filler for reinforcement 
of PCL composites because the longest observable particle lengths were seen at 24 h and 
the smallest particle diameters were obtained at pH 13.70. Both the Young’s and 
compressive moduli of PCL/HA composites were significantly greater as compared to 
unfilled PCL. This increase in stiffness of the composite material will be beneficial for 
bone tissue engineering scaffolds. Furthermore, the inclusion of nano-scale HA particles 
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will impart the superior bioactive and osteoconductive properties of HA to the composite 
materials [3, 16]. 
In summary, the novel sol-gel-hydrothermal process described above is an 
effective method for the synthesis of phase-pure HA. The combination of a nanoscale 
ACP precursor produced by sol-gel chemistry, with a hydrothermal crystallization 
process results in the formation of HA with micro- and nanowire morphologies. This 
surfactant- and solvent-free process allows for tunable particle morphology, while 
maintaining the purity of the final HA product. These HA nanowires are effective fillers 
for the reinforcement of PCL/HA composites. 
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CHAPTER THREE 
 
 
 
CONTROL OF SURFACE TOPOGRAPHY IN BIOMIMETIC 
CALCIUM PHOSPHATE COATINGS1 
 
 
 
 
 
 
 
 
 
 
 
 
  
                                                
 
1Chapter 3 has been reproduced (with some modifications) with permission from:  
Costa, D. O., Allo, B. A., Klassen, R., Hutter, J. L., Dixon, S. J., and Rizkalla, A. S. 
(2012). Control of Surface Topography in Biomimetic Calcium Phosphate Coatings. 
Langmuir, 28(8), 3871-3880. Copyright © 2012, American Chemical Society. 
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3.1 Chapter Summary 
The behavior of cells responsible for bone formation, osseointegration and bone 
bonding in vivo are governed by both the surface chemistry and topography of scaffold 
matrices. Bone-like apatite coatings represent a promising method to improve the 
osteoconductivity and bonding of synthetic scaffold materials to mineralized tissues for 
regenerative procedures in orthopedics and dentistry. Polycaprolactone (PCL) films were 
coated with calcium phosphates (CaP) by incubation in simulated body fluid (SBF).  We 
investigated the effect of SBF ion concentration and soaking time on the surface 
properties of the resulting apatite coatings. CaP coatings were examined by scanning 
electron microscopy (SEM), X-ray diffraction (XRD), Fourier transform infrared 
spectrometry (FTIR) and energy dispersive X-ray spectrometry (EDX). Young’s 
modulus (Es) was determined by nanoindentation, and surface roughness was assessed by 
atomic force microscopy (AFM) and mechanical stylus profilometry.  CaP such as 
carbonate-substituted apatite were deposited onto PCL films. SEM and AFM images of 
the apatite coatings revealed an increase in topographical complexity and surface 
roughness with increasing ion concentration of SBF solutions. Young’s moduli (Es) of 
various CaP coatings were not significantly different, regardless of the CaP phase or 
surface roughness. Thus, SBF with high ion concentrations may be used to coat synthetic 
polymers with CaP layers of different surface topography and roughness to improve the 
osteoconductivity and bone bonding ability of the scaffold. 
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3.2 Introduction 
It is important that tissue engineering scaffolds possess surface chemistry and 
topography that promote cell attachment and differentiation [1]. To promote bone 
healing, a scaffold construct must provide osteogenic, osteoconductive or osteoinductive 
activity at the defect site [2]. For orthopedic and dental applications, calcium phosphate 
(CaP) coatings may render synthetic polymer scaffolds bioactive and osteoconductive, as 
well as improve biocompatibility [3]. Hydroxyapatite (HA) facilitates the attachment, 
proliferation and differentiation of human osteoblastic cells [4], and promotes the 
ingrowth of natural bone [5]. In vivo, various polymer scaffolds coated with a bone-like 
apatite layer show improved osteoconductivity and bone ingrowth compared to uncoated 
implants [6-8]. Apatite coatings have also been cited as a method to overcome fibrous 
tissue encapsulation of scaffolds, a common problem for synthetic polymers implanted in 
vivo [9]. 
Surface coatings of HA or bone-like apatite formed by a biomimetic process have 
been studied previously.  Investigators have produced a bone-like apatite layer on various 
types of organic polymer substrates and titanium metal by soaking in a simulated body 
fluid (SBF) with ion concentrations nearly equal to those of human blood plasma [10, 
11]. However, traditional SBF solutions require lengthy incubation times, typically more 
than 7 days, to produce a uniform apatite coating [12, 13]. Recent efforts to shorten the 
time needed for coating have focused on increasing ionic concentrations. A solution with 
5x the ion concentrations of typical SBF (5xSBF) is capable of depositing various 
crystalline CaP coatings, including carbonated-HA [14], octacalcium phosphate (OCP) 
[15], and dicalcium phosphate dihydrate (DCPD) [16], as well an amorphous calcium 
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phosphate (ACP) within 24 h [17]. The ACP coating can subsequently be converted to 
carbonated-HA by soaking in SBF solutions with crystal growth inhibitors Mg2+ and 
HCO3− [18]. Further increasing SBF ion concentrations (10xSBF) shortens the times for 
CaP deposition to hours [19].  
Surface topography, at the micron and submicron level, affect the attachment, 
proliferation and differentiation of cells on biomaterials [20-23]. Increase in surface 
porosity and roughness of biomaterials improves cellular attachment, proliferation, 
differentiation and bone-ingrowth [23, 24]. Furthermore, changes in HA 
microenvironment has shown an effect on osteoblast proliferation and expression of 
osteogenic markers, osteocalcin and bone sialoprotein [25]. Bone bonding to biomaterial 
surfaces is expected to occur if the material possesses topographical features at both the 
micron level and nanometer range [26]. Discrete nanocrystals of CaP, deposited on 
titanium implants with micron-scale surface roughness, can impart nano-scale surface 
complexity [27]. Implants with such coatings have exhibited improved osteoconduction 
and osseointegration in human clinical trials [28]. 
In view of the above, it would be beneficial to control the surface porosity and 
complexity of biomimetic CaP coatings. However, to the best of our knowledge only a 
few studies have attempted to control surface topography of apatite coatings by altering 
Mg2+ levels or pH of SBF [18, 29]. In the present study, apatite coatings were deposited 
on functionalized polycaprolactone (PCL) films by incubation in supersaturated SBF 
solutions. PCL is a biocompatible and biodegradable polymer, having a relatively slow 
rate of degradation making it an ideal scaffold for bone tissue engineering applications 
where a slowly degrading material is desired [30, 31]. Our objective was to investigate 
the effect of ionic concentration, level of crystal growth inhibitors (Mg2+, HCO3-) and 
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soaking time on the surface properties of the resulting CaP coatings deposited on PCL. 
CaP coatings with tailored surface topography have excellent potential future 
applications on scaffold matrices for bone tissue engineering and regeneration. 
 
3.3 Materials and Methods 
3.3.1 Polycaprolactone (PCL) Film Fabrication and Functionalization 
PCL pellets (5 g, molecular weight = 80,000 g/mol, Solvay Chemicals Inc., 
Houston, TX), were placed in an aluminum foil dish and heated at 120°C to produce a 
viscous liquid which was cooled in a refrigerator for 10 min. Uniform PCL films with a 
thickness of 1 mm were produced by heat pressing for 2 min at 70°C and 670 N.  
Specimens (15 mm diameter) were punched and washed with ethanol for 10 min, then 
dried at room temperature (RT).  Specimens were placed in 10 ml of a 5 M NaOH 
solution at 50 °C and 75 rpm shaking speed (MaxQ 4000, Barnstead) for 48 h.  
Specimens were then removed from the NaOH solution and washed ultrasonically with 
deionized water for 10 min and air dried at RT.  
   
3.3.2 Preparation of Modified Simulated Body Fluid (SBF) Solutions  
Modified SBF compositions (Table 3.1) were prepared based on work done 
previously [10]. Concentrations of ion species (Na+, K+, Mg2+, Ca2+, Cl-, HPO42-, SO42-) 
were adjusted to produce SBF solutions with approximate 5x (5xSBF-A), 7x (7xSBF-A) 
and 10x (10xSBF-A) ion concentrations by sequentially dissolving analytical grade 
CaCl2, MgCl2·6H2O, K2HPO4·3H2O, Na2SO4, KCl, and NaCl (Sigma-Aldrich, USA) in 
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deionized water.  NaHCO3 was added separately, prior to the start of the coating 
procedure (see section 3.3.3). Prior to addition of K2HPO4·3H2O, 1 M HCl solution was 
added to lower the pH to 1.75 to increase solubility. Final pH of (5x, 7x, 10x) SBF-A 
solutions ranged between 2.00-2.25 and was stable for several days when stored at RT.  
SBF solution (SBF-B), nominally free of Mg2+, HCO3- and SO42-, was prepared by 
sequentially adding analytical grade NaCl, CaCl2 and K2HPO4·3H2O to deionized water.  
Prior to addition of K2HPO4·3H2O, 1 M HCl solution was added to lower the pH to a 
final value of 5.75. 
 
3.3.3 Biomimetic Coating Process  
The coating process was adopted from Tas et al. [19], and modified in which 
0.0882 g of NaHCO3 was added to 50 ml SBF-A solution stirring at 500 RPM and 37 °C 
to achieve an approximate pH of 5.90. NaOH-treated PCL films were suspended in the 
SBF-A solution for 24 h, or 48 h (with solution replenishment after 24 h). Following 
treatment in SBF-A, selected samples were incubated in SBF-B for an additional 48 h. 
Incubation of the samples was performed at a temperature of 37 °C and 75 rpm. Coated 
specimens were thoroughly washed with deionized water and air dried. 
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Table 3.1 Ionic concentrations of human blood plasma, SBF-A and SBF-B [10].  
 Medium                                 Ion concentration (mM) 
 Na+ K+ Ca2+ Mg2+ HCO3- Cl- HPO42- SO42- 
Blood plasma 142 5 2.5 1.5 27 103 1 0.5 
10xSBF-A 1420 50 25 15 21 1499 10 5 
7xSBF-A 994 35 17.5 10.5 21 1057 7 3.5 
5xSBF-A 710 25 12.5 7.5 21 739 5 2.5 
SBF-B 1420 20 25 0 0 1470 10 0 
Ionic concentrations were calculated assuming complete dissociation in solution. 
 
3.3.4 Physical and Chemical Characterization of CaP Coatings 
Surface morphologies of CaP coatings were examined using a scanning electron 
microscope (SEM) equipped with an energy dispersive X-ray spectrometer (EDX) for 
elemental analysis (LEO 1540XB FIB/SEM, Carl Zeiss, Oberkochen, Germany). 
Samples were first coated with 3 nm osmium metal using a Filgen OPC 80T instrument. 
Cross sectional images of CaP coatings were taken by SEM after disrupting the coating 
layer by scratching or bending coated PCL substrates. Crystal structure of CaP coatings 
was determined by X-ray diffraction (XRD) using a rotating anode X-ray diffractometer 
model RTP300 (Rigaku Rotaflex, Japan) operating on CoKα radiation at 45 kV and 160 
mA. Spectra were collected in the 2θ range between 5° and 65°, with 0.05° steps and a 
10°/min scan speed. 2θ for equivalent CuKα radiation was obtained using Bragg’s Law, 
λ = 2dsin θ, where λ = 1.54056 and 1.79026 Å for Cu and Co respectively [32]. 
Chemical functional groups of CaP coatings were determined using a Bruker Vector 22 
(Bruker Optics LTD, Milton, ON) Fourier transform infrared spectrometer (FTIR) fitted 
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with a Bruker/Pike MIRacle (Pike Technologies, Madison, WI) attenuated total 
reflection spectrometer. Transmittance spectrums from 4000 to 500 cm-1 wavenumbers 
were collected.  
 
3.3.5 Young’s Modulus (Es) of CaP Coatings 
Es was determined using a nanoindentation technique with a Micro Materials 
NanoTest Indentation machine (Wrexham, UK). A diamond Berkovich indenter was 
used to perform 10 indentations with 100 µm spacing between indentations for each 
specimen. A load-displacement curve was recorded for indentation depths of 500 nm at a 
loading and unloading rate of 0.06 mN/s. The indentation depth of 500 nm was 10% or 
less of the CaP thickness and was selected to ensure that the measured Young’s modulus 
was specific to the CaP coating and not influenced by the underlying polymer substrate 
[33]. The dwell time at maximum load was 2 s and the load-displacement data were used 
to determine the reduced Young’s modulus (Er). The Young’s moduli (Es) of the samples 
were then calculated using the following the relationship: 
( ) ( )1 1 12 2
E E Er
s
s
i
i
=
−
+
−υ υ
 
where Es and υs are the Young’s modulus and Poisson’s ratio of the indented CaP 
coating, respectively, and Ei and υi are the modulus and Poisson’s ratio of the diamond 
Berkovich indenter, having values of 1141 GPa and 0.07 respectively. The Poisson’s 
ratio for universal isotropic pure HA needles of 0.28 was used for υs [34]. 
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3.3.6 Surface Roughness 
Surface roughness of CaP coatings was measured by atomic force microscopy 
(AFM) under contact mode with a Multimode AFM with Nanoscope IIIa controller using 
an NP-S cantilever (Veeco Instruments, Santa Barbara, CA). 3-D height images were 
obtained for a 20 x 20 µm area, and the AFM imaging software was used to determine 
the arithmetic mean (Ra) of the absolute values of the height profile deviations from the 
mean line, and root mean square (Rq) roughness, which represents the square root of the 
arithmetic mean of the squares of the deviations. The Ra and Rq values obtained by 
AFM represent the fine (high resolution) surface roughness. To evaluate the coarse (low 
resolution) surface roughness of CaP coatings, a Surftest SJ-210 mechanical stylus 
profilometer surface roughness tester (Mitutoyo, Kanagawa, Japan) was used to 
determine Ra and Rq values. The coarse surface roughness values were obtained 
according to accepted standards (ISO 4287:1997) with a cut off length, λc = 0.8 mm and 
evaluation length of 4 mm. 
 
3.4 Results 
3.4.1 Characterization of Coating Morphology by SEM 
Functionalized PCL surfaces incubated in 5xSBF-A for 24 h revealed deposition 
of a uniform coating comprised of spherical globules ranging in diameter from 0.5 to 1 
µm as seen in SEM micrographs (Fig. 3.1(A)). The spherical globules, which exhibit no 
distinct surface features, are typical of ACP. Further increasing the ion concentration (7x 
and 10x) of SBF solutions produced CaP coatings with distinct surface features. 
Substrates treated with 7xSBF-A for 24 h had a uniform coating consisting of a highly 
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porous, nanoscale, surface structure (Fig. 3.1(A)), whereas films treated with 10xSBF-A 
(24 h) had coatings consisting of micron range surface pores (Fig. 3.1(A)). After further 
incubation in SBF solutions (SBF-B, devoid of crystal growth inhibitors), samples pre-
coated with 5xSBF-A (24 h) showed a distinct change in topography – previously having 
no distinct surface features, coatings now consisted of smaller globules with a very fine, 
nano-porosity (Fig. 3.1(A)).  Incubating the 7xSBF-A (24 h) samples in SBF-B produced 
a coarse, microscale porous structure, whereas PCL films coated with 10xSBF-A show 
increased surface micro-porosity after further treatment in SBF-B. 
Incubation of PCL in 5xSBF-A for 48 h (with solution replenishment after the 
first 24 h) produced a uniform coating nearly identical to the layer produced by 5xSBF-A 
for 24 h with large spherical globules of 1 to 3 µm (Fig. 3.1(B)). Similarly, substrates 
treated with 7xSBF-A for 48 h had a uniform coating comparable to that after 24 h, 
consisting of nanoscale surface features (Fig. 3.1(B)). In contrast, increasing the soaking 
time to 48 h with 10xSBF-A produced a coating with considerably different surface 
features consisting of a highly rough topography of micron-sized plates oriented 
randomly (isotropic). Further soaking in SBF-B had little effect on the coating 
morphologies with the exception of those produced by 5xSBF-A, which changed from 
large spherical globules with no distinct surface features to a highly porous, honeycomb-
like structure. Both coatings produced from 7xSBF-A and 10xSBF-A largely maintained 
their morphology. 
Cross-sectional images of CaP coatings (Fig. 3.2) demonstrate that the unique 
topographical features were present within approximately 1-2 µm of the surface, whereas 
the remainder of the CaP coating consisted of a dense, uniform layer. Little porosity was 
seen within this deeper layer.  The total thickness of the CaP coatings (produced using 7 
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and 10xSBF-A from 24 to 48 h and further soaked in SBF-B) ranged between 5 and 20 
µm.  
Thus, incubation of functionalized PCL with SBF of different ionic 
concentrations (with and without subsequent incubation in the absence of crystal growth 
inhibitors) can be used to prepare surface coatings with varying topographical features. 
We next addressed the different phases present after incubating the PCL substrates in 
different SBF concentrations, as well as the compositions of the resultant CaP coatings. 
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Figure 3.1 SEM micrographs of CaP coatings on PCL films after immersion in 
various SBF-A solutions for 24 h (A), and 48 h (B) and SBF-B.  Scale bars = 1 µm.  
Images shown are representative of three fields of view taken from three independent 
samples. 
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Figure 3.2 SEM micrographs showing cross-section of CaP coatings on PCL films 
after immersion in various SBF-A solutions for (A) 7xSBF-A (48 h) + SBF-B, (B) 
10xSBF-A (24 h) + SBF-B, and (C) 10xSBF-A (48 h) + SBF-B.  Scale bars = 5 µm. 
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3.4.2 XRD of CaP coatings 
XRD spectra (Fig. 3.3) of functionalized PCL before and after incubation for 24 h 
in 5xSBF-A showed similar patterns of peaks (Fig. 3.3(A)), indicating that the deposited 
layer is likely ACP. Subjecting the 5xSBF-A (24 h) samples to SBF-B resulted in the 
appearance of a sharp peak at 2θ = 11.7° (Fig. 3.3(A)), which is characteristic of the 
crystalline structure of DCPD [35]. Contrary to the results obtained for samples 
incubated in 5xSBF-A, XRD spectra of substrates incubated in 7xSBF-A for 24 h 
indicated the presence of crystalline CaP as revealed by the small peak at 2θ = 11.7° 
corresponding to DCPD and sharp peak at 2θ = 25.8° (Fig. 3.3(A)). Indeed, additional 
incubation of the 7xSBF-A (24 h) coating in SBF-B produced a spectrum with an intense 
peak at 2θ = 25.8°. In addition, a broad peak at 2θ = 32° was observed (Fig. 3.3(A)), 
corresponding to overlapping of the (211) and (112) diffraction planes, and indicative of 
a poorly crystalline, bone-like apatite [36]. Moreover, a small peak was observed at 2θ = 
11.7°, consistent with the presence of DCPD as a minor phase along with HA.  XRD 
analysis of coatings produced using 10xSBF-A revealed an accelerated ability to deposit 
an apatite layer on PCL substrates, as compared to SBF solutions of lower ion 
concentrations (i.e. 5x, 7x). XRD spectra of the coating deposited after 24 h contained 
new peaks at 2θ = 4.7o and 26.1° (Fig. 3.3(A)). The peak at 2θ = 4.7° is likely 
attributable to the presence of OCP, a precursor of HA; whereas the peak 2θ = 26.1° is 
indicative of both OCP and apatite [35, 37]. Exposure of this coating to SBF-B converted 
it to a single phase of poorly crystalline HA, as revealed by the following characteristics: 
a) an intense peak at 2θ = 25.8°; b) a broad peak at 2θ = 32°, corresponding to 
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overlapping of the (211) and (112) diffraction planes; and c) a peak at 2θ = 28.7° of the 
(210) diffraction plane of HA (Fig. 3.3(A)).  
Extending the incubation time in 5xSBF-A from 24 to 48 h produced no 
detectable difference in the XRD spectrum (Fig. 3.3(B)). However, incubation of the 
5xSBF-A (48 h) samples in SBF-B resulted in the presence of both DCPD and apatite 
(Fig. 3.3(B)).  In addition to the peak at 2θ = 11.7° typical of DCPD, new peaks at 25.8°, 
28.7° and a broad diffraction line at 32° of apatite are visible.  Increasing the incubation 
time in 7xSBF-A from 24 to 48 h enhanced the intensity of the peak at 2θ = 25.8° and 
brought about the appearance of a large peak at 2θ = 11.7°, suggesting a predominance of 
DCPD (Fig. 3.3(B)). XRD spectra of the 7xSBF (48 h) samples following additional 
incubation in SBF-B (Fig. 3.3(B)) revealed the formation of apatite only, with 
characteristic peaks at 2θ = 25.8, 28.7, 32 and 53.7° [38]. The DCPD peak at 2θ = 11.7° 
is noticeably absent. Incubation in 10xSBF-A for 48 h was all that was required to induce 
apatite formation on the PCL film as indicated by the appearance of a large peak at 2θ = 
25.8°, as well as the presence of broad peaks at 2θ = 32, 28.7 and 53.7° (Fig. 3.3(B)). 
Additional incubation of these apatite-coated substrates in SBF-B produced no striking 
change in the phase composition of the coatings (Fig. 3.3(B)), with only peaks 
characteristic of apatite remaining. However, it should be noted that peaks attributed to 
the PCL substrate were no longer visible and the relative intensity of the apatite peaks 
were increased. 
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Figure 3.3 XRD pattern of the CaP coatings. PCL films with no treatment and after 
immersion in various SBF-A solutions for (A) 24 h and (B) 48 h and SBF-B.  
Standard peak positions and (hkl) values obtained from JCPDS card # 9-432 (HA), 
19-272 (carbonated-HA), 9-77 (DCPD), and 26-1056 (OCP). 
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3.4.3 FTIR of CaP coatings 
FTIR spectra (Fig. 3.4) corroborated the formation of various crystalline calcium 
phosphate coatings. Substrates soaked in 5xSBF-A for 24 h and SBF-B (Fig. 3.4(A)) 
exhibited major bands for phosphate (1190, 1110, 1040 and 980 cm-1 for P-O ν3 mode, 
and 576 and 525 cm-1 for P-O ν4 mode) and hydrogen-phosphate [790, and 872 cm-1 for 
P-O(H) ν1 mode], which are characteristic of DCPD [38], confirming the XRD results. 
FTIR spectra of the coatings produced from 7xSBF-A and 10xSBF-A for 24 h and SBF-
B (Fig. 3.4(A)) showed typical bands associated with a bone-like apatite [38]. Clearly 
visible is a broad band at 1650 cm-1 assigned to -OH bending of H2O, and intense PO43- 
bands at 1020 cm-1 (ν3), 960 cm-1 (ν1), 600 cm-1 and 560 cm-1 (ν4). Carbonate substitution 
was confirmed by bands at 1430 cm-1 and 873 cm-1, typical of a carbonate-substituted 
HA [35, 38]. HPO42- was also detected by FTIR and revealed by a broad shoulder at 
1100 cm-1 and band at 530 cm-1, and may be due to the presence of minor secondary 
phases such as DCPD and OCP [39, 40]. Similar spectra were observed for coatings 
deposited from 5xSBF-A (48 h) and SBF-B (Fig. 3.4(B)), with exception of an increased 
intensity of the HPO42- band at 530 cm-1 confirming the XRD observation of a mixed 
phase coating consisting of both apatite and a significant presence of DCPD. FTIR 
spectra of coatings produced from both 7xSBF-A and 10xSBF-A for 48 h followed by 
SBF-B treatment (Fig. 3.4(B)) indicated a predominately single-phase apatite, consistent 
with the XRD results. 
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Figure 3.4 FTIR spectra of the CaP coatings. PCL films after immersion in various 
SBF-A for (A) 24 h and (B) 48 h and after subsequent treatment in SBF-B. 
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3.4.4 EDX elemental analysis of CaP coatings 
EDX analysis of the various coatings revealed Ca/P atomic ratio of coating layers 
ranging from 1.00 – 1.50, below the stoichiometric value of 1.67 for HA (Table 3.2). 
There was no significant difference in Ca/P ratio between any of the crystalline CaP 
coatings produced at 24 h, with only the amorphous CaP layer produced by 5xSBF-A 
having a significantly lower Ca/P ratio (p<0.05).  Increasing the soaking time to 48 h had 
no significant effect on the Ca/P ratio of the CaP coatings.  However, at 48 h, CaP 
coatings produced using 10xSBF-A with and without SBF-B treatment had a 
significantly greater Ca/P ratio as compared with layers produced using 5xSBF-A.  The 
highest Ca/P ratio (1.50) was measured for coatings produced by 10xSBF-A (48 h) + 
SBF-B. Deviation of the Ca/P atomic ratio from the stoichiometric value for HA may be 
due to cation substitutions at the Ca2+ sites by Mg2+ or Na+, or substitution at PO43- sites 
by CO32- or HPO42-, or a combination of these substitutions. A difference in the measured 
Mg content of coatings was also observed by EDX.  The Mg/Ca ratio was significantly 
higher (p<0.05) for coatings produced by 5xSBF-A as compared to 7x and 10xSBF-A, at 
both 24 h and 48 h (Table 3.2). There was significantly lower (p<0.05), Mg/Ca ratio 
detected in coatings after treatment with SBF-B (nominally Mg2+-free solution) for all 
SBF-A concentrations, with the exception of 10xSBF-A at 48 h.  The effect of time (24 h 
vs 48 h) on the Mg/Ca ratio for the CaP layers was only significant (p<0.05) for those 
produced by 5xSBF-A and showed a decrease in the Mg/Ca ratio from 24 h to 48 h. 
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Table 3.2 Elemental atomic ratio of CaP coatings. 
Medium                     CO3/P Ca/P Mg/Ca 
    24 h 48 h 24 h 48 h 
10xSBF-A  2.10 1.283a 
(0.057) 
1.412AC 
(0.189) 
0.033d 
(0.013) 
0.024DE 
(0.005) 
7xSBF-A  3.00 1.281a 
(0.041) 
1.319AB 
(0.175) 
0.051d 
(0.016) 
0.046D 
(0.009) 
5xSBF-A 4.20 0.948b 
(0.089) 
1.161B 
(0.121) 
0.210f 
(0.040) 
0.140F 
(0.020) 
10xSBF-A + SBF-B 2.10 1.301a 
(0.023) 
1.500A 
(0.188) 
0.001e 
(0.001) 
0.002E 
(0.003) 
7xSBF-A + SBF-B 3.00 1.273a 
(0.064) 
1.308AB 
(0.036) 
0.002e 
(0.002) 
0.003E 
(0.003) 
5xSBF-A + SBF-B 4.20 1.222a 
(0.026) 
1.270BC 
(0.023) 
0.004e 
(0.003) 
0.009E 
(0.011) 
CO3/P ratios were calculated from ion concentrations used in SBF-A preparations. Ca/P and Mg/Ca ratio 
values are mean (standard deviation) from three EDX spot analyses on three independent samples (n = 3). 
Statistical significance was determined by a two-way ANOVA and a Bonferroni post-test. The effect of 
different SBF-A and SBF-B were determined at each time, where matching lower case letters indicate no 
statistical significance (p > 0.05) at 24 h and upper case letters indicate no statistical significance (p > 0.05) 
at 48 h. There was no significant difference found between Ca/P ratios at 24 h vs 48 h for any of the SBF 
treatments. Bolded text denotes a significant (p < 0.05) effect of time (24 h vs 48 h) on the Mg/Ca ratio. 
 
The XRD, FTIR, and EDX data establish that various CaP coatings are deposited 
on PCL films by incubation in SBF solutions with high ionic concentrations (Table 3.3). 
These results, in conjunction with the SEM micrographs above, demonstrate our ability 
to produce CaP and carbonated apatite coatings with various surface morphologies by 
adjusting ion concentration and soaking time. 
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3.4.5 Mechanical properties of CaP coatings 
The nanoindentation measurement of Es of coatings produced from 5xSBF-A (48 
h), 7xSBF-A (48 h), 10xSBF-A (48 h) and subsequent incubation in SBF-B is displayed 
in Fig 3.5. At an indentation depth of 500 nm, there was a significant increase (p<0.001) 
in the Es value of the CaP-coated substrates as compared to the uncoated PCL films, 
however there was no significant difference in the Es value between the different CaP 
coatings.   
Table 3.3 Crystal phases of CaP coatings  
Medium Crystal Phase 
 24 h 48 h 
5xSBF-A ACP ACP 
7xSBF-A DCPD DCPD 
10xSBF-A OCP/HA HA 
5xSBF-A + SBF-B DCPD DCPD/HA 
7xSBF-A + SBF-B HA/DCPD HA 
10xSBF-A + SBF-B HA HA 
CaP coatings were produced by soaking PCL substrates in 5, 7 or 10xSBF-A for 24 or 48 h, with or 
without subsequent soaking in SBF-B. CaP crystal phases were determined by XRD, FTIR and EDX. 
ACP: amorphous calcium phosphate; DCPD: dicalcium phosphate dihydrate; OCP: octacalcium 
phosphate; HA: hydroxyapatite.  
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Figure 3.5 Nanoindentation measurement of Es of PCL films and after immersion in 
various SBF-A solutions for 48 h and subsequent treatment in SBF-B.  Es values are 
the mean calculated from 10 indentations performed on two independent samples 
(n=20). Error bars are standard error. Groups with matching letters are not statistically 
significant (p > 0.05) as determined by a one-way ANOVA using Tukey’s multiple 
comparison test. 
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As indicated by the XRD and FTIR analyses above, the coatings produced from 
5xSBF-A (48 h) + SBF-B consist of mixed phases of DCPD and apatite, whereas those 
produced from 7xSBF-A (48 h) + SBF-B, and 10xSBF-A (48 h) + SBF-B are single 
phase, poorly crystalline apatite. From the nanoindentation experiments, it is evident that 
the Es remains constant for different CaP phases. The indentation study also reveals little 
to no effect of surface topography or complexity on the mechanical behavior of the CaP 
coatings. 
 
3.4.6 AFM imaging and surface roughness of CaP coatings 
Three CaP coatings, characterized as HA and exhibiting distinct topographies, 
were selected for further study [7xSBF-A (48 h) + SBF-B, 10xSBF-A (24 h) + SBF-B, 
10xSBF-A (48 h) + SBF-B]. AFM height images of these HA coatings revealed fine 
(high resolution) surface features (Fig. 3.6, left panels); whereas height profiles obtained 
using a mechanical stylus profilometer revealed coarse (low resolution) surface features 
(Fig. 3.6, right panels). Apatite coatings were produced by immersing NaOH-treated 
PCL substrates in 7xSBF-A for 48 h (Fig. 3.6(A)), and 10xSBF-A for 24 h (Fig. 3.6(B)) 
or 48 h (Fig. 3.6(C)), and subsequently treated with SBF-B. For each apatite coating, 3-D 
images were obtained for a 20 x 20 µm area and height profiles were measured for a 4 
mm evaluation length. Differences in topography are clearly evident from both the 3D 
height images and height profiles. Apatite coatings produced from 7xSBF-A showed a 
uniform layer of isotropic (randomly distributed) spherical globules with a height 
deviation of approximately 600 nm. Substrates soaked in 10xSBF-A showed apatite 
coatings having an increase in isotropic surface complexity, with many sharp surface 
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features, numerous peaks and valleys, and a height variation near 1200 nm. Ra and Rq 
values measured from the AFM images show a significant increase in surface roughness 
and complexity of apatite coatings when the SBF-A ion concentration was increased 
from 7 to 10 times (Table 3.4). However, no significant difference was observed in the 
AFM roughness values of the apatite layers produced by increasing the soaking time in 
10xSBF-A from 24 to 48 h. The height profiles (Fig 3.6, right) and the Ra and Rq values 
measured by mechanical stylus profilometer indicate a significant increase in the 
roughness when increasing SBF-A concentration from 7x to 10x, and soaking time in 
10xSBF-A from 24 to 48 h. 
The results obtained from both AFM imaging and the mechanical stylus 
profilometer indicate differences in the topography of the apatite coatings produced in 
this study.  Roughness of both fine and coarse surface features is dependent on the ion 
concentration of the SBF-A solutions, whereas soaking time influences the roughness of 
the coarse surface features.  
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Figure 3.6 Three-dimensional AFM images (left) and mechanical stylus profilometer 
height profiles (right) of surface topography of HA coatings produced on PCL 
substrates by immersion in (A) 7xSBF-A (48 h) + SBF-B, (B) 10xSBF-A (24 h) + 
SBF-B, and (C) 10xSBF-A (48 h) + SBF-B within an area of 20 x 20 µm for AFM and 
a 4 mm evaluation length for the mechanical stylus profilometer. 
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Table 3.4 Surface Roughness of CaP Coatings. 
Medium AFM 
Mechanical Stylus 
Profilometer 
 Ra, nm Rq, nm Ra, µm Rq, µm 
7xSBF-A (48 h) + SBF-B 194b 
(28) 
255b 
(39) 
1.01a 
(0.06) 
1.26a 
(0.08) 
10xSBF-A (24 h) + SBF-B 316a 
(26) 
402a 
(32) 
1.26a 
(0.06) 
1.61a 
(0.09) 
10xSBF-A (48 h) + SBF-B 363a 
(38) 
454a 
(44) 
1.97b 
(0.22) 
2.56b 
(0.28) 
Ra and Rq values are mean (standard error of the mean) calculated from the average of three different spot 
analyses on two independent samples (n = 6).  Statistical significance determined by a one-way ANOVA 
and Tukey’s multiple comparisons test.  Effect of SBF-A and SBF-B treatment on surface roughness of 
substrates were determined for apatite coatings, where matching letters indicate groups with no statistical 
difference (p>0.05) in Ra and Rq values as measured by AFM and mechanical stylus profilometer. 
 
3.5 Discussion 
In the present study, the CaP layer deposited on PCL substrates using 5xSBF-A 
was identified as an ACP by XRD, which is in accordance to previous studies which 
demonstrated the ability of a 5xSBF to deposit ACP on titanium substrates [17]. 
Precipitation of various phases of CaP from solution involves the formation of an ACP as 
the initial phase prior to hydrolysis and conversion to other crystalline phases [41-43]. 
The presence of crystal growth inhibitors Mg2+, and HCO3− in the 5xSBF-A inhibits the 
formation of a crystalline CaP phase and, promotes the formation of ACP. Subjecting 
substrates to 48 h soaking had no observable change in coating crystallinity or 
topography. Further treating CaP coatings deposited by 5xSBF-A for 24 h with SBF-B, 
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devoid of crystal growth inhibitors, promoted the transformation to a crystalline DCPD 
phase. Interestingly, when the substrates were pre-coated with 5xSBF-A for 48 h, 
soaking in SBF-B promoted the conversion of the ACP coating layer to mixed phases of 
crystalline DCPD and poorly crystalline carbonated apatite.  Given that the CaP coating 
layers produced by 5xSBF-A for 24 and 48 h showed similar XRD patterns, the 
difference in phase composition measured after soaking in SBF-B is attributed to the 
amount of Mg2+ incorporated in the amorphous CaP layers during the 5xSBF-A 
treatments [44, 45].  
According to theoretical models based on classical crystallization theory, SBF 
solutions containing high concentrations of Ca2+ and PO43-, at pH levels similar to those 
in this study (SBF-B), favor nucleation of HA compared to both DCPD and OCP [46]. 
However, the presence of Mg2+ (Mg/Ca > ~0.2) lengthens the total time required for 
conversion of ACP to HA by prolonging the induction period characteristic of reactions 
involving nucleation. Mg2+ ions poison the surfaces of HA nuclei by adsorbing to the 
active growth sites, thereby preventing or slowing the HA growth rate and thus allowing 
other phases to nucleate [43, 44]. The high Mg2+ content within the ACP layer formed by 
the 5xSBF-A for 24 h as compared to 48 h may be responsible for the increased 
stabilization of the ACP layer in solution, and ultimately delaying the HA formation even 
after 48 h treatment in SBF-B. At higher ion concentrations and acidic pH, as is the case 
in the present study, ACP is known to convert initially into DCPD and/or OCP and 
successively into HA [45]. The delayed dissolution of the ACP phase caused by the 
incorporated Mg2+ (Mg/Ca = 0.21) prevented the hydrolysis of DCPD within 48 h 
soaking in SBF-B. Conversely, the lower Mg2+ content within ACP formed by 5xSBF-A 
after 48 h (Mg/Ca = 0.14) was sufficiently low to allow partial hydrolysis of DCPD into 
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HA after the dissolution of the ACP layer in SBF-B for 48 h. Furthermore, Abbona et al. 
[45], proposed that the slow release of Mg2+ from ACP could be an additional cause for 
delayed HA formation, as Mg2+ ions may induce a mechanical strain caused by a lower 
ionic radius and shorter bond length with oxygen as compared to Ca2+ in ACP. These 
results suggest that the final crystalline phase and kinetics of ACP hydrolysis are 
governed by the initial Mg2+ content in the CaP layer. Increasing the Mg2+ content in CaP 
coating layers delays the conversion to HA and favors other crystalline phases such as 
DCPD.  
Alternatively, XRD for coatings produced after soaking in 7xSBF-A and 
10xSBF-A for 24 h indicated the presence of a crystalline phase. The ability of 7xSBF-A 
and 10xSBF-A solutions to produce a crystalline phase within only 24 h is attributed to 
the lower Mg2+ content within the CaP coatings, and increased level of Ca2+ in the SBF-
A solutions [47]. Although the initial Mg/Ca atomic ratio in the SBF-A (5x, 7x, 10x) 
solutions are identical, the carbonate to phosphorous ratio (CO3/P) varies and has been 
shown to influence the amount of Mg2+ incorporation in synthetic apatite [48]. Mg2+ 
incorporation is known to increase in ACP with an increase in the CO3/P ratio of the 
starting solution [48]. Comparing the ion concentrations of the SBF-A (Table 3.1) 
solutions used in this study, the higher the concentration of SBF-A solution, the lower 
the corresponding CO3/P ratio since the carbonate concentration remains constant 
(approx. 21 mM) for all three conditions. As such, the level of Mg2+ incorporation in the 
CaP coatings decreased with increase in the ion concentration of the SBF-A solutions. 
EDX analysis showed lower Mg/Ca atomic ratio in the coatings produced by 7xSBF-A 
and 10xSBF-A as compared to 5xSBF-A. The decrease in Mg2+ content measured after 
24 h in 10xSBF-A and 7xSBF-A is associated with the lower CO3/P ratio in the starting 
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solutions. As evident in this study, treating 10xSBF-A pre-coated substrates (24 h) in 
SBF-B accelerated the formation of a uniform HA coating, whereas treatment in 7xSBF-
A yielded DCPD as a minor phase along with HA. Extending the soaking time in 7x and 
10xSBF-A to 48 h consequently increased the apatite content of the above-mentioned 
coatings. 
Deposition of CaP coatings from SBF solutions onto material surfaces occurs via 
negatively charged functional groups, such as carboxyl and -OH. These surface 
functional groups act as nucleation sites, first by electrostatic attraction of Ca2+, which 
adsorb PO43- ions from the SBF solution [49]. Once nuclei of critical size are formed on 
the material surface, they spontaneously grow into a dense CaP layer by further 
consuming Ca2+ and PO43- ions from the SBF [11]. Functional groups were produced on 
the PCL surface by NaOH treatment, which has been previously shown to produce 
carboxylate and -OH groups on polyester surfaces by hydrolytic cleaving of the ester 
bonds of PCL [50]. Biomimetic processes using SBF solutions have successfully 
produced CaP coating layers on various material surfaces, including natural and synthetic 
polymers, and titanium [10-18, 51]. Therefore, it is expected that the CaP coatings 
developed in this study can be applied to other materials, given the presence of 
appropriate surface functional groups.  
SEM and AFM micrographs reveal dramatic differences in the coating 
morphology, with a dense isotropic nano-scale topography produced using 7xSBF-A and 
an isotropic, highly rough topography composed of micron-sized plates oriented 
vertically for coatings produced using 10xSBF-A. The difference in the topography of 
the coatings produced by the various solutions may be due to the difference in the Mg/Ca 
atomic ratio found in the coating layer prior to SBF-A refresh and/or SBF-B treatment. 
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EDX results confirmed minor amounts of Mg in all coatings after treatment with SBF-B. 
The subsequent dissolution and release of Mg2+, as well as the initial Mg2+ concentration 
in solution, would have an influence on coating topography since the presence of Mg2+ in 
solution is capable of reducing the surface roughness and producing apatite coatings 
exhibiting finer surface structures [29]. These results indicate that apatite coatings with 
various surface topographies can be produced by adjusting the solution ionic strength and 
the Mg2+ incorporation in coatings prior to immersion in SBF solutions with or without 
Mg2+.   
Apatite coatings with a finer, nano-ordered topography are produced using SBF 
solutions with lower ion concentrations (i.e. 7xSBF-A), which result in higher 
incorporation of Mg2+ prior to immersion in SBF-B. Coatings consisting of highly 
defined, randomly ordered plates are produced using SBF solutions with higher ion 
concentrations (i.e. 10xSBF-A), which deposit CaP coatings with low Mg2+ 
incorporation prior to immersion in SBF-B. The dissolution and release of Mg2+ during 
treatment in refreshed SBF-A, and in SBF-B will be governed by the initial amount of 
Mg2+ in the CaP coatings and will affect the final surface topography.   
There is an extensive literature on the influence of surface topography on cell 
behavior [20-22].  Previous findings indicate that different biological responses would be 
expected towards the CaP coatings with varying micro- and nano-scale surface roughness 
developed in the present study. In this regard, surface roughness of approximately 2 µm 
[as osberved in our 10xSBF-A (48 h) + SBF-B samples] is proposed by some authors to 
induce maximal changes in cell behavior compared to smooth surfaces [21]. Further, 
isotropic nano-scale topography has been shown to increase gene expression of 
osteogenic markers by cultured human osteoprogenitor cells [52]. However, some 
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authors have questioned the in vivo significance of such nano-scale features, as proteins 
attaching to the surface after implantation would likely mask such fine topographies [21]. 
We anticipate that, of the HA coatings synthesized, the 10xSBF-A (48 h) + SBF-B 
coating would provide the optimal topography for promoting osteoblast attachment and 
differentiation. Osseointegration and bone-bonding at the bone-implant interface is 
influenced by surface topography of the implant [26]. Manipulating surface complexity 
at the micro- and nano-scale level of CaP coatings is vital, as the cement line matrix 
deposited during osteogenesis is dependent on such surface features for deposition and 
interlocking [27]. As such, careful control and design of surface roughness and 
topography are critical for the development of optimal CaP coatings to promote 
osteoblast differentiation, bone formation and osseointegration of tissue engineering 
scaffolds and orthopedic implants. 
Material stiffness has been shown to influence osteoblast adhesion and 
maturation [53]. As such, the mechanical properties of the different coatings were 
measured by nanoindentation to determine their Es values. Results indicated that the 
deposited apatite and DCPD/apatite coating layers provided greater Es values when 
compared to uncoated PCL films.  The Es value increases nearly 5-fold when a CaP layer 
is deposited on PCL. No statistical difference was found in Es between the various 
coatings produced using the different SBF-A solutions despite the difference in surface 
porosity and topography. Indeed porosity of HA sintered bodies has been shown to have 
significant influence on the Es values [54]. However, a definitive conclusion on the CaP 
surface topography as the sole influence on mechanical properties cannot be made, as the 
chemical composition of the CaP coatings may also affect Es values.   
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The XRD patterns of coatings deposited from 5xSBF-A show mixed phases of 
DCPD and apatite, whereas 7x and 10xSBF-A produced single phase apatite coatings.  
Although coatings from 7x and 10xSBF-A display similar XRD and FTIR spectra, EDX 
results indicate differences in the Ca/P atomic ratio, which may influence the resulting 
mechanical properties as ion substitutions in HA are capable of modifying the Es of HA 
[55].  The Es values in this study are comparable to the lower range of those measured for 
cortical and trabecular bone of the human femur [56]. 
In summary, bone-like apatite coatings with varying surface topography, 
roughness and complexity were successfully deposited on functionalized PCL films 
using SBF solutions with high ion concentrations and adjusted levels of Mg2+ and  
HCO3-. Coatings produced with lower concentration SBF solutions had a high initial 
Mg2+ incorporation, showed delayed formation kinetics and reduced surface complexity 
with a fine surface topography. In contrast, higher concentration SBF solutions had lower 
Mg2+ incorporation, and accelerated apatite formation, producing a highly rough surface, 
coarse topography consisting of micron-sized plates.  The HA coatings produced with 
higher concentrations SBF solutions had surface roughness values at levels considered 
optimal for osteoblast attachment and differentiation. Mechanical properties of CaP 
coatings at the 500 nm range approached those of human bone and were unchanged with 
coating condition. These bone-like apatite coatings may increase the osteoconductivity 
and bone bonding ability of synthetic materials. 
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CHAPTER FOUR 
 
 
 
SURFACE TOPOGRAPHY OF BIOMIMETIC 
HYDROXYAPATITE COATINGS DIFFERENTIALLY 
REGULATES OSTEOBLAST AND OSTEOCLAST ACTIVITY1 
 
 
 
 
 
 
 
 
 
  
                                                
 
1Chapter 4 has been submitted for publication:  
Costa, D. O, Prowse, P. D. H, Chrones, T, Sims, S. M., Hamilton, D. W., Rizkalla, A. S., 
Dixon, S. J. (2012). Surface Topography of Biomimetic Hydroxyapatite Coatings 
Differentially Regulates Osteoblast and Osteoclast Activity.  
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4.1 Chapter Summary 
The behavior of bone cells is influenced by the surface chemistry and topography 
of implants and scaffolds. Our purpose was to investigate how the topography of 
biomimetic hydroxyapatite (HA) coatings influences the attachment and differentiation 
of osteoblasts, and the resorptive activity of osteoclasts. Using strategies previously 
reported [Langmuir 2012;28:3871-80], we directly controlled the surface topography of 
biomimetic HA coatings on polycaprolactone films. Osteoblasts and osteoclasts were 
incubated on HA coatings having distinct surface topographies. Osteoblast attachment 
and differentiation were significantly greater (p<0.05) when cultured on micro-rough HA 
surfaces (Ra ~2 µm) than on smoother topographies (Ra ~1 µm). The Activity of tartrate-
resistant acid phosphatase, an osteoclast marker, was greater on smoother than on micro-
rough HA surfaces. Furthermore, scanning electron microscopy revealed the presence of 
resorption lacunae exclusively on smooth HA coatings. Inhibition of resorption on 
micro-rough HA surfaces was associated with disruption of filamentous actin sealing 
zones. In conclusion, HA coatings can be prepared with different topographies, which 
regulate responses of osteoblasts, as well as osteoclastic activity and hence susceptibility 
to resorption. Thus, it may be possible to design HA coatings, that induce optimal rates 
of bone formation and degradation specifically tailored for different applications in 
orthopedics and dentistry. 
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4.2 Introduction 
The surface topography and roughness of biomaterials, at the micrometer and 
nanometer scale, affect the attachment, signaling, proliferation and differentiation of cells 
[1-6]. To promote bone regeneration and osseointegration, it is essential that tissue 
engineering scaffolds provide bioactive, osteogenic and osteoconductive stimuli at the 
defect site [7, 8]. Therefore, manipulating the surface topography offers an effective and 
straightforward strategy to improve the biological performance of implant and scaffold 
materials.  
Osteoblasts exhibit increased differentiation and mineralization on roughened 
substratum topographies compared to smooth surfaces [9, 10]. Previous studies have 
reported surface roughness (Ra) in the range of 1-7 µm induces maximal changes in cell 
behavior and stimulation of bone formation [2, 10, 11]. Furthermore, implants having 
average surface roughness < 0.5 µm are typically encapsulated by fibrous tissue [11]. On 
the other hand, less is known about the effects of biomaterial characteristics on osteoclast 
behavior. The chemical composition of resorbable bioceramics has been shown to 
influence the differentiation and resorption activity of osteoclasts in vitro [12-14]. 
Recently, the effect of HA surface roughness on osteoclast behavior was studied [15]; 
however, the reported Ra values (< 0.6 µm) were considerably lower than those widely 
accepted as optimal for osteoblast function (Ra > 1 µm) [2]. Thus, the effect of high 
surface roughness (i.e. Ra > 1.0 µm) of resorbable biomaterials on osteoclast activity 
remains poorly defined.  
The design of implant and scaffold surface features are dependent on the desired 
application. Osteoclast inhibition favors implant stability for total hip arthroplasty, 
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whereas resorbable synthetic biomaterials are intended to be degraded by osteoclastic 
resorption and physiochemical dissolution [16]. Osteoblast and osteoclast functions are 
synergistic; both play a role in skeletal healing, development, and remodeling [17] and 
their complementary activities are a defining feature of the bone-biomaterial interface 
[18, 19]. Therefore, it is important to assess the interaction of biomaterials with both 
osteoblasts and osteoclasts. For many applications, it would be beneficial to identify 
surface features that would be optimal for promoting bone formation by osteoblasts, 
while suppressing the resorptive activity of osteoclasts. However, only a few studies 
have investigated the resorption of biomaterial surfaces by osteoclasts [16, 20]. To the 
best of our knowledge, no previous study has examined the effect of biomaterial 
topography on both osteoblasts and osteoclasts.  
For orthopedic and dental applications, HA coatings can render synthetic 
biomaterials bioactive and osteoconductive [21], facilitating the attachment and 
differentiation of cells of the osteoblast lineage [22] and promoting the ingrowth of 
natural bone [23-25]. Additionally, carbonated-HA coatings exhibit classical resorption 
lacunae after osteoclastic activity [26]. Surface coatings of HA or bone-like apatite 
(formed by a biomimetic process) have been deposited on various types of porous 
polymer scaffolds and titanium metal implants [27, 28]. The biomimetic approach 
involves soaking substrates in a simulated body fluid (SBF) with ion concentrations 
similar to those of human blood plasma. Despite numerous studies showing that surface 
roughness can regulate the osteogenic response to biomaterials, few investigators have 
attempted to directly control the topography of biomimetic coatings [29]. We recently 
found that, by varying the ionic concentration of SBF, we could reliably control the 
topography of biomimetic HA coatings [30]. Solutions with 7 and 10 times the ion 
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concentration of typical SBF (7xSBF and 10xSBF) lead to the deposition of carbonated 
bone-like HA coatings with distinct surface topography and roughness, enabling us to 
systematically study their influence on cell function. 
 In the present study, bone-like HA coatings with smooth (Ra = 1.0 µm) and 
micro-rough (Ra = 2.0 µm) surfaces were deposited on polycaprolactone (PCL) films. 
Our objective was to determine effects of biomimetic HA coatings with varying surface 
topography on the behavior of osteoblasts and osteoclasts. We report that increasing the 
surface complexity of biomimetic HA enhances the attachment and differentiation of 
primary osteoblasts.  Furthermore, we discovered that a high degree of surface roughness 
suppresses the resorption of HA by authentic, freshly isolated osteoclasts. Thus, an HA 
surface topography was identified that simultaneously enhances osteoblast function while 
suppressing osteoclast activity. 
 
4.3 Materials and Methods 
4.3.1 Biomimetic HA coating process 
Biomimetic HA coatings with varying surface roughness were deposited on PCL 
films by a method reported previously [30]. Briefly, modified SBF solutions were 
prepared having approximately 7 times (7xSBF-A) and 10 times (10xSBF-A) the 
concentration of ion species (Na+, K+, Mg2+, Ca2+, Cl−, HPO42‑, SO42‑) compared to 
human blood plasma. An SBF solution (SBF-B), nominally free of Mg2+, HCO3- and 
SO42‑, was also prepared and used as a crystal growth solution. 
NaHCO3 (0.0882 g) was added to 50 mL of modified SBF-A solution stirring at 
500 rpm and 37°C to achieve a pH of 5.90. PCL films (5 g, molecular weight = 80 000 
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g/mol, Solvay Chemicals Inc., Houston, TX) with a diameter of 15 mm were treated with 
NaOH and then suspended in the SBF-A solution for 24 and 48 h (with solution 
replenishment after 24 h) to produce HA coatings with varying surface topography. 
Following treatment in SBF-A, samples were incubated in SBF-B for an additional 48 h. 
Incubation of the samples was performed at a temperature of 37°C and stirring at 75 rpm. 
Coated specimens were thoroughly washed with deionized water and air-dried. 
The topography of biomimetic HA surfaces was assessed by scanning electron 
microscopy (SEM). Samples were coated with 3 nm osmium using a Filgen OPC-80T 
instrument and then examined using a FIB/SEM LEO 1540XB microscope equipped 
with an EDX spectrometer for elemental analysis (Carl Zeiss, Jena, Germany). 
HA coatings were previously characterized using X-ray diffraction (XRD), 
Fourier-transform infrared spectroscopy (FTIR), nanoindentation, and energy dispersive 
X-ray spectroscopy (EDX) [30]. In addition, analysis of the surface topography at high 
and low resolution was previously performed using atomic force microscopy (AFM, to 
assess fine submicron-scale topography) and mechanical stylus profilometry (to assess 
coarse micron-scale topography), respectively. Surface roughness (Ra) was quantified as 
the arithmetic mean of the absolute values of the height profile deviations from the mean 
line. Two Ra values are reported for each surface, the first obtained using AFM and the 
second from profilometry [30]. Analysis of sub-micrometer topography by AFM 
revealed that PCL substrates incubated in 7xSBF-A for 48 h produced HA coatings with 
Ra = 194 nm, whereas profilometry indicated micro-scale topography with Ra = 1.0 µm 
and are designated as having “smoother” (HA1) topography. Substrates incubated in 
10xSBF-A for 24 h produced “submicro-rough” (HA2) surfaces having significantly 
greater roughness (Ra = 316 nm) as measured by AFM, but no difference at low 
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resolution (Ra = 1.3 µm) as determined using profilometry. Incubation in 10xSBF-A for 
48 h yielded HA coatings with both submicrometer and micron-scale roughness, with 
equivalent Ra = 363 nm at high resolution (AFM) and significantly increased Ra = 2.0 
µm at low resolution (profilometry), and therefore, have a “micro-rough” (HA3) 
topography. 
 
4.3.2 Osteoblast isolation and culture 
Rat calvarial osteoblasts (RCO) were isolated from 0- to 5-day-old neonatal 
Sprague Dawley rats. All animal procedures were approved by the University Council on 
Animal Care of The University of Western Ontario and were in accordance with the 
guidelines of the Canadian Council on Animal Care. Briefly, the parietal and occipital 
bones were dissected and washed with phosphate-buffered saline (PBS). The harvested 
bones were minced and subsequently digested by incubation in 700 units/ml of type I 
collagenase (Sigma-Aldrich, St. Louis, MO) at 37°C. The supernatant of the first 
digestion was discarded and the calvarial fragments were treated five more times with 
collagenase (20 min at 37°C), and the subsequent supernatants were collected, combined 
and sedimented. The resulting cell pellet was re-suspended and cultured in α minimum 
essential media (α-MEM) supplemented with 10% (v/v) fetal bovine serum (FBS; Life 
Technologies Inc., Carlsbad, CA), antibiotics and antimycotic (AA; 200 U/mL penicillin, 
200 µg/mL streptomycin, 0.5 µg/mL amphotericin B) (Gibco, Carlsbad, CA). Primary 
RCO cultures were maintained in a humidified 5% CO2 atmosphere at 37°C and, in some 
cases, stored in liquid nitrogen. 
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Prior to cell experiments, RCOs were expanded until 80 to 100% confluent and 
released from 75-cm2 tissue culture plastic flasks using a 0.05% trypsin and 0.2 g/L 
EDTA solution, and cell number was determined using a Multisizer 3 Coulter Counter 
(Beckman Coulter, Mississauga, ON, Canada). Substrata were sterilized in low-
temperature, radio-frequency glow discharge (RFGD) argon plasma using a PDC-32G 
plasma cleaner (Harrick Plasma, Ithaca, NY) for 4 min. For assessment of cell 
attachment and fluorescence labeling, RCOs (passage 2-4) were seeded on substrates in 
24-well plates at 2.5 x 103 cells/cm2; for differentiation experiments, RCOs (primary or 
passage 1) were seeded on substrates in 24-well plates at a density of 25 x 103 cell/cm2.  
 
4.3.3 Osteoblast attachment and morphology 
RCOs were cultured on HA1, HA2 and HA3 surfaces for 6 h. Cells were then 
fixed using 4% paraformaldehyde (PFA) in PBS, and permeabilized with 0.1% Triton-X 
100 in PBS for 5 min. Samples were blocked using 3% bovine albumin (BSA) in PBS for 
30 min. To reveal focal adhesions, substrates were incubated with primary antibodies to 
vinculin (Millipore, Billerica, MA) at 1:100 dilution in 3% BSA in PBS for 1 h. The 
surfaces were rinsed three times with PBS and then incubated for 1.5 h with Alexa Fluor 
488-conjugated goat anti-mouse IgG secondary antibody (1:200 dilution in 3% BSA in 
PBS, Life Technologies Inc.) for visualization of vinculin, and rhodamine-conjugated 
phalloidin (1:100 dilution in 3% BSA in PBS, Cytoskeleton Inc., Denver, CO) for 
visualization of filamentous actin (F-actin). Nuclei were counterstained using 
Vectashield Mounting Medium (Vector Labs, Burlingame, CA) containing 4’,6 
diamidino-2-phenylindole (DAPI).  
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Images were captured using an Axio Observer Z.1 fluorescence microscope (Carl 
Zeiss, Jena, Germany) and AxioImager software. Osteoblast attachment was determined 
on each surface by evaluating the total number of nuclei visible from 10 non-overlapping 
fields of view, selected at random. For quantification of cell spreading, the planar area of 
the cells was measured using AxioVision Software Release 4.8.0.0. The average cell 
planar area was determined from 10 cells on each sample. To assess the number of focal 
adhesions, vinculin labeling was analyzed using ImageJ software (National Institutes of 
Health, Bethesda, MD). The average number of focal adhesions per cell was determined 
for 10 cells by an impartial, blinded observer.  
 
4.3.4 Osteoblast differentiation and quantitative assessment of osteoblast 
marker gene expression   
 RCOs were incubated on each substratum (HA1, HA2 and HA3) and cultured in 
α-MEM (supplemented with 10% FBS and AA) for 3 days. Subsequently, RCO’s were 
cultured in osteogenic medium (regular medium described above supplemented with 2 
mM β-glycerophosphate and 50 µg/mL ascorbic acid) and incubated for an additional 7 
or 14 days (with medium changed every 2-3 days). Total RNA was extracted using 
TRIzol (Invitrogen) prior to the addition of osteogenic medium (day 0) and at days 7 and 
14. RNA was purified using an RNeasy Micro Kit (Qiagen - Canada, Toronto, ON) and 
genomic DNA removed using DNase I (Qiagen), according to the manufacturer’s 
instructions. Purified RNA was stored at -80°C until required. The total RNA 
concentration and purity were determined from absorption at 260 and 280 nm using a 
Nanodrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). 
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Quantitative real-time PCR (RT-qPCR) was performed to determine transcript levels of 
type I collagen (Col1a2), tissue non-specific alkaline phosphatase (Alpl) and osteocalcin 
(Bglap). 
 RT-qPCR was performed using the ABI Prism 7900 HT Sequence Detector 
(Applied Biosystems, Carlsbad, CA, USA) with 15 µl final reaction volumes containing: 
5-25 ng RNA sample; TaqMan One-Step RT-PCR Master Mix Reagents (Applied 
Biosystems); Col1a2, Alpl, Bglap or 18S ribosomal RNA primers and probes (Applied 
Biosystems); and RNase-free water. Reverse transcription was performed at 48°C for 30 
min followed by 40 cycles of amplification at an annealing temperature of 60°C. Col1a2, 
Alpl and Bglap gene expression was normalized to levels of endogenous 18S rRNA. 
Expression is given as fold change relative to day 0 levels for cells cultured on smoother 
(HA1) substrata, calculated using the delta-delta cycle threshold (∆∆CT) method. 
Efficiency was verified using standard curves for each primer-probe set, generated from 
a dilution series of pooled RNA.  
 
4.3.5 Osteoclast isolation and culture 
 Authentic osteoclasts were isolated from the long bones of neonatal New Zealand 
white rabbits as described previously [31]. Briefly, long bones were minced and cells 
suspended in M199 medium supplemented with 15% FBS, antibiotics and antimycotic 
(100 U/mL penicillin, 200 µg/mL streptomycin, 0.5 µg/mL amphotericin B). Dentin was 
used as a control substratum. Slices (6 x 6 mm) were prepared from elephant ivory 
obtained as a gift from the Canadian Wildlife Service and cleaned by sonication in 70% 
ethanol. Substrata (dentin slices, HA1 and HA3) were sterilized by RFGD argon plasma 
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and pretreated with FBS for 1 h. Subsequently, 500 µL of osteoclast suspension was 
carefully added to the top of the dentin, HA1 and HA3 samples and incubated in 
humidified 5% CO2 at 37°C for 1 h. Substrates were then washed gently with PBS to 
remove non-adherent cells, and 1 ml of supplemented M199 medium was added and 
samples were incubated at 5% CO2 for 48 h. For evaluation of pit formation and F-actin 
organization, samples were incubated in humidified 10% CO2 at 37°C for 48 h, 
conditions known to decrease medium pH to ~ 7.0 [32], and stimulate of resorptive 
activity [33].   
 
4.3.6 Tartrate-resistant acid phosphatase (TRAP) activity  
 After 48 h in culture, the osteoclasts were fixed using 4% PFA in PBS for 10 min 
and substrata were rinsed three times with PBS.  Samples were stained for TRAP 
activity, an enzymatic marker of osteoclasts, using an acid phosphatase kit (Sigma-
Aldrich) according to the manufacturer’s protocol without counter-staining with 
hematoxylin. Images were obtained using a Nikon SMZ 1500 stereoscopic zoom 
microscope (Nikon Instruments Inc. Melville, NY) equipped with a Fiber-Lite MI-150 
high intensity illuminator (Dolan-Jenner Industries, Boxborough, MA) and a 
Photometrics CoolSNAP cf CCD camera (Roper Scientific Photometrics, Tucson, AZ). 
Micrographs were analyzed to determine the size distribution of the TRAP-positive 
regions using ImageJ software (to exclude debris, only areas > 60 µm2 were included in 
the analysis). We quantified the total area of TRAP-positive regions, and the total 
number of regions with planar area > 250 µm2 (as an indicator of the number of 
osteoclasts) on five randomly selected fields of view.  
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4.3.7 Resorption activity  
 Determination of osteoclastic resorption was also performed by SEM analysis 
[34]. At the conclusion of the osteoclast incubation (48 h), the majority of non-
osteoclastic cells were removed from the test substrata using Pronase E (0.001% in PBS 
with 0.5 mM EDTA) at 37 °C for 5 min [31]. Samples were then gently washed with 
PBS, replaced in fresh medium and incubated at 37°C for 2 h to allow osteoclast 
morphology to recover. Culture medium was then removed and cells fixed with 4% 
glutaraldehyde solution (Sigma-Aldrich) for 15 min, after which substrata were gently 
rinsed three times with PBS. To preserve osteoclast morphology [35], samples were 
dried using hexamethyldisilazane (HMDS; Sigma-Aldrich). Samples were first 
dehydrated in a series of ethanol dilutions (25%, 50%, 75%, 90%, 95% and 100%) for 5 
min at each concentration. Substrata were then submerged in 100% hexamethyldisilazane 
for 10 min and dried in air. Surface topography of substrata after incubation with and 
without osteoclasts was examined using the FIB/SEM LEO 1540XB microscope. 
Resorption pit planar area was determined by measuring the area of 10-15 pits from two 
independent experiments using ImageJ software. 
 
4.3.8 Fluorescence microscopy 
Fluorescence microscopy was used to visualize the F-actin organization within 
osteoclasts by fluorescence staining. After 48 h in culture, the cells were fixed using 4% 
PFA in PBS and permeabilized with 0.1% Triton-X 100 in PBS for 5 min. The surfaces 
were rinsed three times with PBS and the samples were blocked with 3% BSA in PBS 
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for 30 min. The substrates were incubated for 1.5 h with rhodamine-conjugated 
phalloidin (1:100 dilution in 3% BSA in PBS). Nuclei were counterstained using DAPI 
containing Vectashield Mounting Medium. Osteoclasts were identified as multinucleated 
cells having three or more nuclei. 
To monitor organization of actin within live osteoclasts, adenovirus expressing 
human β -actin-EGFP fusion protein was created using the ViraPower™ adenoviral 
expression system, according to the manufacturer’s protocols (Invitrogen). 
pAd/CMV/V5-DEST and pENTR1A Gateway vectors were used. A NheI-BamHI 
fragment containing actin-EGFP was isolated from the pActin-EGFP vector (Clontech, 
Mountain View, CA) and cloned into the pENTR1A vector. HEK293A cells (Invitrogen) 
were used for adenovirus amplification. A crude viral lysate was prepared in α-MEM 
supplemented with 2% FBS. Preliminary experiments were performed to optimize 
transfection conditions for each virus preparation. Rabbit osteoclasts were isolated and 
cultured on HA3 samples in a 24-well culture plate for 1 day. Viral lysate was then added 
onto each sample (200 µL per sample) and incubated for 20 min at 37°C. Subsequently, 2 
mL of supplemented M199 medium was added to each well and cultures were incubated 
for 24 h before imaging. 
  A confocal microscope (model LSM 510 META; Zeiss) was used to visualize 
the actin organization within the actin-EGFP-transfected live osteoclasts and fixed 
osteoclasts stained with rhodamine-conjugated phalloidin. Images were acquired using 
Zeiss C-Apochromat 40x water-immersion objective. EGFP was visualized using 488-
nm Ar- ion laser excitation and a 500-550 nm emission band pass filter.  Rhodamine was 
visualized using 543-nm HeNe laser excitation and a 565-615 nm emission band pass 
filter.   
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4.4 Results 
4.4.1 Control of surface topography of biomimetic hydroxyapatite coatings 
 We prepared HA surface coatings with varying topographical features and 
roughnesses by incubation of functionalized polycaprolactone (PCL) with simulated 
body fluid (SBF) of different ionic concentrations and for various soaking times (Fig. 
4.1). Detailed characterization of the crystal phase, identification of functional groups, 
substrate stiffness, and surface roughness of the HA coatings have been described in our 
previous study [30]. Each of the HA coatings consisted of the same crystal phase (poorly 
crystalline, bone-like HA) and exhibited carbonate substitution. In addition, EDX 
analyses revealed virtually identical elemental composition (Figure 4.2) and there were 
no significant differences in Ca/P or Na/Ca ratios. 
As shown previously [30], the HA surface roughness was assessed at high 
resolution (sub-micrometer) using AFM and at lower resolution (micro-scale) using 
profilometry. For the purposes of the present study, HA surfaces with Ra = 190 nm and 
1.0 µm as measured by AFM and profilometry, respectively, were considered to have a 
smoother (HA1) surface. HA coatings with Ra = 320 nm and Ra = 1.3 µm were 
considered to be submicro-rough (HA2, i.e. rough at high resolution). Lastly, HA 
coatings with Ra = 360 nm and Ra = 2.0 µm were considered to be micro-rough (HA3) 
and were rough at both high and low resolution. These materials were used to investigate 
the effect of surface topography of biomimetic HA coatings on the behavior of 
osteoblasts and osteoclasts. 
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Figure 4.1 Scanning electron microscope (SEM) images of hydroxyapatite (HA) 
coatings. HA was deposited on polycaprolactone (PCL) discs by immersion in 
modified simulated body fluid (SBF) of different ionic concentrations.  A) Smoother 
(HA1) topography was obtained by initial incubation in 7xSBF-A for 48 h. B) sub-
micrometer rough (HA2) topography was obtained by initial incubation in 10xSBF-A 
for 24 h. C) Sub-micrometer and micro-rough (HA3) topography was obtained by 
initial incubation in 10xSBF-A for 48 h. Images are representative of multiple 
samples from at least 5 independent preparations. Scale bar = 20 µm in all panels.  
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Figure 4.2 Elemental analysis of hydroxyapatite (HA) coatings as determined by 
energy dispersive X-ray spectroscopy (EDX).  HA was deposited on polycaprolactone 
(PCL) discs by immersion in modified simulated body fluid (SBF) of different ionic 
concentrations. A) Representative spectrum from smoother (HA1) topography 
obtained by initial incubation in 7xSBF-A for 48 h. B) Representative spectrum from 
sub-micrometer-rough (HA2) topography obtained by initial incubation in 10xSBF-A 
for 24 h. C) Representative spectrum from micro-rough (HA3) topography obtained 
by initial incubation in 10xSBF-A for 48 h. These data reveal that the elemental 
composition of all 3 substrata was virtually identical. Spectra are representative of 3 
spot analyses from 3 independent preparations. 
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4.4.2 Effect of HA surface topography on osteoblast attachment, spreading 
and focal adhesion formation  
Rat calvarial osteoblasts (RCOs) were cultured on the different HA coatings for 6 
h, then cells were fixed, and nuclei, F-actin and vinculin were labeled.. Osteoblast 
morphology was assessed by fluorescence microscopy of F-actin-labeled cells (Fig. 
4.3(A), red label). Morphology was similar for osteoblasts attached to HA1 and HA2 
surfaces – cells showed long cytoplasmic extensions, filopodia and stress fiber formation. 
By contrast, osteoblasts attached to the rougher HA3 coatings displayed fewer cellular 
projections, lamellipodia, F-actin-rich microspikes and a more diffuse, randomly 
arranged pattern of cytoplasmic F-actin.  
Fluorescence imaging of F-actin and nuclei showed that osteoblasts attached well 
on each of the HA1, HA2 and HA3 surfaces. Interestingly, osteoblast attachment was 
greater by ~ 50% on the HA3 coating compared to the smoother HA1 surface (Fig. 
4.3(B), p < 0.05). Osteoblast spreading was quantified by measuring the planar area of 
cells and was found to be similar on each surface, with mean values ranging from 870-
1050 µm2 (Fig. 4.3(C), p > 0.05). Focal adhesions were observed by 
immunofluorescence imaging of vinculin-labeled cells (Fig. 4.3(A)). Numerous focal 
adhesions appeared at the termini of projections from osteoblasts adhered to HA1 and 
HA2 coatings. In contrast, vinculin showed predominate distribution perinuclear in 
osteoblasts attached to rougher HA3 surfaces. Quantification revealed a markedly greater 
number of focal adhesions in osteoblasts attached to HA1 compared to cells on HA3 
coatings (Fig. 4.3(D), p < 0.05).  
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Figure 4.3 Effects of HA surface topography on osteoblast attachment, spreading and 
focal adhesion formation. Rat calvarial osteoblasts (RCOs) were cultured on the HA 
coatings for 6 h. Cells were then fixed, labeled for nuclei (blue), F-actin (red) and 
vinculin (green). A) Representative fluorescence images of single osteoblasts on 
smoother (HA1), sub-micrometer-rough (HA2) and micro-rough (HA3) coatings.  
Focal adhesions were revealed by vinculin staining (arrows). Scale bars = 50 µm, and 
applies to all panels. B) Osteoblast attachment was quantified as the number of cells 
attached per mm2. Data are means ± SEM from 10 fields of view of triplicate samples 
from n = 4 independent experiments. C) Planar cell area was quantified by image 
analysis.  Data are means ± SEM of triplicate samples from n = 4 independent 
experiments. D) Number of focal adhesions per cell was determined by a blinded 
observer. Data are means ± SEM of n = 6 samples from two independent experiments. 
Data were analyzed by one-way ANOVA and Tukey’s multiple comparisons test. 
Bars labeled with the same lower case letter are not significantly different (p > 0.05). 
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In summary, the surface topography of biomimetic HA coatings influenced 
osteoblast attachment and focal adhesion formation. Micro-rough HA3 surfaces 
supported greater attachment, but fewer focal adhesions than did smoother HA1 coatings.    
 
4.4.3 Effect of HA surface topography on markers of osteoblast 
differentiation 
 RCOs were plated on HA1, HA2 and HA3 surfaces and cultured for 3 days. 
Medium was then supplemented with β-glycerophosphate and ascorbic acid to induce 
osteoblastic differentiation (day 0) and cells were cultured for an additional 7 or 14 days. 
Quantitative RT-PCR revealed that transcript levels of Col1a2 were not significantly 
different on day 0. As expected, by day 7 some modest increases were observed in the 
expression of collagen type I (Fig. 4.4(A)). Interestingly, Col1a2 mRNA levels were 
significantly greater when osteoblasts were differentiated on the micro-rough HA3 
coatings than on the smoother HA1 surfaces (p < 0.05).  
A classic marker of osteoblast differentiation, tissue-nonspecific alkaline 
phosphatase, is encoded by Alpl and plays a critical role in regulating mineralization of 
the extracellular matrix [36]. By day 7, there was marked upregulation of Alpl expression 
in osteoblasts on all 3 substrata (Fig. 4.4(B)). Notably, significant increases in Alpl 
transcript levels were more than 2-fold greater in osteoblasts on the rougher HA3 
surfaces as compared to HA1 coatings (p < 0.05).  
Osteocalcin, also known as bone γ-carboxyglutamic acid-containing protein, is 
secreted only by osteoblasts and is encoded by the gene Bglap. Moreover, osteocalcin is 
expressed by osteoblasts at later stages of differentiation than is tissue-nonspecific 
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alkaline phosphatase [37]. Consistent with expression at later stages of differentiation, 
we observed dramatic upregulation of Bglap transcript levels after 14 days of culture on 
all substrata (Fig. 4.4©). In keeping with the changes observed in Alpl expression, 
significant increases in Bglap transcript levels were more than 2-fold greater in 
osteoblasts on HA3 surfaces, as compared to HA2 and HA1 coatings (p < 0.05). Taken 
together, these data indicate that the biomimetic HA coating with greater surface 
roughness and complexity (HA3, Ra ~ 360 nm and Ra ~ 2 µm) promotes osteoblast 
differentiation. 
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Figure 4.4 Effect of HA surface topography on expression of osteoblast 
differentiation markers. RCOs were plated on HA1, HA2 and HA3 surfaces and 
cultured for 3 days. Medium was then supplemented with β-glycerophosphate and 
ascorbic acid to induce osteoblastic differentiation (day 0) and cells were cultured for 
an additional 7 or 14 days. Quantitative RT-PCR was performed to assess transcript 
levels of collagen type I (Col1a2, A), tissue-nonspecific alkaline phosphatase (Alpl, 
B) and osteocalcin (Bglap, C). Expression was normalized to levels of endogenous 
18S rRNA and is reported as fold change relative to day 0 levels for cells cultured on 
smoother (HA1) substrata. Data are means ± SEM of triplicate samples from n = 3 
independent experiments. Data were analyzed by two-way ANOVA with repeated 
measures and Bonferroni multiple comparisons test. Bars labeled with the same lower 
case letter are not significantly different (p > 0.05). 
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4.4.4 Effect of HA surface topography on osteoclasts as revealed by 
staining for tartrate-resistant acid phosphatase (TRAP) activity 
 Primary osteoclasts and osteoclast precursors were disaggregated from the long 
bones of neonatal rabbits, plated on test substrata and cultured for 2 days. In these 
experiments, we compared the effects of the following surfaces: smoother (HA1); micro-
rough (HA3), which was superior for osteoblast attachment and differentiation; and 
dentin slices, which are resorbable by osteoclasts in vitro and were used as a positive 
control.      
After 2 days, cultures were stained for TRAP, a well-established histochemical 
marker of osteoclasts and late osteoclast precursors [38]. In the absence of cells, no 
TRAP staining was observed on any of the substrata (Fig 4.5(Ai, Bi, Ci)). However, on 
surfaces plated with cells, positive TRAP staining was observed (Fig. 4.5(Aii, Bii, Cii)) 
with the greatest amount of TRAP staining apparent in cultures plated on the less rough 
and smoother HA1 coatings (Fig. 4.5(Bii)).  
Image analysis software was used to quantify the planar area and number of 
TRAP-stained regions on each substratum. Frequency distribution plots of the areas of 
TRAP-stained regions were fit by nonlinear regression using a two-phase exponential 
decay model (Fig. 4.5(Aiii, Biii, Ciii)). The second decay constant was 10-fold smaller for 
HA1 surfaces, indicating a broader range of larger TRAP-positive cells on the smoother 
surfaces (Fig. 4.5(D)). Total TRAP-stained area was significantly greater on HA1 
surfaces than on HA3 coatings (Fig. 4.5(E), p < 0.05), consistent with greater attachment 
and spreading of osteoclasts and osteoclast precursors on the smoother topography. 
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Material with planar area less than 60 µm2 was considered to be debris; 60 to 250 
µm2 was consistent with the size of mononucleated osteoclast precursors, while labeled 
regions greater than 250 µm2 most likely represented multinucleated osteoclasts 
(although we recognize that these could also be contiguous groups of precursors). Using 
these criteria, we estimated the total number of osteoclasts on each substratum (Fig. 
4.5(F)). The number of osteoclasts on smoother HA1 surfaces was approximately 2.5-
fold greater than on micro-rough HA3 coatings (p < 0.05). Thus, surface topography 
appears to have a major influence on osteoclast attachment and spreading.    
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Figure 4.5 Effect of HA surface topography on osteoclasts as revealed by staining for 
tartrate-resistant acid phosphatase (TRAP) activity. Dentin slices (control, A), 
smoother HA1 (B) and micro-rough HA3 (C) were incubated for 2 days in the 
presence and absence of rabbit osteoclasts. Samples were then stained for activity of 
the osteoclast marker enzyme TRAP (red). Image analysis software was used to 
quantify the planar area and number of TRAP-stained regions on each substratum. To 
exclude debris, only areas > 60 µm2 were included in the analysis. A-C) Panels at 
right illustrate frequency distribution plots of the areas of TRAP-stained regions. 
Distributions were fit by nonlinear regression using a two-phase exponential decay 
model. First and second decay constants were (in µm-2): 0.0055 and 0.020 for dentin; 
0.016 and 0.0025 for HA1; and 0.0096 and 0.045 for HA3. D) Plot of nonlinear 
regression curves, fit to the distribution of TRAP regions observed on dentin (green 
curve), HA1 (red curve) and HA3 (blue curve). E) Area of TRAP staining was 
quantified as a percentage of the total area of each substratum. F) Number of TRAP-
positive osteoclasts (planar area > 250 µm2) was also quantified. Data are means ± 
SEM from 5 fields of view of triplicate samples from n = 3 independent experiments. 
Data were analyzed by one-way ANOVA and Tukey’s multiple comparisons test. 
Bars labeled with the same lower case letter are not significantly different (p > 0.05). 
Scale bars = 100 µm and applies to all panels. 
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4.4.5 Effect of HA surface topography on osteoclastic resorption 
 We next explored the ability of osteoclasts to resorb HA coatings. Smoother 
(HA1) HA, micro-rough (HA3) HA and dentin slices were incubated for 2 days in the 
presence and absence of rabbit osteoclasts. Preparations were then fixed and processed 
for analysis by SEM. Dentin, HA1 and HA3 samples incubated without cells showed no 
pits or defects that could be mistaken for resorption lacunae formed by osteoclasts (Fig 
4.6(Ai, Bi, Ci)), the planar areas of which are typically of the order of 1-3 x 103 µm2 [34]. 
As expected, osteoclasts produced distinct resorption lacunae on dentin slices showing 
typical shallow resorption pits, often associated with the presence of an osteoclast (Fig 
4.6(Aii)). Numerous mononucleated cells and erythrocytes were also apparent. 
Osteoclastic resorption pits were observed on smoother HA1 coatings (Fig. 4.6(Bii)). 
However, in contrast to pits on dentin, resorption lacunae on HA1 surfaces showed a 
markedly distinct morphology, appearing as deep, punched-out pits with smaller planar 
area (Fig. 4.6(D)). Strikingly, no evidence of resorption pits was seen on any of the 
micro-rough HA3 surfaces after examination of a total of five surfaces from 3 
independent osteoclast preparations. Nevertheless, osteoclasts were observed on HA3 
coatings exhibiting typical spread morphology (Fig. 4.6(Cii)). In summary, SEM analysis 
revealed a dramatic effect of topography on the ability of osteoclasts to resorb HA.   
Osteoclasts on HA1 substrata were well spread and appeared to be in more 
intimate contact with the surface (Fig. 4.7(A)) than osteoclasts on HA3 coatings (Fig. 
4.6(Cii)). Furthermore, osteoclasts on the smoother HA1 substrata appeared to localize 
selectively to regions devoid of large surface irregularities. Some osteoclasts that 
appeared to be actively resorbing HA1 substrates were slightly dome shaped (Fig. 
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4.7(B)), suggesting apico-basal polarization. Other osteoclasts, associated with 
completely formed resorption lacunae, appeared to be migrating (Fig. 4.7(C)). Fig. 
4.7(D) shows a higher magnification image of the resorption lacunae in Fig. 4.7(C). The 
HA1 appears to be completely removed down to the underlying PCL polymer. A distinct 
ring-like structure is apparent on the inside periphery of lacunae, which we suggest could 
represent partial dissolution of HA at the site of the sealing zone. 
 
 
  
167 
 
 
 
  
Figure 4.6 Effect of HA surface topography on osteoclastic resorption. Dentin slices 
(A), and HA with smoother (HA1, B) and micro-rough (HA3, C) topographies were 
incubated for 2 days in the absence (left panels) and presence (right panels) of rabbit 
osteoclasts. Preparations were then fixed and processed for analysis by SEM. 
Arrowheads indicate resorption pits. Asterisks indicate osteoclasts. Scale bars = 50 
µm. Images are representative of samples from three independent cell isolations. D) 
Pit area was quantified using ImageJ software. Data are means ± SEM of n = 10 to 15 
pits from 2-3 independent cell isolations. 
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Figure 4.7 Osteoclastic resorption on the smooth HA1 coatings. Rabbit osteoclasts 
were cultured for 2 days on the smoother HA1 coatings. Preparations were then fixed 
and processed for analysis by SEM. Arrowheads indicate resorption pits. Asterisks 
indicate osteoclasts. Scale bars = 20 µm. Three osteoclasts are illustrated.  A) 
Osteoclast is well spread and in intimate contact with the HA1 surface. B) Another 
slightly dome-shaped osteoclast appeared to be actively resorbing the HA1 substrate. 
C) A third osteoclast was associated with a distinct resorption lacuna and appeared to 
be migrating. D) A higher magnification image of a part of the resorption lacunae 
shown in panel C. HA1 appears to have been completely removed down to the 
underlying polycaprolactone (PCL) polymer base. A distinct ring-like structure 
(designated by π) is apparent on the inside periphery of lacunae, which could 
represent partial dissolution of HA1 at the site of the sealing zone. 
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4.4.6 Effect of HA surface topography on F-actin organization in 
osteoclasts 
Osteoclasts adhere to substrata via podosomes – dynamic, F-actin-containing 
structures that self-organize into rings, belts and sealing zones, which are essential for 
resorption [39, 40]. We next addressed the effect of substratum topography on sealing 
zone formation by analysis of F-actin organization. Rabbit osteoclasts were cultured on 
the smoother HA1, micro-rough HA3 and dentin slices for 2 days, the studied by 
fluorescence microscopy (Fig. 4.8).  
On both dentin and smoother HA1 coatings, many osteoclasts exhibited typical F-
actin sealing zones (Fig. 4.8(A, B)). Ring-like sealing zones are typically formed by 
active osteoclasts plated on resorbable substrata. In contrast, osteoclasts cultured on 
micro-rough HA3 coatings more often displayed disrupted F-actin organization, with 
individual podosomes and podosome belts along the cell periphery (Fig. 4.8(C)). F-actin 
belts are typically seen in osteoclasts cultured on non-resorbable substrata such as glass 
[39]. Quantification of actin organization revealed that 3-fold more osteoclasts exhibited 
ring-like F-actin sealing zones on HA1 than on HA3 surfaces (Fig. 4.8(D), p < 0.05). We 
also used these data to determine the mean planar area of osteoclasts on HA1 and HA3 
surfaces. There was no significant difference in the size of osteoclasts (with comparable 
number of nuclei) when plated on HA1 or HA3 coatings (Fig. 4.9). This finding argues 
against the possibility that differences in TRAP-stained area (Fig. 4.5) were due to 
greater spreading of osteoclasts on the smoother HA1 topography.   
We employed confocal microscopy to better characterize the actin structures 
formed in osteoclasts adhering to the micro-rough HA3 surfaces. First, rabbit osteoclasts 
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were transduced with adenoviruses expressing actin-EGFP fusion protein. Again, these 
cells failed to form well defined sealing zone structures (Supplementary Fig. S4). 
Moreover, we also used confocal microscopy to examine rabbit osteoclasts on HA3 
surfaces, expressing actin-EGFP fusion protein and then fixed and labeled for F-actin 
(Supplementary Fig. S5). These high resolution images revealed the presence of 
peripheral podosomes and podosome clusters, which were not organized into sealing 
zones known to be essential for osteoclastic resorption. In addition, co-labeling of F-actin 
containing podosomes with both EGFP and rhodamine (Supplementary Fig. S5C) 
validates use of the exogenous actin-EGFP fusion protein for monitoring actin dynamics 
in living cells.   
Taken together, the osteoclast experiments revealed increased presence and 
activity of osteoclasts on the smoother HA surface. Furthermore, failure to resorb the 
micro-rough HA coating may be due to the inability of osteoclasts to form an F-actin 
sealing zone on this more complex topography. 
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Figure 4.8 Effect of HA surface topography on F-actin organization in osteoclasts. 
Rabbit osteoclasts were cultured on dentin slices (A), smoother HA1 (B) and micro-
rough HA3 (C) for 2 days. Preparations were then fixed, labeled for F-actin (red) and 
nuclei (blue) and observed by wide-field fluorescence microscopy. On both dentin and 
HA1 coatings, osteoclasts often exhibited ring-like F-actin sealing zones. In contrast, 
osteoclasts on rougher HA3 coatings displayed disrupted F-actin organization, with 
individual podosomes and podosome belts along the cell periphery. Images are 
representative of multiple samples from five independent cell isolations. Scale bar = 
50 µm. D) The number of osteoclasts exhibiting ring-like F-actin sealing zones was 
quantified on HA1 and HA3 coatings. Data are expressed as a percentage of the total 
number of osteoclasts examined (41 on HA1 and 53 on coatings) from five 
independent cell isolations. F-actin sealing zones were present in a significantly 
greater proportion of osteoclasts on smoother HA1 than on micro-rough HA3 surfaces 
(p < 0.05, based on Fisher’s exact test). 
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Figure 4.9 Quantification of the effect of HA surface topography on spreading of 
osteoclasts. Disaggregated rabbit osteoclasts were cultured on smoother HA1 and 
micro-rough HA3 for 2 days. Preparations were then fixed, labeled for F-actin and 
nuclei and observed by wide-field fluorescence microscopy. Image analysis software 
was used to quantify the planar area of osteoclasts having comparable number of 
nuclei. Data are expressed as a means ± SEM of n = 17-20 (with 3-4 nuclei) and n = 
7-8 (with 5-6 nuclei) osteoclasts from 5 independent cell isolations. Data were 
analyzed by two-way ANOVA and a Bonferroni multiple comparisons test. Bars 
labeled with the same lower case letter are not significantly different (p > 0.05). These 
data reveal that topography did not significantly affect the spreading of osteoclasts. 
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Figure 4.10 Confocal microscopy of actin in living osteoclast adhering to micro-
rough HA3 coating. Rabbit osteoclasts were plated on HA3 surfaces and transduced 
with adenovirus expressing actin-EGFP fusion protein. Cells were then bathed in 
HEPES-buffered M199 medium with 15% FBS at ~26°C and imaged using confocal 
microscopy (40x objective, Zeiss LSM 510 META confocal microscope). Osteoclasts 
failed to form well defined sealing zone structures.  Scale bar = 100 µm. A) Merged z-
stack image of single living osteoclast. B) Orthogonal reconstruction of live osteoclast 
in panel A. 
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Figure 4.11 Confocal microscopy of actin structures in osteoclast adhering to micro-
rough HA3 coating. Rabbit osteoclasts were plated on micro-rough HA3 surfaces and 
transduced with adenovirus expressing actin-EGFP fusion protein. Cells were 
subsequently fixed and F-actin was labeled with rhodamine-conjugated phalloidin. 
Confocal imaging was performed using a 40x objective (Zeiss LSM 510 META 
confocal microscope). The same osteoclast was imaged for EGFP (A, green), which 
labels exogenous actin (globular and filamentous), and rhodamine-conjugated 
phalloidin (B, red), which labels endogenous and exogenous F-actin. C) Merged 
image. Osteoclast exhibits peripheral F-actin podosomes and podosome clusters, 
which were not organized into sealing zones, known to be essential for osteoclastic 
resorption. Co-labeling of F-actin containing podosomes with both EGFP and 
rhodamine (yellow) validates use of the exogenous actin-EGFP fusion protein for 
monitoring actin dynamics in living cells.  Scale bars = 100 µm. 
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4.5 Discussion  
 Our findings further support an important role for the surface topography of 
biomaterials in controlling cell behavior. Our approach to controlling the topography of 
HA coatings offers several advantages compared to other reported techniques. We 
deposited biomimetic HA coatings on PCL by incubation in modified SBF – a 
straightforward method to directly modify the complexity and roughness of HA surfaces 
[30]. This systematic procedure utilizes mild conditions permitting the deposition of 
coatings on temperature-sensitive materials such as synthetic polymers, in contrast to 
techniques such as thermal spraying [41]. Moreover, our solution-based biomimetic 
process allows for the deposition of coatings on complex porous matrices [41], in 
contrast to grinding and polishing of sintered HA discs [4, 15] or line-of-sight deposition 
techniques such as thermal spraying [42] and laser cladding [43].  
 Attachment and spreading define the initial stages of cell-biomaterial interactions. 
These initial interactions affect the morphology and subsequent downstream cellular 
processes such as proliferation and differentiation [44]. HA has been previously shown to 
support the attachment of osteoblastic cells better than glass or pure titanium [45]. In the 
present study, the attachment of RCOs was enhanced by increasing the surface roughness 
and complexity of biomimetic HA. This is in keeping with a previous report that 
roughening of sintered HA discs using grit-polishing increases the attachment of bone 
marrow stromal cells [4].  
 Focal adhesions link the cytoskeleton of cells to the extracellular matrix or 
biomaterial surface. Focal adhesions are composed of proteins including vinculin, which 
mediates interactions between F-actin and integrins [44]. Focal adhesion proteins 
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mediate signal transduction and subsequent changes in gene expression initiated by 
binding to the extracellular matrix or biomaterial surface [46]. The complexity of 
biomaterial surfaces is known to influence the formation of focal adhesions. For 
example, a mesenchymal cell line cultured on polydimethylsiloxane showed increased 
formation of focal adhesions on a micropatterned surface compared to a flat surface [47]. 
In contrast, we found that, as roughness and surface complexity of the HA surfaces 
increased, the number of focal adhesions decreased. Moreover, on micro-rough surfaces, 
osteoblast morphology appeared to be rounded with no stress fiber formation. It is 
possible that differences in focal adhesion formation and consequent signaling contribute 
to the effects of topography on osteoblast differentiation observed in longer term 
cultures.   
 Osteogenic differentiation is comprised of three phases -- cellular proliferation, 
cellular maturation, and matrix mineralization [48]. During these phases, a host of 
collagenous and non-collagenous proteins are expressed. Type I collagen is expressed 
during the initial period of proliferation and ECM synthesis, whereas alkaline 
phosphatase expression occurs during maturation of cells and ECM [48, 49]. 
Furthermore, early stage expression of alkaline phosphatase has been correlated with 
later stage bone nodule formation in vitro [9], consistent with its role in generating 
inorganic phosphate required for matrix mineralization. Osteocalcin is expressed later, 
during the final stage of matrix mineralization [48, 49].  
Increased levels of surface roughness and complexity enhanced collagen type I 
and alkaline phosphatase expression, consistent with accelerated differentiation. 
Furthermore, micro-rough HA coatings having increased levels of submicrometer and 
micro-scale complexity induced dramatically greater levels of osteocalcin expression. 
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Therefore, merely depositing calcium phosphate coatings on synthetic materials is not 
sufficient to produce optimal scaffold and implant biomaterial surfaces. The osteogenic 
potential of biomimetic HA coatings can be further enhanced by the careful control and 
design of the surface complexity and roughness. 
In the present study, the greatest effects on osteoblast attachment, adhesion and 
differentiation were found when comparing HA coatings with smoother (HA1) 
topography to those with micro-rough (HA3) topography. Effects of submicro-rough 
(HA2) substrata were intermediate, suggesting that topographical features at both the 
micro, submicro and nano scales contribute to regulating the behavior of osteoblasts. In 
this regard, some authors have considered nanostructured surfaces as highly desirable for 
promoting the adhesion, growth and maturation of cells on biomaterials [50]; while, 
others have questioned the in vivo significance of such nanoscale structures, as proteins 
attaching to the surface after implantation likely mask such fine features [2].  
The effect of surface topography on osteoclasts was evaluated using authentic, 
mature osteoclasts isolated directly from the long bone of neonatal rabbits, a well 
characterized model for investigating osteoclast behavior [51]. Most previous studies 
examining resorption of synthetic calcium phosphates in vitro have used osteoclast-like 
cells formed from bone marrow, the RAW 264.7 cell line, or human peripheral blood 
monocytes [14, 15, 20, 26, 52]. However, primary cultures of authentic osteoclasts are 
advantageous, as they allow for the assessment of mineral resorption activity 
independent of effects on osteoclast formation, which can complicate the interpretation 
of results [49]. 
 In the present study, we found that the surface topography of biomimetic HA 
coatings has a pronounced effect on their interaction with osteoclasts. Fewer TRAP-
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positive cells were observed on HA surfaces with increased levels of topographical 
complexity and roughness. These results are in contradiction to previous studies using 
osteoclasts differentiated from rat bone marrow on surface-abraded, sintered HA discs 
[52]. In another study, authentic osteoclasts isolated from the long bones of rats were 
cultured on natural versus abraded bone slices [53]. There was no difference in the 
number of TRAP-positive osteoclasts on each surface. Other investigators differentiated 
osteoclast-like cells in vitro from human peripheral blood monocytes on surface-abraded, 
sintered HA discs (with addition of receptor activator of nuclear factor κB ligand 
(RANKL) and macrophage colony stimulating factor (M-CSF)) [15]. In this case, more 
osteoclasts formed on the rougher substratum. However, the degree of surface roughness 
of their sintered HA discs was well below the Ra value of the HA coatings used in the 
present study, which are considered ideal for biomaterials [2, 11]. Interestingly, the 
osteoclastic cells derived from human monocytes were decreased on rough HA discs in 
the presence of human bone marrow stromal cells [15], indicating complex interactions 
between topography, and cells of the osteoblast and osteoclast lineages.  
 In regard to osteoblast-osteoclast interactions, rougher micro-topographies have 
been shown to enhance the production and secretion of osteoprotegerin (OPG) by 
osteoblast-like cells [54]. OPG is a decoy receptor that selectively binds RANKL 
limiting osteoclast differentiation, activation and survival [40]. However, it is unlikely 
that OPG production contributes to the effects of micro-rough topography in the present 
study, as cells are cultured at low density and relatively few osteoblast precursors are 
present. As osteoclast spreading did not appear to differ markedly on smooth and micro-
rough surfaces, the increased TRAP-staining on HA1 surfaces likely represents increased 
numbers of osteoclasts and possibly increased osteoclast activity. However, the small 
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number of cells present in primary cultures of disaggregated rabbit osteoclasts (and their 
heterogeneity) precluded us from performing gene expression studies using this system.    
 In the present study, the susceptibility of the biomimetic HA coating to 
osteoclastic resorption was highly dependent on the surface topography. Resorption 
lacunae were clearly visible on smoother HA coatings, whereas no evidence of resorption 
lacunae was visible on rougher HA coatings. Similar trends have been reported 
previously. For example, slightly fewer pits were formed by osteoclast-like cells cultured 
on roughened versus smooth sintered HA discs (Ra values not reported) [52]. When rat 
osteoclasts were cultured on bone slices of various roughnesses, there was a modest 
effect on resorptive activity, with maximal resorption at Ra = 1.0 µm and approximately 
20% less resorption at Ra = 2.9 [53]. In the present study, we identified a dramatic effect 
of surface roughness on osteoclast activity with no resorption detectable on the rougher 
HA surfaces having increased complexity at the sub-micrometer- and micrometer scale. 
Interestingly, a previous study compared the susceptibility to osteoclastic resorption of 
calcium phosphate coatings, including carbonated apatite and amorphous calcium 
phosphate in vitro [26]. They found distinct resorption lacunae on carbonated apatite 
(with topography similar to our HA1 coatings), but unexpectedly not on relatively 
soluble amorphous calcium phosphate (with very rough topography). It is possible that, 
as in the present study, this difference in susceptibility to resorption was due to 
substratum topography rather than differences in chemistry or phase.   
 In the present study, resorption lacunae on HA1 surfaces appeared as deep, 
punched-out pits, in contrast to pits on dentin, which were shallower with much greater 
planar area. These differences in pit morphology are due presumably to the presence of 
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matrix proteins in dentin, but not in biomimetic HA. In this regard, matrix proteins such 
as osteopontin are known to regulate osteoclast spreading, motility and resorption [55].    
 The resorption of bone and mineral substrates is dependent on the formation of an 
actin-rich compartment, known as the sealing zone [40, 56]. The sealing zone constitutes 
the site where osteoclasts tightly adhere to the substrate forming a diffusion barrier, 
which in turn establishes an extracellular resorption compartment into which protons are 
transported and proteolytic enzymes are secreted [39, 56, 57]. In the case of synthetic 
apatite biomaterials, acidification of this compartment causes mineral dissolution and 
formation of a resorption lacuna. 
 In keeping with the decrease in focal adhesions in osteoblasts, we found that 
osteoclasts plated on micro-rough HA3 coatings displayed disrupted F-actin 
organization, with individual podosomes and podosome belts along the cell periphery 
and few cells exhibiting complete sealing zones.  Given the essential role for sealing 
zones in resorption, it is possible that the failure of osteoclasts to resorb HA3 surfaces 
was due to the presence of surface irregularities that prevented formation of a functional 
sealing zone. In this regard, the continuity of substrate adhesiveness has been shown to 
be of critical importance for the formation and growth of the sealing zone [57]. In these 
studies, when osteoclasts were plated on flat glass substrates, patterned with an array of 
adhesive and non-adhesive regions, non-adhesive barriers as small as 1 µm were found to 
inhibit sealing zone formation. It is conceivable that topographical features may similarly 
disrupt establishment of complete sealing zones.   
In other cell types, adhesion has been shown to depend on surface topography, 
with adhesion decreasing as surface roughness increases [44, 58]. Furthermore, increased 
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surface roughness is also correlated with decreased number of focal adhesions [58], 
consistent with the behavior of RCOs observed in the present study.  
The inability of osteoclasts to resorb micro-rough HA surfaces may be attributed 
to the disrupted sealing zone formation. It is also possible that, even if the osteoclast 
could establish a sealing apparatus, the surface complexity would prevent a functional 
seal. In other words, pathways would still exist that would permit the diffusion of small 
molecules between surface irregularities. Thus, protons would diffuse out of resorption 
compartment and buffers would diffuse in, preventing acidification of the resorption 
compartment and dissolution of the HA.   
 Biomimetic HA coatings represent an ideal method to improve osteoconductivity 
and osseointegration of implants and porous scaffolds [23, 24]. Furthermore, biomimetic 
HA coatings are effective in preventing the fibrous tissue encapsulation commonly seen 
for synthetic polymers in vivo [25]. Our studies establish that the careful control and 
design of the surface topography of biomimetic HA offer a straightforward and effective 
route to improve osteoconductivity of the apatite coatings, while minimizing their 
susceptibility to osteoclastic resorption.   
Synthetic apatite biomaterials are degraded by osteoclasts in vivo and, therefore, 
their susceptibility to osteoclastic resorption is an important characteristic [16, 59]. The 
results of the present study establish that resorption of biomimetic HA coatings is 
dramatically dependent on surface topography, wherein increasing roughness and 
isotropic complexity inhibit degradation, while promoting osteoblast attachment and 
differentiation. This finding may have important implications in designing scaffolds and 
implant coatings with complementary bone-forming stimulus and coating degradation 
rates. If the ultimate goal is for the biomaterial to be used as a synthetic bone substitute, 
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then the degradation rate should be comparable to bone. However, if the intended 
application is a permanent implant, then the resorption rate should be minimized [59]. In 
particular, biomimetic HA coatings have been used as drug delivery systems for the 
therapeutic release of antibiotics and growth factors [60, 61]. The release kinetics of the 
target compound is strongly dictated by the solubility and susceptibility to resorption of 
the mineral coating. We propose that it is possible to design the surface topography of 
biomimetic HA coatings to specifically control the rate osteoclastic degradation and, 
subsequently, the release kinetics of incorporated therapeutic agents.  
In summary, biomimetic HA coatings with differing surface topographies were 
evaluated for their osteoconductivity and bioresorption using osteoblasts and osteoclasts. 
There was a significant increase in osteoblast attachment and expression of osteogenic 
markers, collagen I, alkaline phosphatase, and osteocalcin, when cultured on biomimetic 
HA surfaces with increased sub-micro- and micro-scale surface roughness. In addition, 
F-actin sealing zones were disrupted when authentic osteoclasts were cultured on micro-
rough biomimetic HA. Consistent with this observation, osteoclasts failed to resorb HA 
surfaces with micro-rough topography. These results have important implications for the 
future design and fabrication of biomimetic coatings for scaffolds and drug delivery 
systems. 
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5.1 Summary and Conclusions 
One- and Three-Dimensional Growth of Hydroxyapatite Nanowires during Sol-
Gel-Hydrothermal Synthesis – Chapter 2 is the first report of HA nanowire and nanorod 
synthesis via combination of sol-gel chemistry and hydrothermal treatment. Amorphous 
nano-scale CaP gel was produced using sol-gel chemistry and it was found that 
conversion to crystalline HA occurred after hydrothermal treatment. Morphologies of the 
HA powders varied from nanorods of low aspect ratio, to high-aspect ratio nanowires. 
The particle diameter and length was tunable by adjusting the hydrothermal pH and 
reaction time, respectively. We also found that the nanorods and nanowires were a phase-
pure HA and carbonate substitution was introduced using high pH hydrothermal 
treatment. 
1. Replacement of traditional high-temperature calcination of amorphous CaP 
gel with hydrothermal crystallization produced HA nanorods and nanowires. 
2. Adjustment of hydrothermal pH and temperature allowed for tunable HA 
particle morphology, including nanorods and high aspect ratio nanowires, 
through a one- and three-dimensional crystal growth mechanism. 
3. Characterization of hydrothermal powders revealed phase-pure stoichiometric 
and carbonate-substituted HA. 
4. Discrete HA nanowires dispersed uniformly within a PCL matrix and 
provided effective reinforcement of PCL/HA composites, with improvement 
in tensile and compressive properties. 
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Control of Surface Topography in Biomimetic Calcium Phosphate Coatings – In 
Chapter 3, we reported our discovery that adjusting the ionic concentration of SBF 
solutions and incubation time can effectively control the surface topography of 
biomimetic CaP coatings deposited on PCL films. Various CaP coatings (consisting of 
DCPD, OCP, HA and mixed phases) were obtained from the different SBF preparations. 
The fine-resolution topography of HA coatings was dependent on the ionic 
concentration, whereas the coarse-resolution topography was influenced by soaking time.  
1. Bone-like HA coatings with varying topography and levels of isotropic 
surface complexity were deposited on PCL by incubation in modified SBF 
solutions. 
2. SBF concentration affects high resolution HA surface roughness. 
3. Soaking time affects low resolution HA surface roughness. 
4. The deposited calcium phosphate coatings included DCPD, OCP, and 
carbonated-HA with Ca/P ratio ranging from 1.30 to 1.50. 
5. The surface roughness of apatite coatings varied from 194 to 363 nm 
measured at high resolution, and 1 to 2 µm at low resolution.  
 
Surface Topography of Biomimetic Hydroxyapatite Coating Differentially 
Regulates Osteoblast Osteoclast Activity – Chapter 4 describes the effect of surface 
topography and roughness of the biomimetic HA described in Chapter 3 on the in vitro 
behavior of osteoblasts and osteoclasts. In particular, rat calvarial osteoblasts showed 
enhanced osteogenic response to biomimetic HA coatings with increased isotropic 
surface complexity and roughness. In contrast, osteoclast activity was suppressed when 
authentic rabbit-derived osteoclasts were cultured on biomimetic HA with greater surface 
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complexity and roughness. In keeping with this observation, the formation of distinct 
resorption lacunae was not observed on rough HA coatings, whereas resorption pits were 
observed on biomimetic HA surfaces with less surface roughness and complexity. 
1. Osteoblast attachment to rough HA surfaces was greater than attachment to 
smoother, less complex surfaces. 
2. Formation of focal adhesions by osteoblasts was suppressed when cultured on 
rough HA surfaces. 
3. Osteoblast differentiation was enhanced when cultured on biomimetic HA 
coatings with greater levels of roughness at both high and low resolution. 
4. Osteoclast activity is dependent on surface roughness, with increased TRAP 
staining and greater numbers of osteoclasts on smoother biomimetic HA 
surfaces. 
5. Osteoclasts produced resorption lacunae when cultured on smoother 
biomimetic HA surfaces with (Ra = 194 nm and 1 µm at high and low 
resolution, respectively). 
6. Osteoclasts failed to produce resorption lacunae when cultured on rougher, 
more complex biomimetic HA surfaces (Ra = 363 nm and 2 µm at high and 
low resolution, respectively). 
7. Osteoclasts showed greater propensity to form sealing zone (as indicated by 
formation of F-actin ring-like structure) when cultured on smoother HA 
surfaces. 
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5.2 Contributions of the Research to the Current State of 
Knowledge 
Historical perspective and general significance – An extensive number of 
research contributions in the field of bone tissue engineering has led to the understanding 
of several critical design parameters for biomaterials intended for bone regeneration.  
Brekke et al. [1] compiled a comprehensive list of the design considerations determined 
from a literature review. Design parameters included [1-4]:  
 
1. Biocompatible material that does not induce soft tissue growth at the 
bone/implant interface. 
2. Material provides initial mechanical strength and stiffness matching that of the 
surrounding tissue to allow normal patient activity and provide mechanical 
stimuli to cells. 
3. Biodegradable material that resorbs in a predictable and controllable manner in 
concert with bone regeneration. 
4. Material possesses the surface chemistry and topography that promote cellular 
adhesion, proliferation and appropriate differentiation of osteogenic cells.  
5. Material is osteoconductive, supporting the ingrowth of capillaries and cells from 
host to promote bone ingrowth.  Allows for the attachment, proliferation, 
migration, and differentiation of bone cells. 
 
The overall objective of the current research project was the design and 
development of composite biomaterials suitable for use as synthetic bone graft 
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substitutes. Biomaterials were designed to meet as many of the above criteria as possible 
in order to promote the repair and regeneration of bone defects.  
  
Synthesis of HA Nanowires and Application in Composite Biomaterials – 
Although a goal of biomaterial design for bone regeneration is the development of 
materials with comparable stiffness and strength, scaffolds often fall short due to the 
requirement for a high degree of macroporosity [5]. However, scaffold materials are 
required to be, at the very least, capable of withstanding the in vivo stresses and tractional 
forces produced by cells and the contractile forces exerted by the natural remodeling 
process [3, 6]. Therefore, the use of ceramic fillers, in combination with polymer 
matrices, helps to increase the stiffness of composites and help maintain their structural 
integrity by preventing the collapse of the porous structure in vivo [7]. 
The rationale for biomaterial design was based, in part, on the natural 
nanocomposite structure of bone tissue. Specifically, the composite biomaterial consisted 
of a synthetic organic biodegradable polymer matrix, PCL, in combination with nano-
scale synthetic HA. Thus, the synthetic composite mimics the mineral-collagen 
composite nature of bone. Addition of nano-scale HA as a filler material reinforced the 
PCL matrix and improved the tensile and compressive properties of the composite. It is 
expected that the nano-HA would also provide a continuous bioactive and 
osteoconductive component, as well as help to buffer the acid arising from polymer 
degradation [5].   
Traditionally, HA ceramics are commonly produced by wet chemical methods, 
including sol-gel chemistry. Sol-gel chemistry is a well understood and widely used 
synthesis procedure for production of amorphous inorganic materials, including CaP. 
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The sol-gel technique provides molecular mixing of chemical precursors, allowing for 
control of composition and chemical homogeneity, and produces nano-scale amorphous 
products [8, 9]. However, sol-gel-derived amorphous inorganics require calcination at 
elevated temperatures in the presence of air to produce crystalline ceramics, such as HA. 
The calcination step is often accompanied by the formation of secondary phases such as 
calcium oxide and tricalcium phosphate (TCP) [8, 9], and granular particle shapes [9, 
10]. We have shown for the first time that high temperature calcination can be replaced 
by a hydrothermal crystallization process to produce phase-pure, and carbonated-HA 
nanowires and nanorods with tunable aspect ratio. The facile sol-gel-hydrothermal 
process offers a simple, cost effective, and environmentally friendly synthesis route. 
Furthermore, by simply adjusting the composition of the sol-gel precursor, it is 
anticipated that various CaP-based products, including silica and strontium substituted 
ceramics could be easily synthesized [11]. 
 
Control of Surface Topography of HA Coatings and Characterization of Their 
Interaction with Bone Cells In Vitro – A unique solution-based process was developed 
for the purpose of depositing surface coatings of carbonated-HA on PCL. The coating 
was designed to provide an ideal surface chemistry and topography for enhancing 
osteoblast attachment and differentiation, thereby rendering the biomaterial surface 
osteoconductive and bioactive.  
Deposition of biomimetic HA coatings on PCL, using a modified SBF incubation 
process, offers a facile method to directly modify the complexity, and roughness of HA 
surfaces. The one-step deposition of HA coatings from modified SBF solutions, with 
direct control of surface features is advantageous over typical approaches, which use 
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grinding or polishing of sintered HA discs [12, 13], or various line-of-sight deposition 
techniques such as thermal spraying [14], or laser cladding [15]. To the best of our 
knowledge, we have developed for the first time a technique to control the surface 
topography of a bone-like carbonated-HA coating on a biodegradable synthetic polymer.  
The mild conditions of the biomimetic process allows for the deposition of coatings on 
temperature-sensitive materials such as synthetic polymers, whereas the solution-based 
approach makes it possible to apply the technique to complex porous matrices [16].  
Despite the extensive literature reporting the benefits of roughened surfaces on 
osteoblast behavior and bone formation, few studies have integrated this knowledge into 
the rational design of surface coatings. A previous study investigated the effect of 
biomimetic HA crystal size and morphology on viability, proliferation and gene 
expression in MC3T3-E1 preosteoblastic cells [17]. The authors suggested a differential 
cell response to small changes in apatite microstructure. However, the authors failed to 
characterize macroscopic surface topography and roughness. Therefore, it is not known if 
the changes in osteoblast behavior were due to differences in apatite crystal structure or 
modification of surface topography. We have shown that changes in the ionic 
concentration of SBF and soaking time are critical parameters that affect the biomimetic 
HA surface topography.  
In vitro experiments with osteoblasts revealed dramatic differences in the 
expression of osteogenic markers, indicating that, by simply controlling the surface 
characteristics of the deposited HA, enhancements in cell differentiation can be achieved. 
Furthermore, experiments using authentic osteoclasts indicated for the first time, that a 
specific surface topography inhibits the formation of resorption lacunae. This finding 
may have important implications for the future design of HA surface coatings, because 
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the ideal biomaterial would integrate into the physiological bone formation and 
remodeling process [18] and, therefore, control over resorption kinetics is critical. 
Furthermore, biomimetic HA coatings have been developed as drug delivery systems for 
antibiotics and growth factors [19, 20]. Investigations have shown that the release 
kinetics of the target compound is strongly dictated by the solubility of the mineral 
coating [20]. In vivo, degradation of biomaterials is influenced by several factors 
including body fluid-mediated dissolution, as well as degradation by enzymatic activity, 
body movements and cellular resorption. Our results have shown that the surface 
topography of biomimetic HA coatings can be specifically designed to control the rate of 
osteoclastic degradation, and, therefore, the release kinetics of therapeutic compounds. 
 
5.3 Limitations of the Research and Suggestions for Future 
Studies 
Fabrication of 3D Porous Scaffolds – The objective of this research project was 
to synthesize and characterize calcium phosphate-based resorbable composite 
biomaterials for applications in bone tissue engineering. However, for the promising 
biomaterials to achieve application in bone regeneration, the materials need to be 
fabricated into scaffold constructs with 3D porous structures (with appropriate pore size, 
porosity, and interconnectivity between pores) to allow for cell and tissue ingrowth [4, 
21]. Additionally, high porosity and interconnectivity are critical for the necessary 
diffusion of nutrients and oxygen, and removal of metabolic wastes [21, 22]. 
For bone regeneration, scaffold architecture should ideally mimic that of 
trabecular bone, which is characterized by a random pore structure [1]. It was initially 
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thought that a pore size of 100 µm was the minimum requirement due to cell size, and 
migration, and diffusion issues. However, more recent studies have identified a pore size 
in the range of 200–400 µm as optimal for cell and bone ingrowth, and sufficient 
vascularization [1, 3, 4, 21]. For example, an in vitro and in vivo study [23], which tested 
PCL scaffolds with different a range of different pore sizes, showed that both 
chondrocytes and osteoblasts preferred larger pore diameters in the range of 380–405 µm 
when cultured in vitro. In contrast, when implanted in vivo (cranial defects of rabbits), 
PCL scaffolds with lower pore diameters (ranging from 290–310 µm) showed more new 
bone formation, which progressed further into the center of the scaffold. 
In view of critical scaffold design parameters and their application in bone tissue 
engineering, a number of techniques have been used investigated to fabricate 3D 
scaffolds with high porosity and surface area. The conventional methods for scaffold 
fabrication include drop-on-demand printing [24], gas foaming [25-27], solvent 
casting/particulate leaching [28-32], precipitation casting [33], electrospinning [34], 
microsphere sintering/particulate leaching [28, 32, 35-38], freeze-drying [39] or 
combination of these techniques. 
 
Correlating In Vitro Characteristics with In Vivo Behavior – In Chapter 4, of 
topographically modified biomimetic HA coatings were evaluated using in vitro cell 
culture of osteoblasts (bone formation) and osteoclasts (biomaterial resorption). 
Osteoblast attachment and gene expression experiments highlighted the potential for 
enhancement of bone formation by using roughened biomimetic HA, whereas osteoclast 
experiments illustrated potential control over cell resorption. However, these experiments 
were preformed on 2D film, and, as described above, the application of these 
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biomaterials ultimately requires fabrication of porous 3D scaffolds. Osteoblast 
proliferation, differentiation and protein synthesis may vary when cultured in 3D 
constructs as compared to 2D planar substrates of the same biomaterial [40]. Conversely, 
cell behavior on 2D substrates has been shown to correspond to 3D behavior when planar 
substrates are fabricated with complex micro-roughness [41]. 
In vivo confirmation of the results obtained from in vitro experiments using 
osteoblasts and osteoclasts, will be required before these materials can be tested in a 
clinical setting. Although in vitro osteogenic markers are often indicative of in vivo bone 
formation [42] and isolated rabbit osteoclasts are considered an ideal model of 
osteoclastic behavior in vivo [43], the effects of biomimetic surface roughness on bone 
formation and osteoclastic resorption in vivo are poorly defined. As such, it would be 
beneficial to use a preclinical animal model to ascertain whether increased surface 
roughness of HA coatings evokes greater bone formation compared to less rough 
surfaces in vivo. Moreover, it would be useful to determine the effects of the surface 
topography on osteoclastic resorption in vivo, as well as the overall effect of these 
surface on the balance between bone formation and resorption. 
In this project, osteoclastic resorption was evaluated using SEM analysis of the 
substratum surface. Although no distinct resorption lacunae were observed on the 
rougher HA surfaces (Chapter 4), osteoclastic resorption may have been limited to mild 
surface erosion.  
 
Development of Osteoinductive Biomaterials – Ideally, synthetic bone graft 
substitutes are bioactive, osteoconductive and osteoinductive [44, 45]. In the case of 
noncritical size defects, bioactive and osteoconductive materials are sufficient to 
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accelerate bone regeneration by providing cell anchorage sites and adequate stimulation 
for ECM formation to bridge the defect [5]. However, for nonunion or critical size 
defects, an additional osteoinductive stimulus is necessary to promote bone regeneration 
[44]. CaP biomaterials are considered inherently considered non-osteoinductive, 
although this remains controversial, with some investigators reporting possible 
osteoinductive activity [46]. Nevertheless, the CaP biomaterials could be synthesized so 
as to incorporate osteoinductive growth factors by co-precipitation with the biomimetic 
HA [20]. The biomimetic process used to control the surface topography of deposited 
HA requires low temperature and mild pH, therefore, is a suitable system to incorporate 
therapeutic compounds. Moreover, the topographies produced during the biomimetic 
process may offer a method to control the degradation kinetics, and subsequently, the 
release kinetics. 
 
Combining PCL/HA nanocomposites with CaP Coatings having Tailored 
Topography – The technologies developed in these studies represent promising 
biomaterials for the fabrication of scaffolds for bone regeneration. However, the 
biomaterials need to be combined into a cohesive scaffold material in order to meet the 
clinical needs in orthopedics and dentistry. The next critical step in the development of 
scaffolds include: 1) the fabrication of PCL/HA nanocomposites having a macro-porous 
structure, as described above, and 2) application of CaP coating to the surface of the 
PCL/HA porous nanocomposite. The combination of the HA nanowires having high 
aspect ratio, with a biodegradable polymer would produce osteoconductive 
nanocomposites with appropriate stiffness and strength. Moreover, as described in these 
studies, the CaP coating could be deposited onto the surface of the macro-porous 
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nanocomposite scaffold to meet the different requirements of bone forming stimulus and 
biodegradation, as necessary for the intended application. The CaP-coated 
nanocomposites scaffolds would be ideal for use in pre-clinical animal models to test the 
efficacy for the eventual clinical applications as a synthetic bone-graft substitute.  
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7KLVSHUPLVVLRQLVJUDQWHGIRUQRQH[FOXVLYHZRUOG(QJOLVKULJKWVRQO\
XQOHVV\RXUOLFHQVHZDVJUDQWHGIRUWUDQVODWLRQULJKWV,I\RXOLFHQVHGWUDQVODWLRQULJKWV\RX
PD\RQO\WUDQVODWHWKLVFRQWHQWLQWRWKHODQJXDJHV\RXUHTXHVWHG$SURIHVVLRQDOWUDQVODWRU
PXVWSHUIRUPDOOWUDQVODWLRQVDQGUHSURGXFHWKHFRQWHQWZRUGIRUZRUGSUHVHUYLQJWKHLQWHJULW\
RIWKHDUWLFOH,IWKLVOLFHQVHLVWRUHXVHRUILJXUHVWKHQSHUPLVVLRQLVJUDQWHGIRUQRQ
H[FOXVLYHZRUOGULJKWVLQDOOODQJXDJHV
:HEVLWH7KHIROORZLQJWHUPVDQGFRQGLWLRQVDSSO\WRHOHFWURQLFUHVHUYHDQGDXWKRU
ZHEVLWHV
(OHFWURQLFUHVHUYH,IOLFHQVHGPDWHULDOLVWREHSRVWHGWRZHEVLWHWKHZHEVLWHLVWREH
SDVVZRUGSURWHFWHGDQGPDGHDYDLODEOHRQO\WRERQDILGHVWXGHQWVUHJLVWHUHGRQDUHOHYDQW
FRXUVHLI
7KLVOLFHQVHZDVPDGHLQFRQQHFWLRQZLWKDFRXUVH
7KLVSHUPLVVLRQLVJUDQWHGIRU\HDURQO\<RXPD\REWDLQDOLFHQVHIRUIXWXUHZHEVLWH
SRVWLQJ
$OOFRQWHQWSRVWHGWRWKHZHEVLWHPXVWPDLQWDLQWKHFRS\ULJKWLQIRUPDWLRQOLQHRQWKHERWWRP
RIHDFKLPDJH
$K\SHUWH[WPXVWEHLQFOXGHGWRWKH+RPHSDJHRIWKHMRXUQDOIURPZKLFK\RXDUHOLFHQVLQJDW
KWWSZZZVFLHQFHGLUHFWFRPVFLHQFHMRXUQDO[[[[[RUWKH(OVHYLHUKRPHSDJHIRUERRNVDW
KWWSZZZHOVHYLHUFRPDQG
&HQWUDO6WRUDJH7KLVOLFHQVHGRHVQRWLQFOXGHSHUPLVVLRQIRUDVFDQQHGYHUVLRQRIWKHPDWHULDO
WREHVWRUHGLQDFHQWUDOUHSRVLWRU\VXFKDVWKDWSURYLGHGE\+HURQ;DQ(GX
$XWKRUZHEVLWHIRUMRXUQDOVZLWKWKHIROORZLQJDGGLWLRQDOFODXVHV
$OOFRQWHQWSRVWHGWRWKHZHEVLWHPXVWPDLQWDLQWKHFRS\ULJKWLQIRUPDWLRQOLQHRQWKHERWWRP
RIHDFKLPDJHDQGWKHSHUPLVVLRQJUDQWHGLVOLPLWHGWRWKHSHUVRQDOYHUVLRQRI\RXUSDSHU
<RXDUHQRWDOORZHGWRGRZQORDGDQGSRVWWKHSXEOLVKHGHOHFWURQLFYHUVLRQRI\RXUDUWLFOH
ZKHWKHU3')RU+70/SURRIRUILQDOYHUVLRQQRUPD\\RXVFDQWKHSULQWHGHGLWLRQWR
FUHDWHDQHOHFWURQLFYHUVLRQ$K\SHUWH[WPXVWEHLQFOXGHGWRWKH+RPHSDJHRIWKHMRXUQDO
IURPZKLFK\RXDUHOLFHQVLQJDWKWWSZZZVFLHQFHGLUHFWFRPVFLHQFHMRXUQDO[[[[[$VSDUW
RIRXUQRUPDOSURGXFWLRQSURFHVV\RXZLOOUHFHLYHDQHPDLOQRWLFHZKHQ\RXUDUWLFOHDSSHDUV
RQ(OVHYLHU·VRQOLQHVHUYLFH6FLHQFH'LUHFWZZZVFLHQFHGLUHFWFRP7KDWHPDLOZLOOLQFOXGH
WKHDUWLFOH·V'LJLWDO2EMHFW,GHQWLILHU'2,7KLVQXPEHUSURYLGHVWKHHOHFWURQLFOLQNWRWKH
SXEOLVKHGDUWLFOHDQGVKRXOGEHLQFOXGHGLQWKHSRVWLQJRI\RXUSHUVRQDOYHUVLRQ:HDVNWKDW
\RXZDLWXQWLO\RXUHFHLYHWKLVHPDLODQGKDYHWKH'2,WRGRDQ\SRVWLQJ
&HQWUDO6WRUDJH7KLVOLFHQVHGRHVQRWLQFOXGHSHUPLVVLRQIRUDVFDQQHGYHUVLRQRIWKHPDWHULDO
WREHVWRUHGLQDFHQWUDOUHSRVLWRU\VXFKDVWKDWSURYLGHGE\+HURQ;DQ(GX
$XWKRUZHEVLWHIRUERRNVZLWKWKHIROORZLQJDGGLWLRQDOFODXVHV
$XWKRUVDUHSHUPLWWHGWRSODFHDEULHIVXPPDU\RIWKHLUZRUNRQOLQHRQO\
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KWWSVVFRS\ULJKWFRP$SS'LVSDWFK6HUYOHW
$K\SHUWH[WPXVWEHLQFOXGHGWRWKH(OVHYLHUKRPHSDJHDWKWWSZZZHOVHYLHUFRP$OO
FRQWHQWSRVWHGWRWKHZHEVLWHPXVWPDLQWDLQWKHFRS\ULJKWLQIRUPDWLRQOLQHRQWKHERWWRPRI
HDFKLPDJH<RXDUHQRWDOORZHGWRGRZQORDGDQGSRVWWKHSXEOLVKHGHOHFWURQLFYHUVLRQRI
\RXUFKDSWHUQRUPD\\RXVFDQWKHSULQWHGHGLWLRQWRFUHDWHDQHOHFWURQLFYHUVLRQ
&HQWUDO6WRUDJH7KLVOLFHQVHGRHVQRWLQFOXGHSHUPLVVLRQIRUDVFDQQHGYHUVLRQRIWKHPDWHULDO
WREHVWRUHGLQDFHQWUDOUHSRVLWRU\VXFKDVWKDWSURYLGHGE\+HURQ;DQ(GX
:HEVLWHUHJXODUDQGIRUDXWKRU$K\SHUWH[WPXVWEHLQFOXGHGWRWKH+RPHSDJHRIWKH
MRXUQDOIURPZKLFK\RXDUHOLFHQVLQJDWKWWSZZZVFLHQFHGLUHFWFRPVFLHQFHMRXUQDO[[[[[
RUIRUERRNVWRWKH(OVHYLHUKRPHSDJHDWKWWSZZZHOVHYLHUFRP
7KHVLV'LVVHUWDWLRQ,I\RXUOLFHQVHLVIRUXVHLQDWKHVLVGLVVHUWDWLRQ\RXUWKHVLVPD\EH
VXEPLWWHGWR\RXULQVWLWXWLRQLQHLWKHUSULQWRUHOHFWURQLFIRUP6KRXOG\RXUWKHVLVEHSXEOLVKHG
FRPPHUFLDOO\SOHDVHUHDSSO\IRUSHUPLVVLRQ7KHVHUHTXLUHPHQWVLQFOXGHSHUPLVVLRQIRUWKH
/LEUDU\DQG$UFKLYHVRI&DQDGDWRVXSSO\VLQJOHFRSLHVRQGHPDQGRIWKHFRPSOHWHWKHVLV
DQGLQFOXGHSHUPLVVLRQIRU80,WRVXSSO\VLQJOHFRSLHVRQGHPDQGRIWKHFRPSOHWHWKHVLV
6KRXOG\RXUWKHVLVEHSXEOLVKHGFRPPHUFLDOO\SOHDVHUHDSSO\IRUSHUPLVVLRQ
2WKHU&RQGLWLRQV

Y
,I\RXZRXOGOLNHWRSD\IRUWKLVOLFHQVHQRZSOHDVHUHPLWWKLVOLFHQVHDORQJZLWK\RXU
SD\PHQWPDGHSD\DEOHWR&23<5,*+7&/($5$1&(&(17(5RWKHUZLVH\RXZLOOEH
LQYRLFHGZLWKLQKRXUVRIWKHOLFHQVHGDWH3D\PHQWVKRXOGEHLQWKHIRUPRIDFKHFN
RUPRQH\RUGHUUHIHUHQFLQJ\RXUDFFRXQWQXPEHUDQGWKLVLQYRLFHQXPEHU
5/1.
2QFH\RXUHFHLYH\RXULQYRLFHIRUWKLVRUGHU\RXPD\SD\\RXULQYRLFHE\FUHGLWFDUG
3OHDVHIROORZLQVWUXFWLRQVSURYLGHGDWWKDWWLPH
0DNH3D\PHQW7R
&RS\ULJKW&OHDUDQFH&HQWHU
'HSW
32%R[
%RVWRQ0$
)RUVXJJHVWLRQVRUFRPPHQWVUHJDUGLQJWKLVRUGHUFRQWDFW5LJKWV/LQN&XVWRPHU
6XSSRUWFXVWRPHUFDUH#FRS\ULJKWFRPRUWROOIUHHLQWKH86RU

*UDWLVOLFHQVHVUHIHUHQFLQJLQWKH7RWDOILHOGDUHIUHH3OHDVHUHWDLQWKLVSULQWDEOH
OLFHQVHIRU\RXUUHIHUHQFH1RSD\PHQWLVUHTXLUHG
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 5LJKWVOLQN3ULQWDEOH/LFHQVH
KWWSVVFRS\ULJKWFRP$SS'LVSDWFK6HUYOHW
(/6(9,(5/,&(16(
7(506$1'&21',7,216
6HS
7KLVLVD/LFHQVH$JUHHPHQWEHWZHHQ'DQLHO&RVWD<RXDQG(OVHYLHU(OVHYLHU
SURYLGHGE\&RS\ULJKW&OHDUDQFH&HQWHU&&&7KHOLFHQVHFRQVLVWVRI\RXURUGHUGHWDLOV
WKHWHUPVDQGFRQGLWLRQVSURYLGHGE\(OVHYLHUDQGWKHSD\PHQWWHUPVDQGFRQGLWLRQV
$OOSD\PHQWVPXVWEHPDGHLQIXOOWR&&&)RUSD\PHQWLQVWUXFWLRQVSOHDVHVHH
LQIRUPDWLRQOLVWHGDWWKHERWWRPRIWKLVIRUP
6XSSOLHU (OVHYLHU/LPLWHG
7KH%RXOHYDUG/DQJIRUG/DQH
.LGOLQJWRQ2[IRUG2;*%8.
5HJLVWHUHG&RPSDQ\1XPEHU 
&XVWRPHUQDPH 'DQLHO&RVWD
&XVWRPHUDGGUHVV 7KH8QLYHUVLW\RI:HVWHUQ2QWDULR
 /RQGRQ211$&
/LFHQVHQXPEHU 
/LFHQVHGDWH 6HS
/LFHQVHGFRQWHQWSXEOLVKHU (OVHYLHU
/LFHQVHGFRQWHQWSXEOLFDWLRQ -RXUQDORI6ROLG6WDWH&KHPLVWU\
/LFHQVHGFRQWHQWWLWOH &U\VWDO6WUXFWXUHRI&DOFLXP'HILFLHQW&DUERQDWHG+\GUR[\DSDWLWH
7KHUPDO'HFRPSRVLWLRQ
/LFHQVHGFRQWHQWDXWKRU 7,,YDQRYD29)UDQN.DPHQHWVND\D$%.RO
WVRY9/8JRONRY
/LFHQVHGFRQWHQWGDWH 6HSWHPEHU
/LFHQVHGFRQWHQWYROXPH
QXPEHU

/LFHQVHGFRQWHQWLVVXH
QXPEHU

1XPEHURISDJHV 
6WDUW3DJH 
(QG3DJH 
7\SHRI8VH UHXVHLQDWKHVLVGLVVHUWDWLRQ
,QWHQGHGSXEOLVKHURIQHZ
ZRUN
RWKHU
3RUWLRQ ILJXUHVWDEOHVLOOXVWUDWLRQV
1XPEHURI
ILJXUHVWDEOHVLOOXVWUDWLRQV

)RUPDW ERWKSULQWDQGHOHFWURQLF
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KWWSVVFRS\ULJKWFRP$SS'LVSDWFK6HUYOHW
$UH\RXWKHDXWKRURIWKLV
(OVHYLHUDUWLFOH"
1R
:LOO\RXEHWUDQVODWLQJ" 1R
2UGHUUHIHUHQFHQXPEHU
7LWOHRI\RXU
WKHVLVGLVVHUWDWLRQ
&DOFLXP3KRVSKDWH%DVHG5HVRUEDEOH%LRPDWHULDOVIRU%RQH
5HJHQHUDWLRQ
([SHFWHGFRPSOHWLRQGDWH 2FW
(VWLPDWHGVL]HQXPEHURI
SDJHV

(OVHYLHU9$7QXPEHU *%
3HUPLVVLRQVSULFH 86'
9$7/RFDO6DOHV7D[ 86'*%3
7RWDO 86'
7HUPVDQG&RQGLWLRQV
,1752'8&7,21
7KHSXEOLVKHUIRUWKLVFRS\ULJKWHGPDWHULDOLV(OVHYLHU%\FOLFNLQJDFFHSWLQFRQQHFWLRQ
ZLWKFRPSOHWLQJWKLVOLFHQVLQJWUDQVDFWLRQ\RXDJUHHWKDWWKHIROORZLQJWHUPVDQGFRQGLWLRQV
DSSO\WRWKLVWUDQVDFWLRQDORQJZLWKWKH%LOOLQJDQG3D\PHQWWHUPVDQGFRQGLWLRQVHVWDEOLVKHG
E\&RS\ULJKW&OHDUDQFH&HQWHU,QF&&&DWWKHWLPHWKDW\RXRSHQHG\RXU5LJKWVOLQN
DFFRXQWDQGWKDWDUHDYDLODEOHDWDQ\WLPHDWKWWSP\DFFRXQWFRS\ULJKWFRP
*(1(5$/7(506
(OVHYLHUKHUHE\JUDQWV\RXSHUPLVVLRQWRUHSURGXFHWKHDIRUHPHQWLRQHGPDWHULDOVXEMHFWWR
WKHWHUPVDQGFRQGLWLRQVLQGLFDWHG
$FNQRZOHGJHPHQW,IDQ\SDUWRIWKHPDWHULDOWREHXVHGIRUH[DPSOHILJXUHVKDV
DSSHDUHGLQRXUSXEOLFDWLRQZLWKFUHGLWRUDFNQRZOHGJHPHQWWRDQRWKHUVRXUFHSHUPLVVLRQ
PXVWDOVREHVRXJKWIURPWKDWVRXUFH,IVXFKSHUPLVVLRQLVQRWREWDLQHGWKHQWKDWPDWHULDOPD\
QRWEHLQFOXGHGLQ\RXUSXEOLFDWLRQFRSLHV6XLWDEOHDFNQRZOHGJHPHQWWRWKHVRXUFHPXVWEH
PDGHHLWKHUDVDIRRWQRWHRULQDUHIHUHQFHOLVWDWWKHHQGRI\RXUSXEOLFDWLRQDVIROORZV
´5HSULQWHGIURP3XEOLFDWLRQWLWOH9ROHGLWLRQQXPEHU$XWKRUV7LWOHRIDUWLFOHWLWOHRI
FKDSWHU3DJHV1R&RS\ULJKW<HDUZLWKSHUPLVVLRQIURP(OVHYLHU>25$33/,&$%/(
62&,(7<&23<5,*+72:1(5@µ$OVR/DQFHWVSHFLDOFUHGLW´5HSULQWHGIURP7KH
/DQFHW9ROQXPEHU$XWKRUV7LWOHRIDUWLFOH3DJHV1R&RS\ULJKW<HDUZLWKSHUPLVVLRQ
IURP(OVHYLHUµ
5HSURGXFWLRQRIWKLVPDWHULDOLVFRQILQHGWRWKHSXUSRVHDQGRUPHGLDIRUZKLFKSHUPLVVLRQ
LVKHUHE\JLYHQ
$OWHULQJ0RGLI\LQJ0DWHULDO1RW3HUPLWWHG+RZHYHUILJXUHVDQGLOOXVWUDWLRQVPD\EH
DOWHUHGDGDSWHGPLQLPDOO\WRVHUYH\RXUZRUN$Q\RWKHUDEEUHYLDWLRQVDGGLWLRQVGHOHWLRQV
DQGRUDQ\RWKHUDOWHUDWLRQVVKDOOEHPDGHRQO\ZLWKSULRUZULWWHQDXWKRUL]DWLRQRI(OVHYLHU/WG
3OHDVHFRQWDFW(OVHYLHUDWSHUPLVVLRQV#HOVHYLHUFRP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EHDGYLVHGWKDW\RXUIXWXUHUHTXHVWVIRU(OVHYLHUPDWHULDOVPD\DWWUDFWDIHH
5HVHUYDWLRQRI5LJKWV3XEOLVKHUUHVHUYHVDOOULJKWVQRWVSHFLILFDOO\JUDQWHGLQWKH
FRPELQDWLRQRILWKHOLFHQVHGHWDLOVSURYLGHGE\\RXDQGDFFHSWHGLQWKHFRXUVHRIWKLV
OLFHQVLQJWUDQVDFWLRQLLWKHVHWHUPVDQGFRQGLWLRQVDQGLLL&&&
V%LOOLQJDQG3D\PHQWWHUPV
DQGFRQGLWLRQV
/LFHQVH&RQWLQJHQW8SRQ3D\PHQW:KLOH\RXPD\H[HUFLVHWKHULJKWVOLFHQVHGLPPHGLDWHO\
XSRQLVVXDQFHRIWKHOLFHQVHDWWKHHQGRIWKHOLFHQVLQJSURFHVVIRUWKHWUDQVDFWLRQSURYLGHG
WKDW\RXKDYHGLVFORVHGFRPSOHWHDQGDFFXUDWHGHWDLOVRI\RXUSURSRVHGXVHQROLFHQVHLV
ILQDOO\HIIHFWLYHXQOHVVDQGXQWLOIXOOSD\PHQWLVUHFHLYHGIURP\RXHLWKHUE\SXEOLVKHURUE\
&&&DVSURYLGHGLQ&&&
V%LOOLQJDQG3D\PHQWWHUPVDQGFRQGLWLRQV,IIXOOSD\PHQWLVQRW
UHFHLYHGRQDWLPHO\EDVLVWKHQDQ\OLFHQVHSUHOLPLQDULO\JUDQWHGVKDOOEHGHHPHG
DXWRPDWLFDOO\UHYRNHGDQGVKDOOEHYRLGDVLIQHYHUJUDQWHG)XUWKHULQWKHHYHQWWKDW\RX
EUHDFKDQ\RIWKHVHWHUPVDQGFRQGLWLRQVRUDQ\RI&&&
V%LOOLQJDQG3D\PHQWWHUPVDQG
FRQGLWLRQVWKHOLFHQVHLVDXWRPDWLFDOO\UHYRNHGDQGVKDOOEHYRLGDVLIQHYHUJUDQWHG8VHRI
PDWHULDOVDVGHVFULEHGLQDUHYRNHGOLFHQVHDVZHOODVDQ\XVHRIWKHPDWHULDOVEH\RQGWKH
VFRSHRIDQXQUHYRNHGOLFHQVHPD\FRQVWLWXWHFRS\ULJKWLQIULQJHPHQWDQGSXEOLVKHUUHVHUYHV
WKHULJKWWRWDNHDQ\DQGDOODFWLRQWRSURWHFWLWVFRS\ULJKWLQWKHPDWHULDOV
:DUUDQWLHV3XEOLVKHUPDNHVQRUHSUHVHQWDWLRQVRUZDUUDQWLHVZLWKUHVSHFWWRWKHOLFHQVHG
PDWHULDO
,QGHPQLW\<RXKHUHE\LQGHPQLI\DQGDJUHHWRKROGKDUPOHVVSXEOLVKHUDQG&&&DQG
WKHLUUHVSHFWLYHRIILFHUVGLUHFWRUVHPSOR\HHVDQGDJHQWVIURPDQGDJDLQVWDQ\DQGDOOFODLPV
DULVLQJRXWRI\RXUXVHRIWKHOLFHQVHGPDWHULDORWKHUWKDQDVVSHFLILFDOO\DXWKRUL]HGSXUVXDQWWR
WKLVOLFHQVH
1R7UDQVIHURI/LFHQVH7KLVOLFHQVHLVSHUVRQDOWR\RXDQGPD\QRWEHVXEOLFHQVHG
DVVLJQHGRUWUDQVIHUUHGE\\RXWRDQ\RWKHUSHUVRQZLWKRXWSXEOLVKHU
VZULWWHQSHUPLVVLRQ
1R$PHQGPHQW([FHSWLQ:ULWLQJ7KLVOLFHQVHPD\QRWEHDPHQGHGH[FHSWLQDZULWLQJ
VLJQHGE\ERWKSDUWLHVRULQWKHFDVHRISXEOLVKHUE\&&&RQSXEOLVKHU
VEHKDOI
2EMHFWLRQWR&RQWUDU\7HUPV3XEOLVKHUKHUHE\REMHFWVWRDQ\WHUPVFRQWDLQHGLQDQ\
SXUFKDVHRUGHUDFNQRZOHGJPHQWFKHFNHQGRUVHPHQWRURWKHUZULWLQJSUHSDUHGE\\RXZKLFK
WHUPVDUHLQFRQVLVWHQWZLWKWKHVHWHUPVDQGFRQGLWLRQVRU&&&
V%LOOLQJDQG3D\PHQWWHUPV
DQGFRQGLWLRQV7KHVHWHUPVDQGFRQGLWLRQVWRJHWKHUZLWK&&&
V%LOOLQJDQG3D\PHQWWHUPV
DQGFRQGLWLRQVZKLFKDUHLQFRUSRUDWHGKHUHLQFRPSULVHWKHHQWLUHDJUHHPHQWEHWZHHQ\RX
DQGSXEOLVKHUDQG&&&FRQFHUQLQJWKLVOLFHQVLQJWUDQVDFWLRQ,QWKHHYHQWRIDQ\FRQIOLFW
EHWZHHQ\RXUREOLJDWLRQVHVWDEOLVKHGE\WKHVHWHUPVDQGFRQGLWLRQVDQGWKRVHHVWDEOLVKHGE\
&&&
V%LOOLQJDQG3D\PHQWWHUPVDQGFRQGLWLRQVWKHVHWHUPVDQGFRQGLWLRQVVKDOOFRQWURO
5HYRFDWLRQ(OVHYLHURU&RS\ULJKW&OHDUDQFH&HQWHUPD\GHQ\WKHSHUPLVVLRQVGHVFULEHG
LQWKLV/LFHQVHDWWKHLUVROHGLVFUHWLRQIRUDQ\UHDVRQRUQRUHDVRQZLWKDIXOOUHIXQGSD\DEOH
WR\RX1RWLFHRIVXFKGHQLDOZLOOEHPDGHXVLQJWKHFRQWDFWLQIRUPDWLRQSURYLGHGE\\RX
)DLOXUHWRUHFHLYHVXFKQRWLFHZLOOQRWDOWHURULQYDOLGDWHWKHGHQLDO,QQRHYHQWZLOO(OVHYLHU
RU&RS\ULJKW&OHDUDQFH&HQWHUEHUHVSRQVLEOHRUOLDEOHIRUDQ\FRVWVH[SHQVHVRUGDPDJH
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KWWSVVFRS\ULJKWFRP$SS'LVSDWFK6HUYOHW
LQFXUUHGE\\RXDVDUHVXOWRIDGHQLDORI\RXUSHUPLVVLRQUHTXHVWRWKHUWKDQDUHIXQGRIWKH
DPRXQWVSDLGE\\RXWR(OVHYLHUDQGRU&RS\ULJKW&OHDUDQFH&HQWHUIRUGHQLHGSHUPLVVLRQV
/,0,7('/,&(16(
7KHIROORZLQJWHUPVDQGFRQGLWLRQVDSSO\RQO\WRVSHFLILFOLFHQVHW\SHV
7UDQVODWLRQ7KLVSHUPLVVLRQLVJUDQWHGIRUQRQH[FOXVLYHZRUOG(QJOLVKULJKWVRQO\
XQOHVV\RXUOLFHQVHZDVJUDQWHGIRUWUDQVODWLRQULJKWV,I\RXOLFHQVHGWUDQVODWLRQULJKWV\RX
PD\RQO\WUDQVODWHWKLVFRQWHQWLQWRWKHODQJXDJHV\RXUHTXHVWHG$SURIHVVLRQDOWUDQVODWRU
PXVWSHUIRUPDOOWUDQVODWLRQVDQGUHSURGXFHWKHFRQWHQWZRUGIRUZRUGSUHVHUYLQJWKHLQWHJULW\
RIWKHDUWLFOH,IWKLVOLFHQVHLVWRUHXVHRUILJXUHVWKHQSHUPLVVLRQLVJUDQWHGIRUQRQ
H[FOXVLYHZRUOGULJKWVLQDOOODQJXDJHV
:HEVLWH7KHIROORZLQJWHUPVDQGFRQGLWLRQVDSSO\WRHOHFWURQLFUHVHUYHDQGDXWKRU
ZHEVLWHV
(OHFWURQLFUHVHUYH,IOLFHQVHGPDWHULDOLVWREHSRVWHGWRZHEVLWHWKHZHEVLWHLVWREH
SDVVZRUGSURWHFWHGDQGPDGHDYDLODEOHRQO\WRERQDILGHVWXGHQWVUHJLVWHUHGRQDUHOHYDQW
FRXUVHLI
7KLVOLFHQVHZDVPDGHLQFRQQHFWLRQZLWKDFRXUVH
7KLVSHUPLVVLRQLVJUDQWHGIRU\HDURQO\<RXPD\REWDLQDOLFHQVHIRUIXWXUHZHEVLWH
SRVWLQJ
$OOFRQWHQWSRVWHGWRWKHZHEVLWHPXVWPDLQWDLQWKHFRS\ULJKWLQIRUPDWLRQOLQHRQWKHERWWRP
RIHDFKLPDJH
$K\SHUWH[WPXVWEHLQFOXGHGWRWKH+RPHSDJHRIWKHMRXUQDOIURPZKLFK\RXDUHOLFHQVLQJDW
KWWSZZZVFLHQFHGLUHFWFRPVFLHQFHMRXUQDO[[[[[RUWKH(OVHYLHUKRPHSDJHIRUERRNVDW
KWWSZZZHOVHYLHUFRPDQG
&HQWUDO6WRUDJH7KLVOLFHQVHGRHVQRWLQFOXGHSHUPLVVLRQIRUDVFDQQHGYHUVLRQRIWKHPDWHULDO
WREHVWRUHGLQDFHQWUDOUHSRVLWRU\VXFKDVWKDWSURYLGHGE\+HURQ;DQ(GX
$XWKRUZHEVLWHIRUMRXUQDOVZLWKWKHIROORZLQJDGGLWLRQDOFODXVHV
$OOFRQWHQWSRVWHGWRWKHZHEVLWHPXVWPDLQWDLQWKHFRS\ULJKWLQIRUPDWLRQOLQHRQWKHERWWRP
RIHDFKLPDJHDQGWKHSHUPLVVLRQJUDQWHGLVOLPLWHGWRWKHSHUVRQDOYHUVLRQRI\RXUSDSHU
<RXDUHQRWDOORZHGWRGRZQORDGDQGSRVWWKHSXEOLVKHGHOHFWURQLFYHUVLRQRI\RXUDUWLFOH
ZKHWKHU3')RU+70/SURRIRUILQDOYHUVLRQQRUPD\\RXVFDQWKHSULQWHGHGLWLRQWR
FUHDWHDQHOHFWURQLFYHUVLRQ$K\SHUWH[WPXVWEHLQFOXGHGWRWKH+RPHSDJHRIWKHMRXUQDO
IURPZKLFK\RXDUHOLFHQVLQJDWKWWSZZZVFLHQFHGLUHFWFRPVFLHQFHMRXUQDO[[[[[$VSDUW
RIRXUQRUPDOSURGXFWLRQSURFHVV\RXZLOOUHFHLYHDQHPDLOQRWLFHZKHQ\RXUDUWLFOHDSSHDUV
RQ(OVHYLHU·VRQOLQHVHUYLFH6FLHQFH'LUHFWZZZVFLHQFHGLUHFWFRP7KDWHPDLOZLOOLQFOXGH
WKHDUWLFOH·V'LJLWDO2EMHFW,GHQWLILHU'2,7KLVQXPEHUSURYLGHVWKHHOHFWURQLFOLQNWRWKH
SXEOLVKHGDUWLFOHDQGVKRXOGEHLQFOXGHGLQWKHSRVWLQJRI\RXUSHUVRQDOYHUVLRQ:HDVNWKDW
\RXZDLWXQWLO\RXUHFHLYHWKLVHPDLODQGKDYHWKH'2,WRGRDQ\SRVWLQJ
&HQWUDO6WRUDJH7KLVOLFHQVHGRHVQRWLQFOXGHSHUPLVVLRQIRUDVFDQQHGYHUVLRQRIWKHPDWHULDO
WREHVWRUHGLQDFHQWUDOUHSRVLWRU\VXFKDVWKDWSURYLGHGE\+HURQ;DQ(GX
$XWKRUZHEVLWHIRUERRNVZLWKWKHIROORZLQJDGGLWLRQDOFODXVHV
$XWKRUVDUHSHUPLWWHGWRSODFHDEULHIVXPPDU\RIWKHLUZRUNRQOLQHRQO\
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$K\SHUWH[WPXVWEHLQFOXGHGWRWKH(OVHYLHUKRPHSDJHDWKWWSZZZHOVHYLHUFRP$OO
FRQWHQWSRVWHGWRWKHZHEVLWHPXVWPDLQWDLQWKHFRS\ULJKWLQIRUPDWLRQOLQHRQWKHERWWRPRI
HDFKLPDJH<RXDUHQRWDOORZHGWRGRZQORDGDQGSRVWWKHSXEOLVKHGHOHFWURQLFYHUVLRQRI
\RXUFKDSWHUQRUPD\\RXVFDQWKHSULQWHGHGLWLRQWRFUHDWHDQHOHFWURQLFYHUVLRQ
&HQWUDO6WRUDJH7KLVOLFHQVHGRHVQRWLQFOXGHSHUPLVVLRQIRUDVFDQQHGYHUVLRQRIWKHPDWHULDO
WREHVWRUHGLQDFHQWUDOUHSRVLWRU\VXFKDVWKDWSURYLGHGE\+HURQ;DQ(GX
:HEVLWHUHJXODUDQGIRUDXWKRU$K\SHUWH[WPXVWEHLQFOXGHGWRWKH+RPHSDJHRIWKH
MRXUQDOIURPZKLFK\RXDUHOLFHQVLQJDWKWWSZZZVFLHQFHGLUHFWFRPVFLHQFHMRXUQDO[[[[[
RUIRUERRNVWRWKH(OVHYLHUKRPHSDJHDWKWWSZZZHOVHYLHUFRP
7KHVLV'LVVHUWDWLRQ,I\RXUOLFHQVHLVIRUXVHLQDWKHVLVGLVVHUWDWLRQ\RXUWKHVLVPD\EH
VXEPLWWHGWR\RXULQVWLWXWLRQLQHLWKHUSULQWRUHOHFWURQLFIRUP6KRXOG\RXUWKHVLVEHSXEOLVKHG
FRPPHUFLDOO\SOHDVHUHDSSO\IRUSHUPLVVLRQ7KHVHUHTXLUHPHQWVLQFOXGHSHUPLVVLRQIRUWKH
/LEUDU\DQG$UFKLYHVRI&DQDGDWRVXSSO\VLQJOHFRSLHVRQGHPDQGRIWKHFRPSOHWHWKHVLV
DQGLQFOXGHSHUPLVVLRQIRU80,WRVXSSO\VLQJOHFRSLHVRQGHPDQGRIWKHFRPSOHWHWKHVLV
6KRXOG\RXUWKHVLVEHSXEOLVKHGFRPPHUFLDOO\SOHDVHUHDSSO\IRUSHUPLVVLRQ
2WKHU&RQGLWLRQV

Y
,I\RXZRXOGOLNHWRSD\IRUWKLVOLFHQVHQRZSOHDVHUHPLWWKLVOLFHQVHDORQJZLWK\RXU
SD\PHQWPDGHSD\DEOHWR&23<5,*+7&/($5$1&(&(17(5RWKHUZLVH\RXZLOOEH
LQYRLFHGZLWKLQKRXUVRIWKHOLFHQVHGDWH3D\PHQWVKRXOGEHLQWKHIRUPRIDFKHFN
RUPRQH\RUGHUUHIHUHQFLQJ\RXUDFFRXQWQXPEHUDQGWKLVLQYRLFHQXPEHU
5/1.
2QFH\RXUHFHLYH\RXULQYRLFHIRUWKLVRUGHU\RXPD\SD\\RXULQYRLFHE\FUHGLWFDUG
3OHDVHIROORZLQVWUXFWLRQVSURYLGHGDWWKDWWLPH
0DNH3D\PHQW7R
&RS\ULJKW&OHDUDQFH&HQWHU
'HSW
32%R[
%RVWRQ0$
)RUVXJJHVWLRQVRUFRPPHQWVUHJDUGLQJWKLVRUGHUFRQWDFW5LJKWV/LQN&XVWRPHU
6XSSRUWFXVWRPHUFDUH#FRS\ULJKWFRPRUWROOIUHHLQWKH86RU

*UDWLVOLFHQVHVUHIHUHQFLQJLQWKH7RWDOILHOGDUHIUHH3OHDVHUHWDLQWKLVSULQWDEOH
OLFHQVHIRU\RXUUHIHUHQFH1RSD\PHQWLVUHTXLUHG
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KWWSVVFRS\ULJKWFRP$SS'LVSDWFK6HUYOHW
1$785(38%/,6+,1**5283/,&(16(
7(506$1'&21',7,216
6HS
7KLVLVD/LFHQVH$JUHHPHQWEHWZHHQ'DQLHO&RVWD<RXDQG1DWXUH3XEOLVKLQJ*URXS
1DWXUH3XEOLVKLQJ*URXSSURYLGHGE\&RS\ULJKW&OHDUDQFH&HQWHU&&&7KHOLFHQVH
FRQVLVWVRI\RXURUGHUGHWDLOVWKHWHUPVDQGFRQGLWLRQVSURYLGHGE\1DWXUH3XEOLVKLQJ*URXS
DQGWKHSD\PHQWWHUPVDQGFRQGLWLRQV
$OOSD\PHQWVPXVWEHPDGHLQIXOOWR&&&)RUSD\PHQWLQVWUXFWLRQVSOHDVHVHH
LQIRUPDWLRQOLVWHGDWWKHERWWRPRIWKLVIRUP
/LFHQVH1XPEHU 
/LFHQVHGDWH 6HS
/LFHQVHGFRQWHQWSXEOLVKHU 1DWXUH3XEOLVKLQJ*URXS
/LFHQVHGFRQWHQWSXEOLFDWLRQ ,%06%RQHN(\
/LFHQVHGFRQWHQWWLWOH &DWKHSVLQ.$QHZPROHFXODUWDUJHWIRURVWHRSRURVLV
/LFHQVHGFRQWHQWDXWKRU 6HYJL%5RGDQ/H7'XRQJ
/LFHQVHGFRQWHQWGDWH -DQ
9ROXPHQXPEHU 
,VVXHQXPEHU 
7\SHRI8VH UHXVHLQDWKHVLVGLVVHUWDWLRQ
5HTXHVWRUW\SH DFDGHPLFHGXFDWLRQDO
)RUPDW SULQWDQGHOHFWURQLF
3RUWLRQ ILJXUHVWDEOHVLOOXVWUDWLRQV
1XPEHURI
ILJXUHVWDEOHVLOOXVWUDWLRQV

+LJKUHVUHTXLUHG QR
)LJXUHV )LJXUH
$XWKRURIWKLV13*DUWLFOH QR
<RXUUHIHUHQFHQXPEHU
7LWOHRI\RXUWKHVLV
GLVVHUWDWLRQ
&DOFLXP3KRVSKDWH%DVHG5HVRUEDEOH%LRPDWHULDOVIRU%RQH
5HJHQHUDWLRQ
([SHFWHGFRPSOHWLRQGDWH 2FW
(VWLPDWHGVL]HQXPEHURI
SDJHV

7RWDO 86'
7HUPVDQG&RQGLWLRQV
7HUPVDQG&RQGLWLRQVIRU3HUPLVVLRQV
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KWWSVVFRS\ULJKWFRP$SS'LVSDWFK6HUYOHW
1DWXUH3XEOLVKLQJ*URXSKHUHE\JUDQWV\RXDQRQH[FOXVLYHOLFHQVHWRUHSURGXFHWKLVPDWHULDO
IRUWKLVSXUSRVHDQGIRUQRRWKHUXVHVXEMHFWWRWKHFRQGLWLRQVEHORZ
 13*ZDUUDQWVWKDWLWKDVWRWKHEHVWRILWVNQRZOHGJHWKHULJKWVWROLFHQVHUHXVHRIWKLV
PDWHULDO+RZHYHU\RXVKRXOGHQVXUHWKDWWKHPDWHULDO\RXDUHUHTXHVWLQJLVRULJLQDOWR
1DWXUH3XEOLVKLQJ*URXSDQGGRHVQRWFDUU\WKHFRS\ULJKWRIDQRWKHUHQWLW\DVFUHGLWHG
LQWKHSXEOLVKHGYHUVLRQ,IWKHFUHGLWOLQHRQDQ\SDUWRIWKHPDWHULDO\RXKDYH
UHTXHVWHGLQGLFDWHVWKDWLWZDVUHSULQWHGRUDGDSWHGE\13*ZLWKSHUPLVVLRQIURP
DQRWKHUVRXUFHWKHQ\RXVKRXOGDOVRVHHNSHUPLVVLRQIURPWKDWVRXUFHWRUHXVHWKH
PDWHULDO

 3HUPLVVLRQJUDQWHGIUHHRIFKDUJHIRUPDWHULDOLQSULQWLVDOVRXVXDOO\JUDQWHGIRUDQ\
HOHFWURQLFYHUVLRQRIWKDWZRUNSURYLGHGWKDWWKHPDWHULDOLVLQFLGHQWDOWRWKHZRUNDVD
ZKROHDQGWKDWWKHHOHFWURQLFYHUVLRQLVHVVHQWLDOO\HTXLYDOHQWWRRUVXEVWLWXWHVIRUWKH
SULQWYHUVLRQ:KHUHSULQWSHUPLVVLRQKDVEHHQJUDQWHGIRUDIHHVHSDUDWHSHUPLVVLRQ
PXVWEHREWDLQHGIRUDQ\DGGLWLRQDOHOHFWURQLFUHXVHXQOHVVDVLQWKHFDVHRIDIXOO
SDSHUWKLVKDVDOUHDG\EHHQDFFRXQWHGIRUGXULQJ\RXULQLWLDOUHTXHVWLQWKHFDOFXODWLRQ
RIDSULQWUXQ1%,QDOOFDVHVZHEEDVHGXVHRIIXOOWH[WDUWLFOHVPXVWEHDXWKRUL]HG
VHSDUDWHO\WKURXJKWKH
8VHRQD:HE6LWH
RSWLRQZKHQUHTXHVWLQJSHUPLVVLRQ

 3HUPLVVLRQJUDQWHGIRUDILUVWHGLWLRQGRHVQRWDSSO\WRVHFRQGDQGVXEVHTXHQWHGLWLRQV
DQGIRUHGLWLRQVLQRWKHUODQJXDJHVH[FHSWIRUVLJQDWRULHVWRWKH6703HUPLVVLRQV
*XLGHOLQHVRUZKHUHWKHILUVWHGLWLRQSHUPLVVLRQZDVJUDQWHGIRUIUHH

 1DWXUH3XEOLVKLQJ*URXS
VSHUPLVVLRQPXVWEHDFNQRZOHGJHGQH[WWRWKHILJXUHWDEOHRU
DEVWUDFWLQSULQW,QHOHFWURQLFIRUPWKLVDFNQRZOHGJHPHQWPXVWEHYLVLEOHDWWKHVDPH
WLPHDVWKHILJXUHWDEOHDEVWUDFWDQGPXVWEHK\SHUOLQNHGWRWKHMRXUQDO
VKRPHSDJH
 7KHFUHGLWOLQHVKRXOGUHDG
5HSULQWHGE\SHUPLVVLRQIURP0DFPLOODQ3XEOLVKHUV/WG>-2851$/1$0(@
UHIHUHQFHFLWDWLRQFRS\ULJKW\HDURISXEOLFDWLRQ
)RU$23SDSHUVWKHFUHGLWOLQHVKRXOGUHDG
5HSULQWHGE\SHUPLVVLRQIURP0DFPLOODQ3XEOLVKHUV/WG>-2851$/1$0(@
DGYDQFHRQOLQHSXEOLFDWLRQGD\PRQWK\HDUGRLVM>-2851$/
$&521<0@;;;;;
1RWH)RUUHSXEOLFDWLRQIURPWKH%ULWLVK-RXUQDORI&DQFHUWKHIROORZLQJFUHGLW
OLQHVDSSO\
5HSULQWHGE\SHUPLVVLRQIURP0DFPLOODQ3XEOLVKHUV/WGRQEHKDOIRI&DQFHU5HVHDUFK
8.>-2851$/1$0(@UHIHUHQFHFLWDWLRQFRS\ULJKW\HDURISXEOLFDWLRQ)RU$23
SDSHUVWKHFUHGLWOLQHVKRXOGUHDG
5HSULQWHGE\SHUPLVVLRQIURP0DFPLOODQ3XEOLVKHUV/WGRQEHKDOIRI&DQFHU5HVHDUFK
8.>-2851$/1$0(@DGYDQFHRQOLQHSXEOLFDWLRQGD\PRQWK\HDUGRL
VM>-2851$/$&521<0@;;;;;

 $GDSWDWLRQVRIVLQJOHILJXUHVGRQRWUHTXLUH13*DSSURYDO+RZHYHUWKHDGDSWDWLRQ
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8.>-2851$/1$0(@UHIHUHQFHFLWDWLRQ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\HDURISXEOLFDWLRQ

 7UDQVODWLRQVRIZRUGVXSWRDZKROHDUWLFOHUHTXLUH13*DSSURYDO3OHDVHYLVLW
KWWSZZZPDFPLOODQPHGLFDOFRPPXQLFDWLRQVFRPIRUPRUHLQIRUPDWLRQ7UDQVODWLRQV
RIXSWRDZRUGVGRQRWUHTXLUH13*DSSURYDO7KHWUDQVODWLRQVKRXOGEHFUHGLWHG
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2008-097::2: 
 
Submitted by IACUC: 
Turner, Andrew M Protocol 
Number: 2008-097. 
Title: In Vitro and In Vivo Influence of Substratum Topography and 
Chemistry on 
Osteoblast, Osteoclast, and Fibroblast Physiology<br><br> 
 
A YEARLY RENEWAL to Animal Use Protocol 2008-097 has been 
approved. 
 
 
 
1.  This number must be indicated when ordering animals for this 
project. 
2.  Animals for other projects may not be ordered under this number. 
3.  If no number appears please contact this office when grant 
approval is received. If the application for funding is not successful 
and you wish to proceed with the project, request that an internal 
scientific peer review be performed by the Animal Use Subcommittee 
office. 
4.  Purchases of animals other than through this system must be 
cleared through the ACVS office.  Health certificates will be required. 
 
 
 
REQUIREMENTS/COMMENTS 
Please ensure that individual(s) performing procedures on live animals, 
as described in this protocol, are familiar with the contents of this 
document. 
The holder of this Animal Use Protocol is responsible to ensure that all 
associated safety components (biosafety, radiation safety, general 
laboratory safety) comply with institutional safety standards and have 
received all necessary approvals. Please consult directly with your 
institutional safety officers. 
 
 
 
Regards, 
Animal Use Subcommittee 
 
 
 
The University of Western Ontario 
Animal Use Subcommittee / University Council on Animal Care 
Health Sciences Centre, London, Ontario CANADA - N6A 5C1 
http://www.uwo.ca/animal/website/AU
S/index.htm 
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  Of	  Osteoclasts	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  Bone	  Resorption//	   Ion	  Transport	  
And	  Signalling	  In	  
Skeletal	  Cells:	  P2	  Nucleotide	  Receptor	  Function	  In	  Bone	  
 
 
Approval	  Date:	  08/08/2012	  
Official	  Notice	  of	  Animal	  Use	  Subcommittee	   (AUS)	  Approval:	  Your	  new	  Animal	  Use	  Protocol	  (AUP)	  entitled	  
"Role	  Of	  
Cytosolic	  Calcium	  In	  The	  Regulation	  Of	  Osteoclasts	  And	  Bone	  Resorption//	   Ion	  Transport	  And	  Signalling	  In	  
Skeletal	  Cells:	  P2	  
Nucleotide	  Receptor	  Function	  In	  Bone	  
 
"	  has	  been	  APPROVED	  by	  the	  Animal	  Use	  Subcommittee	  of	  the	  University	  Council	  on	  Animal	  Care.	  This	  
approval,	  although	  valid	  for	  four	  years,	  and	  is	  subject	  to	  annual	  Protocol	  Renewal.2008-­‐-­‐-­‐043-­‐-­‐-­‐06::5	  
 
1.	  	  This	  AUP	  number	  must	  be	  indicated	  when	  ordering	  animals	  for	  this	  project.	  
2.	  	  Animals	  for	  other	  projects	  may	  not	  be	  ordered	  under	  this	  AUP	  number.	  
3.	  	  Purchases	  of	  animals	  other	  than	  through	  this	  system	  must	  be	  cleared	  through	  the	  ACVS	  office.	  
Health	  certificates	  will	  be	  required.	  
 
The	  holder	  of	  this	  Animal	  Use	  Protocol	   is	  responsible	   to	  ensure	  that	  all	  associated	  safety	  components	  
(biosafety,	  radiation	  safety,	  general	  laboratory	  safety)	  comply	  with	  institutional	   safety	  standards	  and	  
have	  received	  all	  necessary	  approvals.	  Please	  consult	  directly	  with	  your	  institutional	   safety	  officers.	  
Submitted	  by:	  Copeman,	  Laura	  
on	  behalf	  of	  the	  Animal	  Use	  Subcommittee	  
University	  Council	  on	  Animal	  Care	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